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As pesticide use rises in the US annually, the need for extensive characterization of the 
risks associated with these substances also increases.  Herbicides represent the most 
frequently used type of pesticides.  3,4-dichloropropionanilide (propanil) and 2,4-
dicholorophenoxyacetic acid (2,4-D) are two of the most commonly used herbicides.  
These experiments evaluated the effects of propanil and 2,4-D on the humoral immune 
response in C57BL/6 mice following heat-killed Streptococcus pneumoniae (HKSP) 
immunization.  Intraperitoneal exposure of 150 mg/kg propanil on the same day as HKSP 
immunization enhances the splenic T-independent type 2 antibody response to 
phosphorylcholine (PC) antigen 4-6-fold.  Maximal PC enhancement occurs 7 days post-
exposure.  Propanil exposure 9 days following HKSP immunization enhances the T-
dependent antibody response to the pneumococcal surface protein A (PspA).  2,4-D 
exposure decreases the PC-specific antibody response in the bone marrow and the 
antibody serum titers 10 days post-exposure.  Mixture exposure to the herbicides did not 
produce any synergistic effects.  In addition, aspiration of the mixture of herbicides did 
not affect the antibody response.  Ovariectomy and inhibition of ovarian steroid synthesis 
abrogates the PC-specific antibody enhancement in propanil-treated mice.  Several 
studies examined the direct and indirect estrogenic activity of propanil.  Interestingly, 
propanil enhances the PC-specific splenic antibody response independent of an estrogenic 
mechanism.  Although male mice also had enhanced antibody responses following 
propanil exposure, orchiectomy did not affect the enhancement.  Finally, propanil 
exposure did not enhance survival following a suboptimal immunization to a virulent 
strain of S. pneumoniae.  Altogether, these results provide a number of findings that 
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CHAPTER 1: GENERAL INTRODUCTION 
PROPANIL 
Background and General Toxicity 
The pesticide 3,4-dichloropropionanilide (propanil) is an herbicide that is 
predominantly used for the control of weeds on commercial rice crops.  Numerous 
studies have investigated the toxicological potential of propanil.  It has been established 
in the literature that propanil has a number of immunotoxic effects.  This report will 
provide a brief background of the general toxic effects of propanil exposure and primarily 
focus on the immunotoxicity studies that have been performed in both in vivo and in vitro 
models.  In addition, epidemiological reports examining the immunotoxic effects of 
propanil on professional applicators and people living in areas of propanil use will be 
summarized.   
 Propanil is in the acetanilide chemical family (U.S. EPA OFFICE OF 
PESTICIDE PROGRAMS, 2003).  Approximately 99% of the propanil used in the 
United States is for the control of weeds on rice crops (U.S. EPA OFFICE OF 
PESTICIDE PROGRAMS, 2003).  Roughly 50-70% of all rice grown in the U.S. is 
treated with propanil (U.S. EPA OFFICE OF PESTICIDE PROGRAMS, 2003).  A 2001 
estimate by the Environmental Protection Agency (EPA) ranks propanil as the 17th most 
used pesticide in the U.S.  The range of propanil app ication extends throughout the lower 
southern states along the Mississippi River and in some areas of California.  Propanil is 
restricted exclusively to commercial use and it is readily degraded in the soil and water.  
The half-life in the soil is 1-3 days and 2-3 days in the water (Wauchope et al., 1992).  
Given the lack of residential use of propanil and the short half-life, exposure of the 
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chemical is primarily restricted to applicators and residents who live near the treated 
farms.  The preferred method of application is via groundboom sprayers and aerial 
methods (U.S. EPA OFFICE OF PESTICIDE PROGRAMS, 2003).   
 The most common routes of propanil exposure include inhalational, dermal, 
orbital, and to a lesser extent, oral.  Upon entry i to the organism, propanil is rapidly 
metabolized in the liver by the enzyme acylamidase into the major metabolite 3,4-
dichloroaniline (DCA) (Williams et al., 1966).  Other metabolites of propanil include 2’-
hydroxypropanil and 6’-hydroxypropanil (McMillan et al., 1990a).  DCA is subsequently 
metabolized to 6-hydroxy-3, 4-dichloroaniline and N-hydroxy-3, 4-dichloroaniline.  Due 
to the rapid metabolism of the parent compound, propanil remains at detectable 
concentrations in the blood of rats for approximately 48 hours following exposure 
(Izmerov, 1984).   
 Following exposure to propanil, a number of toxic side effects are induced 
including hemolytic anemia, methemoglobinemia, and myelotoxicity.  In vivo studies in 
Sprague-Dawley rats have shown that inhibition of the acylamidase activity with 
triorthotolyl phosphate decreased the amount of methemoglobinemia formed following a 
400 mg/kg intraperitoneal (i.p.) exposure to propanil (Singleton et al., 1973).  In addition, 
i.p. injections of the metabolite N-hydroxy-3, 4-dichloroaniline into rats was found to 
induce the same amount of hemolytic anemia as the parent compound (McMillan et al., 
1991).  In vitro studies analyzing the ability of propanil metabolites to oxidize 
hemoglobin in erythrocyte suspensions confirmed that N-hydroxy-3, 4-dichloroaniline 
was the most potent oxidizing metabolite (McMillan et al., 1990a).  Altogether, theses 
studies indicate that metabolism of the parent compound is necessary for anemia.  
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 Duration of the anemic effects differ according to the exposure concentration of 
propanil (McMillan et al., 1990b).  Analysis of blood samples from acutely exposed 
Sprague-Dawley rats treated with 300 mg/kg of propanil showed that 
methemoglobinemia effects peak at 4.5 hours post-exposure and these effects can be 
detected for as long as 24 hours (McMillan et al., 1990b).  However, 100 mg/kg of 
propanil induced a peak in methemoglobin levels at 1.5 hours and could be detected for 
12 hours (McMillan et al., 1990b).  These data indicate that the anemic effets induced 
by propanil are brief and these effects do not persist following the clearance of propanil 
from the blood.   
More recently, myelotoxic effects have also been establi hed following propanil 
exposure (Malerba et al., 2002; Blyler et al., 1994).  Ex vivo colony-forming assays from 
the bone marrow of acutely exposed C57Bl/6 mice demonstrated that the early stem cell 
progenitors, myeloid stem cells (CFU-S) and erythroid burst-forming units (BFU-E), are 
decreased in number following 200 mg/kg propanil exposure (Blyler et al., 1994).  
However, the more differentiated cell types such as erythroid colony-forming units 
(CFU-E), granulocyte/macrophage progenitor cells (GM-CFU), macrophages (CFU-M), 
and neutrophils (CFU-G) are not reduced in number following propanil treatment (Blyler 
et al., 1994).  Similar effects on the early erythroid stem cells are seen with human cord 
progenitor cells following propanil treatment (Malerba et al., 2002).  In vitro exposure to 
cord blood demonstrated that the CFU-E and BFU-E progenitors had 50% of their growth 
inhibited  (IC50) by 234 and 441 µM of propanil, respectively (Malerba et al., 2002).  The 
more differentiated CFU-GM progenitors had an IC50 of greater than 500 µM, indicating 
similar susceptibility to the effects of propanil on the more immature progenitors in both 
 4 
humans and mice (Malerba et al., 2002).  However, unlike mice, DCA is far less toxic to 
human CFU/BFU-E progenitors than its parent compound (Malerba et al., 2002).   
 Initial chronic and acute exposure studies found that secondary immune organs 
are also affected after exposure to propanil (Barnett et al., 1989; Ambrose et al., 1972).  
Female and male rats exposed for 2 years to 400 ppm of ropanil mixed in their feed 
have increased spleen weights, but the heart, kidney, liv r and testes weights are 
unaffected (Ambrose t al., 1972).  In a subchronic study, female and male rats t eated 
for 3 months with 1000 and 3300 ppm of propanil, respectively, did not have altered 
organ weights except increased spleen sizes (Ambrose et al., 1972).  Additionally, 
acutely exposed C57Bl/6 mice treated i.p. with 200 mg/kg of propanil had decreased 
thymus weights and increased spleen weights (Barnett a d Gandy, 1989).  These studies 
suggest that propanil may be more toxic to secondary immune organs than other 
nonimmune organs.  The relevance of these immunotoxic effects will be discussed in 
more detail in later sections.   
Other studies using common toxic endpoints such as mutagenicity, reproductive 
toxicity, and carcinogenicity have yielded negative results.  Propanil has not been found 
to be mutagenic as determined in Salmonella reversion assays (McMillan et al., 1988).  
The EPA has determined that propanil is not a carcinogen in humans (U.S. EPA OFFICE 
OF PESTICIDE PROGRAMS, 2003).  Reproductive studies in rats have shown that 
chronic oral propanil exposure does not cause any ab ormalities in the fertility of the 
parents nor does it affect the health of the offspring (Ambrose et al., 1972).  Propanil is 
classified in the “slightly toxic” toxicity class III for oral exposures and toxicity class IV 
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for inhalation and dermal exposures (U.S. EPA OFFICE OF PESTICIDE PROGRAMS, 
2003).   
Assessment of the effects of propanil on humans demonstrates that the greatest 
risk of toxic exposure is most hazardous with applicators and manufacturing workers.  
Examination of immune changes in farm-families exposed to propanil observed decreases 
in IL-2+ cells and natural killer (NK) cell counts (McClure et al., 2001).  However, these 
lower counts were associated with the preseason measurements and the cell counts 
rebounded during the spray season (McClure et al., 2001).  This could be due to the low 
particulate concentration of propanil in family homes lying adjacent to the spray fields 
(Richards et al., 2001).  Non-applicator personnel working in adjacent propanil-treated 
fields were also exposed to very low concentrations of propanil (Barnes et al., 1987).  
These personnel were exposed to concentrations that were several orders of magnitude 
lower than the concentrations shown to be toxic (Barnes et al., 1987).  However, 61% of 
production workers exposed to propanil had chloracne indicating the higher risk of 
toxicity (Morse et al., 1979). 
Innate immune studies 
 The innate immune system is responsible for not only rapidly eliminating 
pathogens, but also initiating adaptive immune respon es.  Immunotoxic effects on cells 
of this system may also compromise the ability of an organism to control initial infections 
until an adaptive immune response can be generated.  Two important effector cells of the 
innate immune system are macrophages and NK cells.   
 Propanil has been demonstrated to inhibit macrophage function.  LPS-stimulated 
peritoneal macrophages harvested from mice 7 days following i.p. propanil exposure 
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(200 mg/kg) have reduced production of IL-6 (32% of c ntrol) and TNF-α (55 % of 
control) (Xie et al., 1997b).  In addition, oral exposure to propanil (400 mg/kg) also 
reduced the production of IL-6 (40% of control) (Xie et al., 1997b).  However, 
macrophage TNF-α production is more sensitive to the effects of an oral exposure to 
propanil.  Forty mg/kg of propanil reduced the leves of TNF-α approximately the same 
amount as an i.p. exposure of 200 mg/kg of propanil (Xie et al., 1997b).  This data 
suggests that different routes of exposure can affect th  extent of immunotoxicity on 
macrophages.  However, the sensitivity of macrophages to the effects of propanil varies 
depending on the endpoint studied and the route of exposure.   
 Both Ca2+ release and NF-κB regulate the production of IL-6 and TNF-α in 
macrophages.  Ca2+, in combination with diacylgylcerol (DAG), stimulates protein kinase 
C (PKC).  At the cytoplasmic membrane, PKC enhances th  phosphorylation of some 
transcription factors for cytokine transcription, such as NF-κB.  Macrophages treated in 
vitro with propanil have a significant reduction in intracellular Ca2+ release (Xie et al., 
1997a).  In addition, NF-κB p65 subunit is decreased in the nucleus of propanil-treated 
macrophages (Frost e al., 2001).  The binding of NF-κB to the TNF-α promoter is 
reduced in propanil-treated cells after 18 hours of in vitro exposure (Frost et al., 2001).  
These data suggest the mechanism regulating the reduction in inflammatory cytokine 
production in propanil-treated macrophages is an effect on NF-κB and Ca2+.   
 NK cell function is also inhibited following propanil exposure.  Mice treated i.p. 
with propanil and DCA have reduced NK cell cytotoxicity.  NK cells harvested from the 
spleens of mice treated i.p. with 50 mg/kg of propanil have an approximate 20% 
reduction in their ability to lyse a target cell (Barnett et al., 1992).  The metabolite, DCA, 
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also inhibits the cytolytic ability of NK cells simlar to the parent compound (Barnett t 
al., 1992).  The data suggests that propanil may reduce the capacity of cells of the innate 
immune system to fight new infections.   
T cell toxicity 
One of the first studied immunotoxic effects induced by propanil was observed on 
T cells (Barnett and Gandy, 1989).  T cells are essntial in facilitating a potent adaptive 
immune response.  Briefly, CD4+ T cells are responsible for activating and coordinating 
the humoral immune response as well as cell-mediated mmune responses.  CD8+ T cells 
function primarily in executing cell-mediated immune responses.  The thymus is the 
organ responsible for T cell development and maturation.   
As mentioned previously, propanil induces thymic atrophy.  Thymic atrophy is 
seen in acutely exposed mice approximately 2-4 dayspost-exposure (Cuff et al., 1996).  
Thymic weight is reduced in these mice for up to 7 days following an i.p. dose of 200 
mg/kg of propanil (Barnett and Gandy, 1989).  By da7, the thymus has begun to 
recover from the initial atrophy (Cuff et al., 1996).  After 14 days post-exposure, the 
thymus has fully recovered from the original insult (Cuff et al., 1996). Analysis of the 
circulating T cell populations in the mesenteric lymph nodes and the spleen 7 days post-
exposure shows that mature T cell numbers are unaffected as a result of the thymic 
atrophy (Zhao et al., 1995).  Failure to detect decreases in the mature T cell populations 
of immune organs may indicate that thymic atrophy is an endpoint to determine the 
extent of propanil exposure rather than a direct measure of damage to immune function.  
The decrease in thymic weight is accompanied by a loss in total thymic 
cellularity, as well as an overall decline in the number of T cells in the various 
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developmental stages of maturation (Zhao et al., 1995).  Exposure doses as low as 100 
mg/kg decrease the number of all the CD3+ and CD3- subpopulations (Zhao et al., 1995).  
Mice treated i.p. with 200 mg/kg propanil have the largest decrease in the percentage of 
CD3+CD4+CD8+ (DP) thymocytes 4 days post-exposure (Cuff et al., 1996).  This data 
indicates that the DP cells are the most sensitive of the thymocyte populations (Cuff et
al., 1996).  The decrease observed in the immature population results in a downstream 
effect of decreasing the number of the more mature CD4+ single positive (SP) and CD8+ 
SP cells (Zhao et al., 1995; Cuff et al., 1996).   
The primary mechanism by which propanil induces thymic atrophy is a result of 
increased levels of glucocorticoids (Cuff et al., 1996; de la Rosa et al., 2005).  Acute i.p. 
propanil exposure with doses of 50 mg/kg in C57Bl/6 mice increases the levels of 
corticosterone in the serum to approximately 1000 ng/ml compared to approximately 60 
ng/ml for control mice (de la Rosa et al., 2005).  The increase in corticosterone serum 
levels peaks within one hour following propanil exposure and returns to baseline levels 
within 24 hours (de la Rosa et al., 2005).  Inhibition of the glucocorticoid receptors (GR) 
with the GR antagonist RU486 or removal of the adrenal glands, the primary site for 
glucocorticoid production, abrogates the thymic atrophy induced by propanil (Cuff et al., 
1996; de la Rosa et al., 2005).  In response to the sudden loss in the thymoc te 
populations, the recovery of the thymocyte population is generated by an increase in the 
percentage of cycling DP and CD8+ SP cells 4 days post-exposure (Cuff et al., 1996).  
However, the percentage of cycling thymocyte subpopulations returns to normal by day 
7, indicating that recovery is initiated rapidly after exposure (Cuff et al., 1996). 
 9 
The extent of thymic atrophy induced by propanil can also be increased when 
combined with other herbicides (de la Rosa et l., 2005).  The herbicide 2,4-
dichlorophenoxyacetic acid (2,4-D) does not decrease the number of DP or CD4+ SP cells 
following a 150 mg/kg i.p. exposure (de la Rosa et l., 2005).  However, the addition of 
150 mg/kg of 2,4-D combined with a 150 mg/kg dose of pr panil can induce a greater-
than-additive decrease in the number of both the DP and CD4+ SP cell populations (de la 
Rosa et al., 2005).  This data demonstrates the potential for other chemicals to enhance 
the toxicity of propanil (de la Rosa et al., 2005).   
Analysis of T cell function after in vivo exposure to propanil has indicated that T 
cells are relatively resistant to the toxic effects of propanil.  As mentioned previously, 
propanil exposure causes splenomegaly (Barnett and G y et al., 1989; Ambrose et al., 
1972).  The spleen is also an important secondary lymphoid organ.  Therefore, the spleen 
was chosen for early immunotoxic characterization studies.  Mixed lymphocyte reactions 
(MLR) are typically used to characterize CD4+ function.  MLR of spleen cells from mice 
treated with an acute i.p. dose of propanil 1 week prior to harvest demonstrated that only 
at the highest doses tested of 400 mg/kg was there a significant decrease in the MLR 
(Barnett and Gandy, 1989).  In vivo cell mediated immune responses were assessed using 
the contact hypersensitivity reaction (CHR) (Barnett and Gandy, 1989).  The CHR was 
also decreased in animals treated with only the highest tested dose of 400 mg/kg (Barnett 
and Gandy, 1989).  Finally, proliferation of splenocytes from mice treated in vivo with 
propanil was determined following ex vivo stimulation with the T cell mitogen, 
Concanavalin A (ConA).  Again, only animals treated with the highest tested dose had 
significant reductions in proliferation (Barnett and Gandy, 1989).  However, ConA 
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stimulated splenocytes from animals treated i.p. with 200 mg/kg of propanil had a 
significant reduction in IL-2 production (27% of control) and IL-6 production (45% of 
control) (Zhao et al., 1998).  Altogether, the studies characterizing the T cell toxicity of 
propanil indicate that several endpoints are requird to establish an accurate inference of 
propanil’s toxicity. 
Mechanistic studies on the regulation of IL-2 in T cells demonstrated that in vitro 
propanil treatment decreases IL-2 transcription rate as well as IL-2 message stability 
(Zhao et al., 1999).  DNA binding of the IL-2 transcription factor, AP-1, is also reduced 
for up to 4 hours post-exposure in propanil-treated c lls (Brundage t al., 2004).  In 
addition, propanil reduces the phosphorylation and the total protein levels of the subunit 
of AP-1, c-jun (Brundage t al., 2004).  These data suggest that propanil decreases the T-
cell production of IL-2 by suppressing the activity of one of the subunits of a key 
transcription factor, however, the molecular mechanism by which propanil reduces 
phosphorylation is unknown. 
B cell toxicity and the humoral response 
As mentioned previously, propanil was found to be my lotoxic and induce 
splenomegaly.  The bone marrow microenvironment is the site of B cell maturation prior 
to release into circulation.  The spleen is an important site for early and late antibody 
production to bacterial pathogens (Martin et al., 2001; Zandvoort et al., 2002; Manz et 
al., 2002).  Approximately 40% of the lymphocytes in the spleen are B lymphocytes 
(Salazar et al., 2005).  Altogether, these organs represent two important sites for 
evaluating the immunotoxic effects of propanil on B cells.   
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Propanil exposure decreases the number of developing B cells in the bone marrow 
available for maturation.  B cell maturation proceeds from the pro-B cell to pre-B cell and 
finally to the immature IgM+ B cell (Rosenberg et al., 1994).  In vivo i.p. propanil 
exposure at the lowest studied dose of 50 mg/kg decreased the number of murine pre-B 
cells in the bone marrow (~50% of control) 7 days po t-exposure (de la Rosa et al., 
2003).  Immature IgM+ B cells are also decreased in number (~50% of control) at doses 
of 150 mg/kg (de la Rosa et al., 2003).  However, this decrease in immature B cells does 
not result in a loss of circulating B cells as determined by an analysis of splenocyte 
populations (Salazar et al., 2005).  Total splenic B cell numbers, as well as the circulating 
follicular B cell population, remain unchanged following propanil exposure (Salazar et 
al., 2005).   
Although propanil exposure does not effect the number of B cells in the 
periphery, it can suppress B cell function.  Exposure to 400 mg/kg of propanil suppresses 
splenic B cell proliferation after ex vivo stimulation with the B cell mitogen 
lipopolysaccharide (LPS) (Barnett and Gandy, 1989).  Analysis of the antibody response 
to both T-independent type 2 (TI-2) and T-dependent (TD) model antigens found that 
these responses are more sensitive to propanil’s toxic effects than B cell proliferation 
(Barnett and Gandy, 1989; Barnett t al., 1992).  Exposure to propanil on day 0 followed 
by immunization with sheep red blood cells (SRBC) on day 4 decreased the number of 
SRBC plaque forming cells (PFC) in a dose dependent fashion (Barnett and Gandy, 
1989).  Fifty mg/kg of propanil was the lowest dose to significantly reduce the number of 
SRBC PFC (67.5% of control) (Barnett and Gandy, 1989).  Higher doses of propanil and 
DCA, 200 mg/kg and 150 mg/kg, respectively, were found to decrease the number of 
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PFC in animals immunized with DNP-Ficoll 4 days following propanil exposure (75% of 
control) (Barnett et al., 1992).  Altogether, these reports suggest that propanil exerts 
immunotoxic effects either directly on B cells or their supporting microenvironment 
critical for their normal function.  
Adaptive immune response to bacterial challenges 
In general, the collective in vivo studies on immune function indicate that propanil 
has suppressive effects on the immune system.  Challenging the immune system with live 
bacteria provides important information toward understanding the relevance of altered 
immune function on individual lymphocyte populations.  Live bacterial challenge studies 
provide information demonstrating the effect of decreased immune cell function on 
clearing infections caused by common pathogens.  These studies are important for 
predicting risk of infection that is associated with a specific level of immunotoxicity. 
The toxic effects of propanil on the cell-mediated immune response were studied 
using a Listeria monocytogenes infection model in C57BL/6 mice (Watson et al., 2000).  
L. monocytogenes is an intracellular pathogen that requires an effectiv  cell-mediated 
immune response to clear the infection.  Animals were exposed to propanil and 
challenged with live L. monocytogenes.  Ex vivo Con A and heat-killed L. monocytogenes 
(HKLM) stimulated splenocyte and liver cultures from the propanil-treated and L.
monocytogenes challenged animals had an approximate 50% reduction in IFN-γ 
production (Watson et al., 2000).  However, analysis of spleen and liver endogenous 
cytokine levels from propanil-treated and L. monocytogenes infected animals showed no 
significant differences in IL-6, IFN-γ, TNF-α, and IL-1β when compared to L. 
monocytogenes-infected control animals (Watson et al., 2000).  Additionally, animals 
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treated with 200 mg/kg of propanil and a LD50 of L. monocytogenes did not demonstrate 
any greater susceptibility to infection than control animals (Watson et al., 2000).  This 
indicates that a 200 mg/kg exposure to propanil produces immunotoxic effects on cell-
mediated immunocytes measured in vitro, but does not significantly affect the host’s 
ability to mount an effective immune response.  A limitation of this study is that L. 
monocytogenes infections can be initially controlled in mice lacking an adequate 
cytotoxic T cell response (Bancroft et al., 1991).  However, there have been no studies 
reported to date characterizing the effect of an acute propanil exposure on the immune 
response to a pathogen that predominantly requires a competent cytotoxic T cell response 




 2,4-D is a chlorinated phenoxy herbicide used for the control of broadleaf weeds 
throughout the year in both the public and private sector.  2,4-D is the most used pesticide 
ingredient in the home and garden sector in the United States and is the fifth most used 
active ingredient in the agricultural sector.  2,4-D is predominantly used in the Midwest, 
Great Plains, and the Northwest (U.S. EPA OFFICE OF PESTICIDE PROGRAMS, 
2005).    
2,4-D is readily metabolized in both the soil and the water.  The half-life of 2,4-D 
in the water under aerobic and anaerobic conditions is 15 and 312 days, respectively.  
The half-life in the soil is approximately 59 days.  Aerobic microbial metabolism is the 
major mechanism by which 2,4-D is degraded in both the water and soil.  The major 
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metabolite of aerobic aquatic degradation is 2-chlorohydroquinone.  Minor metabolites 
from aerobic microbial degradation include 2,4-dichlorophenol (2,4-DCP) and carbon 
dioxide.  Conversely, anaerobic aquatic degradation results in the predominant formation 
of 2,4-DCP and carbon dioxide.  The major metabolite f microbial degradation of 2,4-D 
in the soil yields 2,4-DCP (Veeh et al., 1996).   
The most common routes of exposure for 2,4-D include dermal and oral exposure, 
and to a lesser extent, inhalation (Garabrant et al., 2002). Despite the rapid degradation of 
2,4-D in the environment, exposure to humans is widespread.  An analysis of 1000 
randomly selected adults residing in the U.S. found that 12% had measurable levels of 
2,4-D in the urine and 64% had detectable concentrations of the metabolite 2,4-DCP (Hill 
et al., 1995).  The median and maximum concentration of 2,4-D in the urine was 1.8 
µg/liter and 37 µg/liter, respectively (Hill et al., 1995).  Following oral exposure in 
Fischer 344 rats, 2,4-D concentrations peak within the blood in 10-20 minutes (Pelletier 
et al., 1989).  Dermal exposures in rats demonstrates that 2,4-D is rapidly absorbed 
similarly to oral exposure and peaks 30 minutes post-exposure (Pelletier et al., 1989).  
Upon entry into humans, 2,4-D is not metabolized (Knopp et al., 1992).  2,4-D is widely 
distributed throughout the body due to its water solubility and does not accumulate to any 
specific organ (Pelletier et al., 1989).  The half-life of 2,4-D in the urine is approximately 
17 hours and 11 hours in the plasma (Sauerhoff et al., 1977).  Due to the rapid clearance, 
inability to be metabolized, or locate to a particular tissue, 2,4-D is not believed to 
accumulate in repeatedly exposed humans (Garabrant and Philbert, 2002).   
General toxicity 
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The toxicity of 2,4-D has been extensively studied.  Numerous reports have 
evaluated the potential of 2,4-D to cause reproductive, carcinogenic, neurological, 
endocrinological and immunotoxic effects.  The acceptable daily intake for 2,4-D as 
established by the World Health Organization (WHO) is .013 mg/kg/day (Zeljezic et al., 
2004).  The conclusions from these studies have suggested that 2,4-D has very little 
overall toxicity (Munro et al., 2002). 
A number of genotoxic assays performed in a fibroblastic cell line found that 2,4-
D does not increase the amount of DNA repair (Jacobi et al., 1991; Clausen et al., 1990; 
Galloway et al., 1987).  However, lymphocytes from human donors were exposed to a 
commercial formulation of 2,4-D in vitro and demonstrated that chromosomal aberrations 
were increased at concentrations that have been established by the WHO to lack any 
associated health risks (Zeljezic and Garaj-Vrhovac, 2004).  The duration and 
concentration of lymphocyte exposure to 2,4-D has not been determined, thereby 
preventing an accurate assessment of genotoxic risks for lymphocytes (Zeljezic and 
Garaj-Vrhovac, 2004).  Lymphocytes from humans exposed to 2,4-D in an occupational 
setting were analyzed for sister chromatid exchange (SCE) frequency and found no 
significant changes in SCE frequency in 2,4-D workers (Linnainmaa, 1983). Altogether, 
the literature supports the hypothesis that 2,4-D does not increase the risk for developing 
cancer (Munro et al., 2002). 
Adverse neurotoxic effects such as myotonia, characte ized by difficulty relaxing 
skeletal muscles, can be observed in animals treated wi h high doses of 2,4-D (50-500 
mg/kg) (Elo et al., 1989).  Locomotor effects have also been observed in rats at doses as 
low as 15 mg/kg/day, but these effects were transient (Mattsson et al., 1997).  Other 
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potentially lasting effects such as demyelination in the CNS have not been observed in 
animals (Garabrant and Philbert, 2002).  Since the concentration of 2,4-D required to 
induce neurotoxic effects also causes systemic toxii y, 2,4-D is considered to be mildly 
toxic to the nervous system (Garabrant and Philbert, 2002). 
Reproductive toxicity following 2,4-D exposure has been assessed in a number of 
animal studies.  Maternal rats and rabbits exposed to doses in excess of 90 mg/kg/day had 
litters with reduced fetal weights and increased fetal variations (Charles et al., 2001).  
Male mice and rats exposed chronically to 2,4-D did not produce any changes in the 
testes and did not affect reproductivity (Charles et al., 2001; Charles et al., 1996).  There 
have been no published studies demonstrating that 2,4-D exposure induces reproductive 
or teratogenic effects in humans (Garabrant and Philbert, 2002; Munro et al., 2002).   
The ability of 2,4-D to disrupt the endocrine system is of recent interest and less 
studied compared with more common toxicological endpoints.  The ability of 2,4-D to 
bind to the estrogen receptor was studied using an in vitro model in MCF-7 breast cancer 
cells (Lin and Garry, 2000).  2,4-D was found to induce estrogen receptor mediated 
growth at concentrations of 1 µg/ml (Lin and Garry, 2000).  This concentration was 
roughly 500-fold less efficacious than E2 and is not considered to be estrogenic (Lin and 
Garry, 2000).  Another approach analyzing the enzymes responsible for metabolizing E2 
found that rats exposed to 375 mg/kg of 2,4-D had elevated amounts of CYP1A and 
CYP1B in the liver, kidney, and the mammary gland (Badawi et al., 2000).  These 
increased enzyme levels corresponded to a marked increase in estradiol and estrone 
(Badawi et al., 2000).  However, further dose response studies are needed to 
appropriately quantify the sensitivity for this effect.  Finally, a preliminary study in 
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amphibians found that 2,4-D inhibited progesterone-dependent oocyte maturation, as well 
as, disrupt the actin cytoskeleton of oocytes (Lin and Garry, 2000).  Additional studies 
are required to determine if 2,4-D is able to affect the progesterone pathway in mammals. 
Immunotoxicity 
Immunotoxic studies have suggested that 2,4-D has modest toxicity.  Exposure to 
2,4-D in CD-1 mice via a dermal administration and  ip immunization of sheep red 
blood cells (SRBC) on the following day decreased the number of SRBC-specific plaque 
forming cells (PFC) on day 5 post-immunization (Blakley et al., 1986).  The decrease in 
SRBC-specific PFC was dose dependent (Blakley and Schiefer, 1986).  The lowest 
measured dose of 2,4-D to decrease SRBC-specific PFC was 100 mg/kg, which 
decreased the PFC 10% from controls (Blakley and Schiefer, 1986).  In addition, acute 
dermal exposure did not affect the ex vivo proliferative responses of splenocytes to either 
the T cell mitogen, ConA, or the B cell mitogen, LPS (Blakley and Schiefer, 1986).  
Conversely, an acute oral exposure of 2,4-D in BDF1 mice via gastric intubation and 
followed by an ip vaccination to SRBC on the next day, demonstrated that the number of 
SRBC-specific PFC was increased when measured on the fifth day of immunization 
(Blakley, 1986).  The effect on PFC was not dose dependent and increased the number of 
SRBC PFC 1.5 to 2.4-fold following exposures of 50 to 200 mg/kg (Blakley, 1986).  
Animals treated with 2,4-D had normal proliferative responses in splenic T cells 
following ConA stimulation (Blakley, 1986).  This suggests that the variation in SRBC 
PFC responses after oral or dermal exposure to 2,4-D is not likely due to changes in T 
cell function (Blakley, 1986).  A proposed hypothesis for enhancement versus 
suppression of the antibody response in 2,4-D exposed animals is that 2,4-D acts as a 
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hapten when given orally (Blakley, 1986).  However, this hypothesis has not been 
experimentally tested.  
Since 2,4-D is widely used for many different commercial and private 
applications, it is often applied in mixtures.  Examining the effect of mixture interactions 
on the immune response is a more relevant method for evaluating immunotoxicity of 2,4-
D.  Initial studies demonstrate that mixture exposure with 2,4-D can enhance the 
immunotoxic effect of a single 2,4-D exposure. 
A common commercial mixture of 2,4-D is Tordon 202C, which contains a 1:16 
ratio of the herbicide picloram and 2,4-D (Blakley, 1997).   The lowest tested dose of 2.5 
mg picloram/kg/day and 50 mg 2,4-D/kg/day decreased th  antibody response to SRBC 
33% after 26 days of daily oral exposure (Blakley, 1997).  An analysis of the effects of a 
single picloram or 2,4-D exposure was not performed, thereby preventing an 
interpretation of the mixture interaction.  Another commonly occurring herbicide mixture 
includes propanil and 2,4-D.  An acute ip exposure to 2,4-D did not affect pre-B or 
immature IgM+ B cells 2 days post-exposure (de la Rosa et al., 2003).  However, a 50 
mg/kg mixture decreased both the pre-B and IgM+ B cells.  When the propanil and 2,4-D 
mixture effect was analyzed on thymocytes, 200 mg/kg of 2,4-D decreased the number of 
CD4+CD8+ and CD4-CD8+.  However, a 150/150 mixture decreased these thymoc te 
populations the same magnitude as a single 200 mg/kg exposure of 2,4-D.  These 
findings suggest that the immunotoxic effects of 2,4-D may be enhanced when combined 
with other active herbicide ingredients.   
There is little direct evidence that 2,4-D exposure aff cts human immune 
function.  A published study on 10 farmers who used 2,4-D on their crops suggests that 
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there may be a risk for short-term immunosuppression (Faustini et al., 1996).  Blood 
samples were analyzed 7 days pre-exposure, 1-12 days post-exposure, and 50-70 days 
post exposure (Faustini et al., 1996).  CD4+, CD8+ T cells, and NK cells were all reduced 
1-12 days post exposure (Faustini et al., 1996).  In addition, proliferative responses to 
ConA were decreased 50% from pre-exposure samples (Faustini et al., 1996).  By 50-70 
days post exposure, the lymphocyte numbers and proliferation were normal.  This data 
indicates that occupational exposure to 2,4-D exerts immunotoxic effects seen in animal 
studies.  Given the widespread use of 2,4-D and its po ential to be immunotoxic in 
greater-than-additive fashion when combined with propanil, further studies evaluating 
mixture effects on adaptive immune responses is warranted.  
 
STREPTOCOCCUS PNEUMONIAE 
Streptococcus pneumoniae is a gram-positive coccus that kills approximately 1 
million children worldwide each year (Kruetzmann et al., 2003).  The antibody response 
to S. pneumoniae provides an excellent model for studying the humoral immune response 
to both TI-2 and TD antigens.  The immunodominant antigen that elicits the TI-2 
response is the cell wall polysaccharide phosphorylcholine (PC).  One of the surface 
proteins that elicits a strong TD antibody response is pneumococcal surface protein A 
(PspA).  Both of these antigens are important targets for vaccine development since 
robust antibody responses to these antigens are immunoprotective.  In addition, these 
antigens serve as virulence factors for the bacteria.  PC enables the bacterium to transport 
across endothelial and epithelial membranes (Cundell et al., 1995; Tuomanen et al., 
1995).  PspA inhibits the function of complement (Tu et al., 1999).   
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This section is divided into five parts concentrating on literature relevant to 
regulation of the TI-2 antibody response.  The first section will provide background 
information on the spleen, specific sites in the spl en involved in the response, and 
kinetics of the response.  The second section will define the B cell subpopulations 
responsible for producing TI-2 antibodies.  The third and fourth sections will describe 
mechanisms for enhancing or suppressing the TI-2 antibody response by the innate 
immune system and T cells.  The final section will br efly compare and contrast the PspA 
and PC response for the purpose of identifying possible mechanisms for later discussion. 
Site of humoral immune response 
The central location for PC-specific antibody production is the spleen.  The 
necessity of the spleen is made apparent in individuals with asplenia.  Splenectomized 
patients are afflicted with chronic respiratory infections primarily caused by S.
pneumoniae (Davidson and Wall, 2001).  In addition, splenectomized individuals do not 
respond well to capsular polysaccharide vaccines (Davidson and Wall, 2001).    
 The marginal zone (MZ) in the spleen is the site primarily responsible for the TI-2 
antibody responses (Guinamard et al., 2000).  The MZ of the spleen is defined as the 
compartment consisting of a broad band of cells surrounding the periarteriolar lymphoid 
sheath (PALS) containing T cells and the B cell folicles (Vos et al., 2000).  It has long 
been known that children under 2 years of age have poor responses to polysaccharide 
vaccines, which coincides with the maturation of MZB cells (Timens et al., 1989).  In 
addition, TI-2 antigens rapidly localize to the MZ within 15 minutes after an ip injection 
(Harms et al., 1996; van den Eertwegh et al., 1992).  Studies in Pyk-2 deficient mice, 
animals lacking a tyrosine kinase involved in growth factor receptor and chemokine 
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stimulation, showed that these mice do not develop MZ B cells (Guinamard et al., 2000).  
However, the B cell populations in the bone marrow, the B1 cells in the peritoneum, and 
the serum Ig levels were all identical to wild type mice (Guinamard et al., 2000).   
Subsequent immunization with TNP-Ficoll demonstrated that Pyk-/- mice had 
dramatically reduced TNP-specific IgG2a (30% of contr l), IgG3 (2% of control), and 
IgM (30% of control) serum titers (Guinamard et al., 2000).  These observations strongly 
support the hypothesis that MZ B cells are responsible for producing the TI-2 specific 
antibodies.  
As mentioned previously, TI-2 antigens are rapidly localized to the marginal 
zone.  TI-2 antigen ligation of the B cell receptor (BCR) triggers B cell migration to the 
outer T cell borders in the spleen within the first 24 hours (Garcia et al., 1999b).  By 48 
hours, the number of TI-2 antigen specific B cells increases in the T cell zones, in the red 
pulp, and along the red pulp: T zone junction (Vinuesa et al., 2001).  At 2-5 days, the 
antigen-specific B cells exponentially divide and differentiate into plasma cells primarily 
in extrafollicular foci in the red pulp of the spleen (Vinuesa et al., 2001).  B cell 
proliferation is the most rapid between days 3 and 5 (Vinuesa et al., 2001).  After day 7, 
the number of plasma cells decreases during the second week of the response.  After day 
14, the number of plasma cells remains static for at least 90 days (Garcia et al., 1999b). 
Responding B cell population 
TI-2 responses are distinguished by early isotype class switching that occur more 
rapidly than T-dependent responses to protein antige s (Wu et al., 1999).  Isotype 
switching is observed as early as 3-4 days following immunization with polysaccharides 
(Leemans et al., 1999).  Six days following heat-killed S. pneumoniae (HKSP) 
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immunization, the IgG isotypes reach maximal levels (Wu et al., 2002).  The 
predominant isotypes produced to PC following HKSP vaccination are IgG3 and IgG2b 
and to a lesser extent IgG1 and IgG2a (Wu et al., 1999).   
The composition of responding B cells to a TI-2 response are predominantly high 
affinity B cells.  Two days following antigen presentation, there are a 3-fold greater 
number of high affinity B cells entering cell cycle compared to low affinity B cells (Shih 
et al., 2002).  The three major idiotypes specific for PC that dominate the early humoral 
response are T15, M167 or M511, and M603 (Perlmutter e  al., 1984).  T15 antibodies 
have the highest affinity of the three idiotypes.  T15 is also the idiotype expressed by the 
majority of PC-specific antibody secreting cells (ASC) (Feeney et al., 1989; Martin et al., 
2001).  These idiotypes have also been shown to undergo very little somatic 
hypermutation and do not enter germinal centers (Feeney and Thuerauf, 1989; Wiens et 
al., 2003).  T15 plasmablasts found in both the spleen and peritoneal cavity largely 
express the B1 B cell phenotype 3 days post immunization (Martin et al., 2001).  The 
composition of MZ plasmablasts and B1 blasts is dependent on the route and dose of 
antigen administration (Martin et al., 2001).  A high dose of HKSP (Sharer et al., 2003) 
given iv generates a larger T15 antibody response than a high dose given ip (Martin et al., 
2001).  Low doses (Van Ravenzwaay et al., 2003) given iv produce a reduced antibody 
response that is comparable to the high ip response.  However, low ip doses initiate 
strong peritoneal B1 responses, which prevent sufficient amounts of antigen to reach the 
spleen thereby preventing a local splenic response (Martin et al., 2001).  It is currently 
unknown what the peritoneal B1 cells, splenic B1 cells, and MZ B cells contribute to the 
PC-specific serum titers.   
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Numerous studies reporting the importance of both MZ B cells and B1 cells in the 
TI-2 response have failed to reconcile the conflicting data demonstrating the 
contributions of these two B cell populations in TI-2 antibody responses.  A recent report 
performed in transgenic mice (PV1TgL) containing B cells that are specific only for a 
synthetic TI-2 like Ag (PVP-360) suggests that B-1a cells are derived from MZ B cells 
(Whitmore et al., 2004).  Naïve PV1TgL mice do not express B-1 B cells but contain 
splenic MZ B cells.  Three days and 5 days after immunization, antigen-specific B-1a 
cells begin to appear in the spleen and peritoneal cavity, respectively (Whitmore t al., 
2004).  By days 5 and 8, the B-1a populations are the predominant B cell populations in 
the spleen and peritoneum, respectively.  These data suggest that the MZ B cells may be 
the precursor population for B1a cells (Whitmore et al., 2004).  Altogether, these studies 
demonstrated that PC responses require both MZ B cells and B1 B cells for TI-2 antibody 
production. 
Role of Innate Immunity 
The MZ B cells are characterized by their high exprssion of the CD21/CD35 
molecules on their surface.  The CD21/CD35/CD19 core eptor complex is critical for 
recognizing and binding complement components on the B cell.  CD35, complement 
receptor 1 (CR1), binds the C3b and the C4b degradation components of the complement 
cascade (Vos et al., 2000).  CD21 (CR2) binds the complement component C3d.  CD19 
is a coactivator that is directly associated with CD21 and likely mediates the intracellular 
signaling of CD21 (Fearon et al., 2000).  The high expression of these complement 
binding receptors suggests that complement activation has an important role in TI-2 
responses. 
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Components of the complement cascade are hypothesized to be one of the earliest 
signals necessary for TI-2 recognition.  One of the rol s of complement receptors in TI-2 
responses is to lower the activation requirements necessary for antibody production.  
CD21/CD35 knockout mice vaccinated with 105 CFU HKSP and challenged with 5000 
CFU of live S. pneumoniae had a survival rate of 33% compared to 100% survival rate 
for wild type animals (Haas et al., 2002).  However, increasing the immunization dose t  
107 CFU HKSP for CD21/CD35-/- mice allowed all the mice to survive the live challenge 
(Haas et al., 2002).  This study suggests that stimulation of the complement receptors 
lowers the threshold for B cell activation.  Other r ports have shown that both CD19 and 
CD21 lower the threshold for antigen stimulation in vitro.  Mongini et al. demonstrated 
that CD21 and IgM receptor stimulation reduced the minimum concentration of antigen 
bound to mIgM required for entry into S phase by 100-fold (Mongini et al., 1997).  
Deletion of CD19 in mice reduced the number of high-affinity plasma cells in response to 
an NP-Ficoll vaccination by approximately 40% (Shih et al., 2002).  However, activation 
of low-affinity plasma cells was completely abrogated in CD19-/- mice (Shih et al., 2002).  
These results indicate that the role of complement r ceptors in the TI-2 response is to 
lower the amount of antigen required for B cell activation.   
Localization of antigen to the MZ is dependent on fu ctional CR.  Mice deficient 
in either the complement component C3 or the compleent receptors CR1/2 are unable 
to localize TNP-Ficoll to the MZ (Guinamard et al., 2000; Shih et al., 2002).  As 
expected, C3-/- mice and mice depleted of complement via cobra venom factor 
subsequently have reduced IgG and IgM serum titers to TI-2 antigens (Guinamard et al., 
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2000; Harms et al., 1996).  These data demonstrate that complement depen nt 
localization of TI-2 antigens is crucial for normal antibody production. 
The deposition of TI-2 antigens on the spleen occurs in specific sites and cell 
types.  For example, complement bound antigens accumulate on follicular dendritic cells 
(FDC).  FDC have high expression of both CD21 and CD35 (Peset Llopis et al., 1996).  
Complement component C3d binds to Ab/Ag complexes, which form immune complexes 
(IC) that are recognized by CD21 (Fearon and Carroll, 2000).  The IC are then 
transported to FDC and presented on its surface.  Once presented, the IC are easily 
recognized by MZ B cells thereby aiding their activation (Fearon and Carroll, 2000).  
Because FDC present complement components efficiently, they are able to amplify an 
antibody response.  A series of studies demonstrated that FDC enhance the Ab response 
10-1000 fold in a CR2 dependent manner to ovalbumin (Q  et al., 1998).   
It is currently hypothesized that FDC have a role in the early isotype switching 
during the Ab response to TI-2 antigens.  This hypothesis is supported by several 
findings.  It has been observed that MZ B cells migrate to FDC within 24 hours following 
iv injection of Ag (Whipple et al., 2004).  Another study demonstrated that TI-2 antige s 
do not require the presence of specific Ig to produce C3d binding and this allows for a 
rapid uptake and presentation of TI-2 antigens by FDC thereby enabling rapid 
recruitment and activation of B cells (Peset Llopis et al., 1996).  When serum containing 
nonspecific antibody for pneumococcal polysaccharides (PPS) and complement were 
added to the spleens of vaccinated or naïve mice, no difference in PPS or C3d FDC 
localization was observed between the two groups (Pe et Llopis et al., 1996).  However, 
inactivation of complement in the serum reduces PPSand C3d localization to FDC (Peset 
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et al., 1996).  These studies suggest that a reduced requirement for specific Ig to initiate 
C3d binding enables a rapid uptake and presentation by FDC in the case of TI-2 antigens, 
thereby enabling rapid recruitment and activation of B cells (Peset Llopis et al., 1996).   
Other antigen presenting cells (APC) involved in early TI-2 antigens presentation 
and localization include MZ macrophages.  MZ macrophages have been observed to 
rapidly take up TI-2 antigens shortly after injection (van den Eertwegh et al., 1992).  
Phagocytosis of TI-2 antigens by MZ macrophages occurs independent of complement 
(van den Eertwegh et al., 1992).  Splenic deposition of TI-2 antigens is also dependent on 
the presence of MZ macrophages.  Removal of MZ macrophages reduces the localization 
of TI-2 antigens to both the red pulp of the spleen and the MZ, while increasing 
deposition of antigens in the follicles (van den Eertw gh et al., 1992).  The increased 
localization of TI-2 antigens in the follicles corresponded with an increased humoral 
response to the antigen (van den Eertwegh et al., 1992).  This demonstrates that MZ 
macrophages have an important role in regulation of the TI-2 response, which is largely 
suppressive.   
In addition to complement, other innate immune factors that regulate early isotype 
switching to TI-2 antigens include pro-inflammatory and anti-inflammatory cytokines as 
well as toll-like receptors (TLR).  Neutralizing the pro-inflammatory cytokine TNF-α via 
an injection with monoclonal antibody 1 day post-HKSP vaccination suppressed the IgG 
anti-PC response 2-3 fold (Khan et al., 2002).  Other pro-inflammatory cytokines such as 
IL-6 and IFN-γ have been shown to moderately influence early PC isotype switching.   
Mice deficient in IL-6 and IFN-γ have significantly reduced IgG2a and IgG2b serum 
titers, respectively (Khan et al., 2002).  The anti-inflammatory cytokines have the 
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opposite effect on control of isotype switching.  Mice deficient in IL-4 and IL-10 
production have elevated IgG2a serum titers (2-fold) and increased IgG1 and IgG3 titers, 
respectively (Khan et al., 2002).  The peak splenic mRNA production for both the pro-
inflammatory and anti-inflammatory cytokines occurs between 2-6 hours post-
vaccination and returns to baseline within 24 hours.  This indicates that these cytokines 
influence the beginning of the TI-2 response.  
Other innate signaling molecules such as, toll-like receptors (TLR), also play a 
role in antibody responses to polysaccharides.  TLR2-/- mice have significantly reduced 
PC titers 7 days following vaccination with either purified polysaccharides or HKSP 
(Khan et al., 2005; Sen et al., 2005).  Survival to a lethal challenge of S. pneumoniae is 
also mildly compromised in naive TLR2-/- mice (Khan et al., 2005).  However, 
vaccinated TLR2-/- mice survive a lethal challenge similarly to normal ice (Khan et al., 
2005).  In addition, TLR stimulation enhances a polysaccharide response.  Mice treated 
once with the TLR9 ligand unmethylated CpG-containing oligodeoxynucleotide (CpG-
ODN) and alum and vaccinated twice with purified polysaccharide have enhanced 
primary and secondary antibody titers (Sen et al., 2006). CpG and alum treatment 
produced the greatest enhancement on day 21 (Sen et al., 2006).  This data suggests that 
TLR are important for stimulating the TI-2 antibody response. 
Role of T cells 
The precise role of T cells in regulating the TI-2 humoral response is poorly 
understood.  T cells are required for normal TI-2 responses.  However, T cell deficient 
mice are able to produce antibody responses to polysaccharides, albeit, very poorly 
(Briles et al., 1982b).  Mice deficient in αβ T cells have a 6-10 fold reduction in IgG3, 
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IgG2b, IgG1, but not IgM PC specific serum antibody, indicating their importance for 
isotype switching (Wu et al., 1999).  Removal of γδ T cells, however, does not 
significantly affect PC serum titers (Wu et al., 1999).  The relative importance of CD4+ 
and CD8+ T cells has produced conflicting results.  CD4+ T cells are more effective at 
stimulating the anti-PC serum response than CD8+ T cells following HKSP vaccination 
(Wu et al., 2002).  Injection of 2x106 CD4+ T cells into athymic mice increased the IgG 
PC-specific serum response approximately 100-fold cmpared to a 5-fold increase in 
animals given CD8+ T cells (Wu et al., 2002).  However, more recent findings suggest 
that CD8+ T cells have a greater impact on TI-2 antibody respon es than CD4+ T cells 
(Kobrynski et al., 2005).  CD8-/- mice vaccinated with 23-valent pneumococcal 
polysaccharide vaccine Pneumovax failed to produce et ctable polysaccharide antibody 
in the serum.  In contrast, CD4-/- mice did not have significantly different titers compared 
to wt mice in response to the Pneumovax vaccination (K brynski et al., 2005).  A 
possible explanation for the discrepancy between thse studies is that CD8+ cells are 
involved in responses to soluble polysaccharides and CD4+ cells are critical for whole 
bacterial responses (Kobrynski et al., 2005).   
It has long been known that polysaccharide antigens ca not be presented on a 
MHC molecule.  However, it is apparent that T cells contribute to PC antibody responses.  
Recent data suggests that T cells are activated in a noncognate fashion, which does not 
involve T cell receptor (TCR) antigen recognition in the context of MHC.  Transgenic 
mice with T cells expressing only a TCR that is incapable of responding to a protein Ag 
did not affect PC-specific serum titers following HKSP vaccination (Wu et al., 2002).  In 
addition, transgenic mice deficient in MHCII peptide loading have normal serum PC 
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titers (Wu et al., 2002).  These results indicate that specific recognition of antigen by the 
TCR is not required for normal TI-2 antibody responses.   
Several studies have demonstrated that other T cell coactivating molecules are 
important for noncognate T cell polysaccharide respon es.  These coactivators have also 
been shown to be important for isotype switching.  For example, studies have shown that 
B7:CD28 interactions are required for normal TI-2 responses.  Blockade of B7 
interactions with CD28 via in vivo administration of CTLA-4 Ig prior to HKSP 
vaccination suppresses PC-specific IgG sera titers but does not affect PC-specific IgM 
titers (Wu et al., 2002; Wu et al., 1999).   
CD28 stimulation on T cells also upregulates the expr ssion of CD137 (4-1BB) 
on T cells (Wu et al., 2003).  Ligands for CD137 are found on APC such as dendritic 
cells and B cells.  Several experiments have demonstrated the importance of CD137 in 
the TI-2 response.  Mice deficient in CD137 expression have significantly reduced IgM 
and IgG anti-PC responses following HKSP vaccination (Wu et al., 2003).  In addition, in 
vivo administration of anti-CD137 mAb to HKSP vaccinated mice increases proliferation 
in splenic CD4+ T cells in a B7 dependent manner 14 days post-immunization (Wu et al., 
2003).  Anti-CD137 administration also was found to increase B cell and CD8+ T cell 
proliferation (Wu et al., 2003).  These data demonstrate that CD28 and CD137 
cooperatively regulate splenic proliferation and isotype switching following HKSP 
vaccination. 
A third coactivating molecule on the T cell that is al o necessary for PC Ig 
production is CD40L.  CD40L-KO mice have a marked ruction in anti-PC IgM and a 
complete abrogation of anti-PC IgG responses following HKSP vaccination (Wu et al., 
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1999).  Antibodies specific for CD40 also act as an adjuvant for T-independent antibody 
responses.  Anti-CD40 treatment increases the number of NP-specific ASC 25-fold 
following NP-Ficoll immunization (Garcia et al., 1999a).  The increase in NP-specific 
ASC does not occur until 6 days post-immunization (Garcia et al., 1999a).  The growth of 
plasmablasts is also sustained in the red pulp as demonstrated by immunohistochemistry 
(Garcia et al., 1999a).  These data suggests that CD40 ligation increases the TI-2 
response by extending proliferation rather than increasing the number of B cells recruited 
to the response. 
Finally, CD1, the MHC class I-like molecule, presents several types of glycolipids 
and nonpeptide Ags (Kobrynski et al., 2005).  Mice that do not express CD1 have 
undetectable polysaccharide serum titers following P eumovax vaccination (Kobrynski et 
al., 2005).  CD1 expressing APC are hypothesized to present polysaccharide antigens to 
CD8+ T cells, thereby contributing to their activation.  β2m-/- mice, which lack functional 
CD1, MHC class I, and FcRn, have suppressed polysaccharide antibody responses 
following Pneumovax vaccination (Kobrynski et al., 2005).  However, reconstitution of 
β2m-/- mice with normal CD8+, B cells, and macrophage/monocytes restored the 
polysaccharide antibody response to those of normal mice (Kobrynski et al., 2005).  
Altogether, these data demonstrate the panoply of coactivators that affect PC responses.   
PspA response 
 This section will briefly compare and contrast the major differences between the 
development of the antibody response to the TD protein antigen, PspA, with the PC 
antibody response.  The differences between the PspA response and PC response are due 
primarily to the TD and TI-2 nature of the responses.  T-dependent responses involve 
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cognate T cell responses, affinity maturation of B cells in germinal centers, and high 
antibody output during the second week of the antibody response.  Both TD and TI-2 
responses require CD21 receptors, early cytokine production, and T cell-associated 
coreceptors.   
 TD antigens, such as PspA, are processed and presented by several types of APC 
such as dendritic cells, macrophages, and B cells.  The antigen bound to APC then 
migrates to the PALS region of the spleen and present th  antigen to T cells.  B cells 
migrate through the high endothelial venules (HEV) into the T cell zone.  B cells 
expressing a specific mIg for the immunizing antigen are upheld.  Next, a primary focus 
of activated B cells and T cells localize at the T:B cell border as early as 2 days post-
immunization (Jacob et al., 1991).  B cells rapidly proliferate in the primary foci, which 
peaks by day 8 (Jacob et al., 1991).  Between 4 and 12 days, some of these B cells in the 
primary foci will continue to differentiate into plasma cells and migrate to the red pulp 
where they will produce antibody of low affinity during the primary phase of the TD 
response (Liu et al., 1991).   
 The production of high affinity antibodies during TD responses depends on the 
formation of germinal centers.  Germinal centers are characterized by three cellular 
components: FDC, B cells, and T cells (Han et al., 1995).  Formation of germinal centers 
is observed by day 8 and persists until day 16 in the spleen (Jacob et al., 1991).  Germinal 
center formation requires several costimulating molecules including those that are also 
required for PC responses.   
 CD21/CD35, CD40L, and B7 costimulation are all required for establishment and 
maintenance of germinal centers.  B cells that do not express CD21 and CD35 fail to 
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survive selection in germinal centers (Fischer et al., 1998).  Deletion of both CD21 and 
CD35 on B cells also markedly reduces serum antibody titers to TD antigens (Croix et 
al., 1996).  Administration of anti-CD40L antibody at the time of vaccination with a TD 
antigen severely reduces both germinal center formation nd the sera antibody titers (Han 
et al., 1995).  CD40L is also necessary for maintaining germinal centers as demonstrated 
when anti-CD40L is administered late in the response after germinal centers have already 
formed (Han et al., 1995).  In addition to CD40L, B7-2 is necessary for normal germinal 
center formation.  Administration of anti-B7-2 antibody at the time of vaccination 
decreases the number of germinal centers formed and serum titers by 50% (Han et al., 
1995).   
 PspA-specific antibodies are measurable in the serum by day 6 and maximal by 
day 10 (Wu et al., 2000).  The predominant isotypes produced are IgG2b, IgG1, and 
IgG2a (Wu et al., 1999).  CD4+ T cell help is required for at least the first 6 days during 
the PspA response (Wu et al., 2000).  However, PC responses only require CD4+ T cell 
help for the first 2 days (Khan et al., 2004).   
 As mentioned previously, costimulatory molecules present on T cells are required 
for normal antibody responses and isotype switching for TD and TI-2 responses.  B7-2 
but not B7-1 stimulation is necessary for normal PspA responses (Wu et al., 2000).  In 
addition, mice deficient in CD40L have nearly undetectable anti-PspA IgG responses 
(Wortham et al., 1998).  As opposed to the PC response, deletion of CD137 does not 
affect the PspA response (Wu et al., 2003).  
 Studies suggest that early cytokine production has a greater impact on the PspA 
response compared to the PC response.  TNF-α is required during the first 48 hours 
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following vaccination for the PspA response (Khan et al., 2002).  Other pro-
inflammatory cytokines such as IFN-γ and IL-6 are also required for IgG PspA switching 
(Khan et al., 2002).  Lack of anti-inflammatory cytokines IL-4 and IL-10 were both 
found to increase IgG anti-PspA titers (Khan et al., 2002).  The effect of IL-10 deletion 
produced a similar effect of general IgG increase to both PC and PspA antigens, however 
the increase was not consistently significant (Khan et al., 2002).  
 
ENDOCRINE REGULATION OF THE IMMUNE SYTEM 
 Endocrine regulation of the immune system is a well-established phenomenon.  
The predominant classes of sex steroids produced by the gonads that regulate the immune 
response are estrogens, androgens, and progestins.  The humoral immune response, in 
particular, is strongly influenced by sex hormones.  This is evidenced by a number of 
observations.  Autoantibody-mediated diseases afflict females at a much higher rate than 
males.  For example, systemic lupus erythematosus (SLE) and Sjögrens’ syndrome afflict 
women 9 times more frequently than men (Ansar et al., 1985).  In addition, female mice 
have higher IgM and IgG serum titers than males (Eidinger et al., 1972).   
 This section will provide background information oprevious hormone studies 
that identified immunomodulating effects leading to altered antibody responses.  The 
three major classes of sex hormones are discussed.  The effect of estrogen on the humoral 
response is given the greatest emphasis.  The estrog n section will also present data 
demonstrating similar immunomodulating effects on the antibody response, thymus, and 
BM that is observed in both 17β-estradiol (E2) and propanil-treated animals. 
ESTROGEN 
 34
Autoimmune vs. nonautoimmune animals 
The sex hormone E2 is one of the first steroid hormones to be identified as an 
immunomodulator.  Early studies were performed in the autoimmune mouse strain, 
NZB/W.  This strain will spontaneously develop lupus-like symptoms that eventually are 
lethal.   
Initial studies found that when male NZB/W mice were castrated and treated with 
E2, the mortality rate was greatly increased and resembled the mortality rate of female 
NZB/W mice (Roubinian et al., 1978).  Subsequent studies found that E2 increased the 
antibody responses in autoimmune mice (Brick et al., 1985).  Castrated male NZB/W 
mice treated with E2 for 10 weeks increased the number of IgM PFC to the TI-2 antigen 
TNP-Ficoll 3-4-fold (Brick et al., 1985).  E2 also increased the number of IgG and IgM 
PFC 3-fold to the TI-1 antigen, TNP-LPS.  The IgG and IgM PFC responses to the TD 
antigen SRBC was increased 2-fold following E2 treatment (Brick et al., 1985).  In 
contrast, nonautoimmune DBA/2 mice did not have significantly changed PFC to TNP-
Ficoll, TNP-LPS, or SRBC following identical E2 treatment (Brick et al., 1985).  These 
early studies suggested that E2 stimulates the antibody response only in autoimmune 
mice. 
 Subsequent studies established that E2 exposure increases the antibody responses 
in nonautoimmune rats and mice, as well.  Male Sprague Dawley rats treated with E2 3 
days prior to SRBC immunization had a 4-fold increase in antibody titers 6 days post-
immunization (Myers and Petersen, 1985).  E2 treatmn  3 days prior to the secondary 
immunization also yielded a similar increase in antibody titers (Myers and Petersen, 
1985).  However, in contrast to earlier findings demonstrating that E2 increases in the 
 35
number of PFC, the number of PFC was not affected in the nonautoimmune mice 
suggesting that E2 treatment increased antibody synthesis in the plasma cells (Myers and 
Petersen, 1985).   
A more prolonged exposure to E2 induced a greater enhancement of the humoral 
response.  Castrated C57BL/6 mice were chronically exposed to E2 via pellet 
implantation for 4-6 months.  The total number of IgG and IgM ASC in the spleen were 
increased 6-fold and 3-fold, respectively (Verthelyi and Ahmed, 1998).  The chronic E2 
exposure is characterized by a decrease in both the perc nt and number of B cells in the 
spleen, which suggests that more splenic B cells becom  activated (Verthelyi and Ahmed, 
1998).  The total number of IgG bone marrow ASC wasalso increased 12-fold in E2 
exposed mice (Verthelyi and Ahmed, 1998).  In addition o increasing the number of 
ASC in the spleen and BM, the amount of immunoglobulin produced by each plasma cell 
is also increased (Verthelyi and Ahmed, 1998).  Morph metric analysis of the spots 
obtained from ELISPOT assays demonstrated that the density and area of the splenic and 
BM ASC were significantly increased in chronically E2 treated mice (Verthelyi and 
Ahmed, 1998).  Finally, vaccination of the E2 exposed mice with a variety of 
autoantigens such as dsDNA and actin or killed whole bacteria such as Actinobacillus 
pleurpneumoniae or Brucella abortus yielded increased antibody serum titers to all tested 
antigens (Verthelyi, and Ahmed, 1998).   
 Altogether, these data established that E2 increases the antibody response in both 
nonautoimmune and autoimmune animals.  The antibody response is increased both by 
increasing the number of plasma cells and increasing the immunoglobulin synthesis by 
each plasma cell.  The data also suggest that the incr ased response is the result of 
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polyclonal activation.  However, the initial evidenc  presented conflicting data on the 
duration of an E2 exposure required for an increased ntibody response.   
A conclusive time course of E2 exposure necessary to enhance the humoral 
response is currently unknown.  For example, periphal blood mononuclear cells 
(PBMC) from rhesus macaque females treated for 18 hours with E2 increases the percent 
of IgG and IgA ASC (Lu et al., 2002).  In contrast to the macaque studies, the lupus 
prone BWF1 mice require 2 months of chronic E2 pellet exposure until IgG and IgM 
anti-DNA serum titers are increased (Yurino et al., 2004).  Variation in animal models 
and lack of antibody kinetic studies precludes a conclusion of the duration of E2 exposure 
required for an enhanced response.   
E2 sensitive B cell subpopulations 
It is hypothesized that the amplification of the ASC by E2 disproportionately 
affects certain B cell subpopulations.  The B cell subpopulations, B1 B cells and MZ B 
cells, have both been shown to be targets for E2 induced proliferation and activation.  B1 
B cells from BWF1 mice cultured with E2 for 4 days had an approximate 2-fold increase 
in IgM production (Yurino et al., 2004).  However, the classically defined B cell 
population, B2 B cells, cultured under identical conditions did not produce significantly 
different concentrations of IgM (Yurino et al., 2004).  Another study found that B1 B 
cells from C57BL/6 mice exposed to E2 for 2-3 months and pretreated with bromelain 
had increased numbers of splenic bromelain-specific PFC.  However, the number of B2 B 
cell PFC in the spleen was not affected (Ansar et al., 1989).  
The MZ B cell population is also sensitive to the eff cts of E2.  R4A-IgG2b 
BALB/c mice are a nonautoimmune strain of mouse that produce an easily detectable 
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autoimmune B cell that is normally removed during the course of maturation (Grimaldi et 
al., 2006).  When these mice are treated with E2 chronically, they develop a lupus-like 
phenotype (Grimaldi et al., 2001).  Phenotypic analysis of the splenic anti-DNA ASC 
demonstrates that MZ B cells are increased 4-fold cmpared to control animals (Grimaldi 
et al., 2001).  In contrast, follicular B cells are not significantly increased (Grimaldi and 
Diamond et al., 2001).  Altogether, these studies suggest that the E2-induced increase in 
ASC is not the result of polyclonal activation, since particular subsets are affected.  These 
data also suggests that the subpopulations of B cells affected by E2 exposure are also 
involved in the production of TI-2 antibodies. 
Mechanisms for E2-induced antibody enhancement 
The expression of ERα has been suggested to be the receptor regulating the 
increased antibody response.  The ERα and ERβ are expressed on lymphocytes including 
B cells, suggesting a mechanism for a direct effect of E2 on B cells (Grimaldi et al., 
2002).  Analysis of ER mRNA expression in peritoneal B1 and splenic B2 B cells from 
8-12 month old BWF1 mice treated chronically with E2 demonstrated that ERα is 
significantly increased in B1 B cells compared to control animals (Yurino et al., 2004).  
However, ERα expression in B2 B cells is unaffected (Yurino et al., 2004).  ERα has 
been shown to regulate the increased humoral immune response following chronic E2 
exposure.  Nonautoimmune C57BL/6J/129 castrated male ice treated with E2 5 
days/week for 2.5 weeks have significantly increased numbers of IgA, IgG, and IgM 
ASC in both the spleen and BM (Erlandsson et al., 2003).  Deletion of ERα in mice 
abrogates the increased ASC in the spleen or BM (Erlandsson et al., 2003).  However, 
ERβ-/- mice had similar ASC responses as control mice (Erlandsson et al., 2003).  
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Altogether, these data suggest that the E2-induced B cell activation is mediated through 
ERα. 
 E2 exposure elicits a number of changes in the gentic expression profile of B 
cells that decreases tolerance.  BALB/c mice treated with E2 for 3-6 weeks have 
increased expression of the proteins VCAM-1 (40%), CD22 (40%), SHP-1 (20%), and 
Bcl-2 (20%) (Grimaldi et al., 2002).  VCAM-1 functions as a ligand for VLA-4 and is 
hypothesized to protect B cells from apoptosis during early B cell development.  CD22 
and SHP-1 regulate the antigen threshold required for B cell activation.  Bcl-2 increases 
survival of autoreactive B cells.  The percent increase in these proteins induced by E2 is 
sufficient to alter B cell survival (Grimaldi et al., 2002).   
It is hypothesized that increased expression of these proteins decreases the 
amount of stimulation required for activation and protects against apoptosis during B cell 
development.  For example, Bcl-2 expression is also increased in the bone marrow of 
pro/pre B cells and immature B cells (Grimaldi et al., 2002).  Supporting experiments 
show that E2 exposure decreases the percentages of BM B220+ cells, but transitional 
splenic type 2 B cells, which differentiate into mature splenic B cells, are increased 
(Grimaldi et al., 2001).  In addition, transitional splenocytes from E2-treated mice 
demonstrated that these cells were resistant to apoptosis (Grimaldi et al., 2002).  These 
data suggest that certain B cells during development in both the BM and spleen have anti-
apoptotic expression patterns that results in increased survival.   
 Other studies evaluating the effect of E2 on B cell maturation revealed that 
autoreactive B cells are eliminated from circulation, albeit less effectively than in normal 
mice (Grimaldi et al., 2006).  R4A-IgG2b BALB/c mice treated with E2 for5-6 weeks 
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have a 4-fold increase in mature autoreactive B cells ompared with control animals 
(Grimaldi et al., 2006).  Autoreactive B cells survive in greater numbers throughout 
maturation in the BM and the spleen (Grimaldi et al., 2006).  High affinity autoreactive B 
cells survived in slightly greater numbers than lowaffinity autoreactive B cells in E2 
treated mice to enter into the splenic transitional pool from the BM, suggesting that some 
autoreactive B cells are eliminated in the BM similarly to normal animals (Grimaldi et 
al., 2006).  However, E2 dramatically increased the number of high affinity autoreactive 
B cells that survived the splenic transitional stages to enter the mature B cell population 
(Grimaldi et al., 2006).  Normal mice had a 3-fold reduction in high affinity autoreactive 
B cells during the transitional to mature stages, but the number of high affinity 
autoreactive B cells in E2 treated mice was not reduc  (Grimaldi et al., 2006).  
Interestingly, E2 treatment did not affect the deletion of low affinity autoreactive B cells 
during the differentiation of transitional B cells into mature B cells (Grimaldi et al., 
2006).  These data indicate that E2 increases the number of autoreactive B cells by 
impairing the removal of high affinity autoreactive B cells during the immature and 
transitional phases of maturation.   
Effects of E2 on B cell maturation in the BM 
The effects of E2 on lymphopoiesis further upstream in the B cell maturation 
stages in the BM indicate a suppressive effect.  The number of B220+ cells in the BM is 
decreased 5-fold following 2.5 weeks of treatment in C57BL/6J/129 castrated mice 
(Erlandsson et al., 2003).  Furthermore, the E2 decreases the number of pro-B cells, pre-
B cells, and immature IgM+ B cells 70-80% compared to control animals (Erlandsson et 
al., 2003).  Selected deletion of the ERα and ERβ in mice demonstrated that both 
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receptors are required for the E2-mediated decrease in th  pro-B and IgM+ B cell 
populations (Erlandsson et al., 2003).  ERα alone regulates the E2-mediated deletion of 
pre-B cells (Erlandsson et al., 2003).   
Effects of E2 on the thymus 
E2 also affects T cell development by inducing thymic atrophy and T cell 
apoptosis.  E2 decreases the thymocyte population approximately 80% of controls 
(Screpanti et al., 1989).  The decrease is primarily in the CD4+CD8+ population 
(Screpanti et al., 1989).  The mechanism regulating E2-mediated thymic atrophy is 
Fas/FasL dependent (Do et al., 2002).  In contrast with antibody responses and 
lymphopoeisis, E2-mediated thymic atrophy requires both ERs for the maximal effect 
(Erlandsson et al., 2001).  The increase in thymic atrophy is correlated with changes in 
the populations of T cells in the spleen of developing mice, however, no studies have 
been performed to determine if these changes affect adaptive immune responses 
(Erlandsson et al., 2001). Altogether, these data emphasize the diverse 
immunomodulating affects of estrogen.  
PROGESTERONE  
The other major immumodulatory female sex hormone is progesterone.  Analysis 
of the effects of progesterone on immune function and ntibody production suggest an 
inhibitory or an opposing effect to estradiol.   In vitro progesterone treatment on PBMC 
from rhesus macaques inhibits the number of IgG and IgA ASC approximately 90% from 
controls (Lu et al., 2002).  Progesterone has also been found to induce TH2 cytokine 
production.  In vitro culture with progesterone of human cloned T cells from multiple 
sclerosis patients induced all of the clones to produce IL-4 and suppressed inflammatory 
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cytokine production (Correale et al., 1998).  The progesterone regulated protein, 
progesterone induced blocking factor (PIBF), regulates some of the immunomodulatory 
effects of progesterone.  In vitro treatment with PIBF on ConA stimulated murine splenic 
CD4+ and CD8+ T cells induced both cell populations to produce the TH2 cytokines IL-4, 
IL-10, and IL-3 (Szekeres-Bartho and Wegmann, 1996).  However, the expression of the 
TH1 cytokine, IFN-γ, was not affected (Szekeres-Bartho and Wegmann, 1996).  
Progesterone may downregulate the antibody response by also affecting apoptosis and 
bcl-2 expression.  Progesterone decreases the expression of bcl-2 in estrogen treated 
Jurkat T cells and increases apoptosis (McMurray et al., 2001).  It is currently unknown if 
lymphocytes express progesterone receptors (Bouman et al., 2005).  These data suggest 
that progesterone antagonizes the effects of estrogen. 
 Progesterone is hypothesized to have the greatest aff c on mucosal immune 
responses.  Subcutaneous progesterone exposure increased the number of antigen specific 
ASC in the vagina and the uterus following intranasal or vaginal immunization with 
cholera toxin B (Johansson et al., 1998).  An opposing study demonstrated that 
progesterone exposure decreases resistance to a viral challenge (Gallichan and Rosenthal, 
1996).  Mice treated with progesterone prior to i.n. immunization with glycoprotein B 
from herpes simplex virus increased the ratio of IgG to IgA vaginal titers (Gallichan and 
Rosenthal, 1996).  In addition, progesterone administrat on or elevated levels of 
progesterone associated with the diestrus stage of the estrus cycle increase viral load 
following vaginal HSV challenge (Gallichan and Rosenthal, 1996).  Altogether, these 
data present a contrasting set of data concerning the effect of progesterone on mucosal 
challenges that differs according to antigen exposure. 
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ANDROGENS 
Androgens represent the third major sex hormone produced by the gonads.  
Numerous studies have demonstrated that testosterone suppresses the humoral response.  
The androgen receptor is expressed on B cells (Benten t al., 2002).  NZB/W female 
mice chronically treated with testosterone had a 3-5 fold increase in survival time 
compared to controls (Roubinian et al., 1979).  In addition, female OVX NZB/W mice 
treated with testosterone had a 2-fold reduction in the number of IgM PFC following 
TNP-Ficoll immunization (Brick et al., 1985).  The numbers of IgG and IgM PFC were 
also reduced in the testosterone treated females 2-3 fold following TNP-LPS 
immunization (Brick et al., 1985).  Androgen replacement therapy in patients with 
Klinefelter’s syndrome demonstrated a significant reduction in serum IgA, IgG, and IgM 
serum titers (Kocar et al., 2000).  Experiments suggest that compounds that are 
antiandrogenic do not have contrasting effects on the immune system.  The antiandrogen, 
flutamide, does not significantly affect the anti-IgM response following SRBC 
immunization and chronic flutamide treatment (O'Conn r et al., 2002; Ladics et al., 
1998).  These studies indicate that androgens are immunosuppressive with regards to 
humoral responses and antiandrogens are neither immunostimulatory nor 
immunosuppressive. 
   
SUMMARY 
 These experiments employed the HKSP immunization model t  study the effects 
of herbicide exposure on the humoral immune response.  Previous reports demonstrated a 
number of immunotoxic effects induced by propanil ad 2,4-D.  These studies were 
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conducted to determine if these previously observed immunotoxic effects affect an 
adaptive immune response to a common bacteria.   
 The experiments in Chapter 2 establish an environmentally relevant route of 
herbicide exposure to study these immunotoxic effects.  Chapter 3 characterizes the 
effects of propanil, 2,4-D, and 1:1 mixture of the wo herbicides on the PC and PspA-
specific responses following HKSP immunization.  Chapter 4 determines if propanil 
selectively enhances TI-2 antibody responses as well as determine the time of exposure 
and antigen concentration requirements for the enhanced antibody response.  Chapter 5 
examines the role of the endocrine system in the enanced antibody response following 
propanil exposure.  Finally, Chapter 6 explores the eff ct of the propanil-induced 

























CHAPTER 2: COMPARISON BETWEEN ASPIRATION 




















 Previous published data on the immunotoxic effects of propanil exposure have 
been performed using an ip exposure (de la Rosa et al., 2005).  As mentioned in the 
General Introduction, human exposure to propanil occurs primarily via inhalational, 
dermal and oral routes.  The goal of these experiments is to establish a model to study an 
environmentally relevant route of exposure for propanil.  This new exposure model will 
be applied to contrast and compare the effects of propanil exposure on immune function 
that has previously been established to be susceptible following ip exposure.  In addition, 
mixture interactions will be studied in the new exposure model.   
 An aspiration route of exposure was chosen based on the result of preliminary 
experiments performed in the laboratory.  Dermal studies found that propanil was not 
readily transported across the skin (data not shown).  As mentioned in the General 
Introduction, previous experiments have demonstrated that oral exposures to propanil 
require approximately twice the concentration to induce the same toxicity as ip exposures 
(Xie et al., 1997b).  For these reasons, an inhalational model was studied. 
 Propanil has previously been shown to induce thymic atrophy that is easily 
measured by decreases in thymic weight and in the number of thymocyte subpopulations 
(de la Rosa et al., 2005).  In addition, 2,4-D induces a greater-than-additive effect on the 
thymus when administered with propanil (de la Rosa et al., 2005).  One of the common 
routes of occupational exposure to 2,4-D includes inhalation (Garabrant and Philbert, 
2002).  For these reasons, thymic atrophy was chosen a  the endpoint for evaluating the 
efficacy of herbicide exposure by aspiration.  Long-term goals for this research include 
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evaluating the effects on a humoral response following vaccination.  Therefore, the 




 Six to eight week old C57Bl/6 female mice were purchased from Hill Top Lab 
Animals (Scottdale, PA).  Mice were housed in microisolator cages in pathogen free 
conditions at West Virginia University’s animal facility.  Mice were kept on a 12 hr light-
dark cycle and allowed to acclimate to the facility for 1 week.  These studies were 
conducted in accordance with all federal and institutional guidelines for animal use and 
were approved by the West Virginia University Institutional Animal Care and Use 
Committee. 
Pesticides 
 Propanil, 3,4-dichloropropionanilide, 99% pure was purchased from Chem 
Service.  2,4-D, Dimethylamine salt of 2,4-dichlorophenoxyacetic acid was purchased 
from Universal Cooperatives.  2,4-dichlorophenoxyacetic acid, 99.5% pure was 
purchased from Chem Service.   
Herbicide  exposures 
 For aspiration, pesticides were diluted in 12 µl of olive oil and 8 µl DMSO.  
Three or 4 mg of purified pesticide was dissolved in DMSO/olive oil for a 150-mg/kg or 
200 mg/kg treatment, respectively.  Mixture exposure  were prepared by dissolving both 
herbicides in the 20µl olive oil and DMSO solution.  Animals were lightly anesthesized 
with 150 µl of a 5mg/ml solution of Nembutal prior to pesticide exposure.  Mice were 
 47
suspended vertically and the tongue was extended with forceps to prevent swallowing of 
the herbicides.  Herbicides were pipetted at the bas  of the tongue and subsequently 
inhaled. 
  For ip exposures, propanil was dissolved in peanut oil at a concentration of 15 
mg/ml or 20 mg/ml for 150 mg/kg or 200 mg/kg exposure .  Commercial formulation of 
2,4-D was diluted in sterile PBS at the appropriate concentration for a 150 mg/kg or 200 
mg/kg injection.  Herbicides were injected ip in 200 µl volumes.   
Bacterial preparation and immunization with R36A 
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to 
mid-log phase in Todd-Hewitt broth  (Becton Dickinso , Sparks, MD) + .05% yeast 
extract (Becton Dickinson) and stored at –80°C.  For immunization, stock was cultured in 
a candle jar for 18 hrs at 37°C on blood agar plates (Becton Dickinson).  A few 
characteristic colonies were selected and suspended i  200 ml Todd-Hewitt broth + .05% 
yeast extract.  Bacteria were grown at 37°C to an absorbance reading at 650nm of 0.4 and 
heat killed for 4 hours in a 60°C water bath.  A final concentration of 109 CFU/ml was 
established in PBS based on colony counts.  Sterility was confirmed by culture.  Heat-
killed stock was stored at -20°C in 1 ml aliquots.  Mice were immunized ip with 2x108 
CFU on the same day as herbicide exposure. 
Organ preparation 
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott 
Laboratories, North Chicago, IL).  Spleen and thymus wet weights were recorded.  
Spleens were mechanically dissociated through Spectra nylon mesh (Spectrum Labs, 
Rancho Dominguez, CA) in complete cell media containing RPMI-1640 (BioWhitaker, 
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Walkersville, MD), 10% heat inactivated fetal bovine serum (FBS, Hyclone Laboratories, 
Inc, Logan, UT), 10 mM HEPES (Sigma), 1 mM L- glutamine (Gibco, Rockville, MD), 
5x10-5 M 2-mercaptoethanol (Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml 
streptomycin (Gibco).  Thymuses were mechanically dissociated between microscope 
slides in complete cell media.  Red blood cells in the spleen and thymus were lysed with 
Tris-buffered ammonium chloride.  Cell suspensions were washed twice and counted 
using a hemacytometer.  Viability was determined using Trypan blue dye exclusion. 
Measurement of antibody secreting B cells (ASC) in the spleen 
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbo , MI) were coated 
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) overnight at 4°C.  
In all subsequent steps, plates were washed with PBS + .01% Tween-20.  Plates were 
blocked with 200 µl/well complete medium + 25% FBS for 2 hours at 37°C.  Plates were 
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or 
1x106 cells/ml.  All samples were plated in triplicate.  Plates were incubated for 4-6 hours 
at 37°C in a 5% CO2 incubator.  After washing, goat anti-mouse alkaline phosphatase 
(AP) conjugated IgG or IgM antibodies (Southern Biotechnology Associates, 
Birmingham, AL), diluted 1/250 in PBS + 1%BSA + .05% Tween-20, were added to the 
appropriate wells (100 µl/well).  Plates were incubated overnight at 4°C and washed.  
SIGMAFAST 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablets 
(Sigma-Aldrich, St. Louis, MO) were dissolved in distilled water and added at 100 µl/
well.  Color development was stopped by washing with d stilled water.  The number of 
spots/well was counted using a dissection microscope (Olympus Optical Co., Melville, 
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NY).  The number of ASC was calculated by using the mean number of spots from 
triplicate wells.  The number of ASC was normalized to 1x106 B cells.   
Flow cytometric analysis 
Splenic cells were stained with the appropriate combinations of rat anti-mouse 
B220-APC (RA3-6B2), rat anti-mouse CD4-FITC (GK1.5), or rat anti-mouse CD8α-PE 
(53-6.7) (BD PharMingen, San Diego, CA).  All steps were performed in PBS 
supplemented with 1% FBS and 0.04% sodium azide (Sigma).  Briefly, 1 x 106 cells were 
stained in a total volume of 25 µl of antibodies at the appropriate concentrations fr 25 
minutes on ice in the dark.  After incubation, cells were washed twice and fixed in 0.04% 
paraformaldehyde overnight at 4°C (Fisher Scientific, Pittsburgh, PA).  The following 
day cells were washed twice to remove the paraformaldehyde and resuspended in 1 ml of 
staining media.  For each sample, 10,000 cells werecoll cted for analysis on a Becton-
Dickinson FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).  
Analysis was performed using WinMDI software (Joseph Trotter, Scripps Institute, San 
Diego, CA).  Population percentages, obtained from fl w cytometric analysis, were used 
to calculate the absolute cell number by multiplying the percentage of cells in a 
population by the total number of cells harvested pr organ.   
Statistics 
One-way analysis of variance (ANOVA) was performed for all statistical analyses 
using a Tukey-Kramer t-test to perform multiple comparisons between all treatment 
groups.  A significance level of p ≤ 0.05 was used for all tests.  Statistical analysis wa  
performed using JMP software (SAS Institute Inc., Cary, NC).  All experiments were 
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Aspirated herbicides decrease thymic weight similarly to an ip injection. 
 Mice were treated with either a 150 mg/kg or 200 mg/kg concentration of 
herbicides.  Animals were exposed to either individual propanil or 2,4-D treatments or a 
1:1 mixture of the two herbicides.  Mice were exposed to the herbicides via either an ip or 
aspiration route of exposure.  Animals that received the herbicides via the aspiration route 
did not remain unconscious as long as animals receiving herbicides via the ip route.  
Propanil-treated mice exposed via the aspiration route were unconscious for 
approximately 45 min compared to 30 min in animals receiving Nembutal alone.  
However, ip injected mice receiving propanil were unconscious for 6-8 hours.  A 150/150 
mg/kg ip mixture herbicide exposure to the mixture of herbicides significantly decreased 
the thymic weights in a greater-than-additive fashion compared to the single herbicide 
exposures (Figure 1).  Aspiration exposure to the mixture of herbicides was not 
significantly different from the ip mixture exposure (Figure 1).  In addition, 150 mg/kg 
single herbicide exposures were not significantly different between both aspiration and ip 
routes of exposure (Figure 1). Aspirated or ip injected 200 mg/kg single propanil and 
aspirated or ip injected mixture herbicide exposure produced statistically similar thymic 
atrophy (Figure 1).  However, single 2,4-D exposure was an approximate LD50 when the 
herbicide was aspirated (data not shown).  Surviving mice exposed to 2,4-D by aspiration 
induced similar decreases in thymus size compared to ip injected animals (Figure 1).   
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Aspirated herbicides decrease the number of thymocytes similar to ip injected 
herbicides. 
Thymocyte populations were analyzed from the thymuses of herbicide-treated 
animals.  The total number of thymocytes from 150 mg/kg and 200 mg/kg in mixture 
treated animals were decreased similarly in both aspirated or ip injected groups (Figure 
2).  Aspirated 200 mg/kg propanil and 2,4-D significantly decreased the number of 
thymocytes compared to aspirated controls (Figure 2).  In contrast, ip injected 200 mg/kg 
propanil and 2,4-D were not significantly decreased from ip vehicle controls (Figure 2).   
Analysis of the CD4+CD8+, CD4+CD8-, and CD4-CD8+ subpopulations 
demonstrate a similar magnitude of reduction in mixture treated animals via either the 
aspiration or ip route of exposure (Figures 3A, 3B,C).  Single exposures produced 
similar decreases in thymocyte subpopulations regardless of aspiration or ip injection 
(Figures 3A, 3B, 3C).  The statistical significance of single exposures varied with 
concentration and route of exposure, however, the gen ral effect of the herbicides on the 
thymocyte subpopulations is similar regardless of the route of exposure (Figures 3A, 3B, 
3C). 
Aspirated herbicides do not affect the number of ASC. 
 Since herbicide exposure induced thymic atrophy similarly in aspirated and ip 
injected animals, the effect of aspirated herbicides on the antibody response to an ip 
HKSP immunization was examined.  Previous experiments demonstrated that propanil 
and 2,4-D mixture exposure increases the number of PC-specific ASC following HKSP 
immunization (de la Rosa dissertation).  Mice were immunized with HKSP and treated 
with herbicides via either aspiration or ip injection.  Mixture herbicide exposure 
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increased the number of IgG and IgM PC-specific ASC when animals were ip injected 
with a 150/150 mg/kg herbicide mixture (Figure 4).  However, aspirated herbicides did 
not significantly increase the number of PC-specific ASC compared to aspirated vehicle 
mice (Figure 4).   
 
DISCUSSION 
 These experiments begin to explore how the toxic effects of the herbicides 2,4-D 
and propanil differ when animals are exposed via different routes.  These experiments use 
established immunotoxic effects induced by ip exposure to evaluate the efficacy of an 
environmental route of exposure on immune function.  Propanil and mixture treatments 
produced similar immunotoxic effects on the thymus when animals were aspirated or ip 
injected.  2,4-D treatments were more lethal when anim ls were aspirated instead of ip 
injected.  The cause of increased mortality for aspir ted 2,4-D compared to ip or dermal 
exposures is not currently known.  However, the thymic atrophy induced in the surviving 
animals was similar in both exposure models.  Animals exposed to herbicides via 
aspiration did not have significantly different antibody responses.  Altogether, these data 
demonstrate the importance of considering exposure routes when evaluating the toxicity 
of chemical exposures.   
 Propanil induces thymic atrophy by increasing glucocorticoids in ip injected mice.  
Although aspirated propanil treatment induces similar thymic atrophy as ip injection, the 
mechanism has not been studied.  However, given the similarity of the response in ip vs. 
aspiration, it is plausible that the mechanisms are the same. Aspirated herbicides did not 
exhibit the overt neurotoxicity that is observed in ip injected animals.  This result 
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suggests that the hind leg paralysis and the period of unconsciousness induced by the 
toxicity from ip injected herbicides is not involved in thymic atrophy.   
 The route of immunization and the site of the antibody response might be 
responsible for the inability of aspirated herbicides to enhance the antibody response.  IP 
immunizations typically pass through the subdiaphragm tic lymphatics (Smith et al., 
1996).  Since the mechanism that is responsible for nhancing the antibody response 
following herbicide exposure is probably different from the one regulating thymic 
atrophy, it is unknown what is required for splenic effects.  Respiratory exposure to 
herbicides may induce a more localized effect.  Since p immunization does not produce 
strong antibody responses in the lung, a different ou e of immunization may be 
necessary.  Follow-up studies may utilize an antige that elicits a strong local antibody 
response via respiratory challenge.  Preliminary experiments with live aspirated S.
pneumoniae were unsuccessful due to a high mortality associated with herbicide and 
bacterial challenge.  Death was observed within hours f exposure, suggesting acute 
respiratory distress.  Future experiments may attempt an immunization several days prior 
to herbicide exposure to allow for complete clearance of the antigen and a reduction in 
inflammation.   
 Altogether, these data demonstrate the importance of route of administration 
when analyzing toxicity of chemical exposure.  Thymic atrophy is readily induced by 
herbicide exposure and the sensitivity of the assay m y serve as an endpoint for 
determining pesticide exposure.  However, effects on humoral responses are dependent 
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Figure 1.  Aspirated herbicides decrease thymic weight similarly to ip injection.   
C57BL/6 female mice (5/group) were treated with vehicl  control, 150 or 200 mg/kg 
propanil, 150 or 200 mg/kg 2,4-D, or a 150/150 or 200/ 00 mixture.  Mice were exposed 
via aspiration or ip injection and thymic weights were recorded on day 2.  Values 
represent the mean ± SD.  * Significantly different from vehicle, p ≤ .05.  # indicates a 
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Figure 2.  Aspirated herbicides decrease the number of thymocytes similarly to ip 
injection.   
C57BL/6 female mice (5/group) were treated with vehicl  control, 150 or 200 mg/kg 
propanil, 150 or 200 mg/kg 2,4-D, or a 150/150 or 200/ 00 mixture.  Mice were exposed 
via aspiration or ip injection and thymocyte numbers were counted on day 2.  Values 
represent the mean number of thymocytes ± SD.  * Significantly different from vehicle, p 
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Figure 3.  Aspirated herbicides decrease thymocyte subpopulations similar to ip 
injection.   
C57BL/6 female mice (5/group) were treated with vehicl  control, 150 or 200 mg/kg 
propanil, 150 or 200 mg/kg 2,4-D, or a 150/150 or 200/ 00 mixture.  Mice were exposed 
via aspiration or ip injection.  The thymocyte subpopulations (A) CD4+CD8-, (B) CD4-
CD8+, and (C) CD4+CD8+ were enumerated by flow cytometry on day 2.  Values 
represent the mean number of thymocytes ± SD.  * Significantly different from vehicle, p 




























Figure 4.  Aspirated herbicides do not affect the number of PC-specific ASC.   
C57BL/6 female mice (5/group) were treated via aspir tion or ip injection with vehicle 
control or a 150/150 mixture and vaccinated ip with 2x108 CFU HKSP.  Numbers of PC-
specific IgG and IgM ASC were determined by ELISPOT assay on day 7.  Values 
represent the mean ± SD of ASC/1x106 B cells.  * Significantly different from vehicle, p 
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Propanil (3,4-dichloropropionanilide) and 2,4-D (2,4-dichlorophenoxyacetic acid) 
are commonly used herbicides that have toxic effects on the immune system.  The present 
study determined the effect of exposure to these chemicals on the immune response to a 
bacterial vaccine.  The antibody responses to the T-independent type 2 antigen, 
phosphorylcholine (PC) and the T-dependent antigen, pneumococcal surface protein A 
(PspA) were characterized in C57BL/6 mice following heat-killed Streptococcus 
pneumoniae (HKSP) immunization and single or mixture herbicide exposure.  Propanil 
exposure significantly increased the number of PC-specific IgM, IgG2b, and IgG3 
antibody secreting B cells (ASC) in the spleen 4-6 fold over control animals in a dose 
dependent manner.  However, the number of ASC in the bone marrow and serum titers 
were comparable in control and propanil-treated mice.  In contrast, 2,4-D exposure 
decreased the number of PC-specific IgM and IgG bone marrow ASC 2-3 fold from 
control animals.  The decrease in bone marrow ASC in 2,4-D-treated mice corresponded 
to a 3-4 fold decrease in PC-specific IgM, IgG2b, and IgG3 serum titers compared to 
control mice.  The number of ASC in the spleens of 2,4-D-treated mice was, however, 
comparable to control mice.  The antibody response to PspA was not affected by any of 
the treatments.  There were no mixture interactions between the two herbicides in any of 
the responses measured.  These results characterize the primary PC-specific antibody 
response in the bone marrow, spleen, and serum following HKSP vaccination and 
herbicide exposure.  The differential effects of propanil and 2,4-D on the antibody 
response to a bacterial vaccine demonstrate the potential of chemical exposure to 
augment or suppress immune responses to vaccines and infectious diseases. 
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INTRODUCTION 
 The class of pesticides, commonly referred to as herbicides, is extensively used 
both commercially and by individuals making them ubiq itous in the environment.  The 
immune system, in particular, is reported to be sensitive to the toxic effects of herbicides 
(Faustini et al., 1996; Short and Colborn, 1999). Since infectious diseases are a major 
cause of morbidity and mortality worldwide, it is important to determine if exposure to 
these compounds compromises the immune response to an infection.  2,4-
dichlorophenoxyacetic acid (2,4-D) and 3,4-dichloropropionanalide (propanil) are 
commonly used herbicides marketed as a chemical mixture under the product names of 
NOX-D and Herbanil 368 (Crop Protection Handbook, 2003).  Previous research has 
demonstrated that 2,4-D and propanil are immunotoxic to the primary immune organs 
and to specific immune cell functions, however, the eff cts of an exposure to a mixture of 
these herbicides on an i  vivo immune response has not been studied (de la Rosa et al., 
2003; de la Rosa et al., 2005; Barnett and Gandy, 1989; Blakley, 1997).  This study was 
performed to determine if exposure to these herbicides, either alone or as a mixture, 
altered the primary humoral immune response to the model bacterial vaccine, heat-killed 
Streptococcus pneumoniae (HKSP).   
 Propanil is an amide class herbicide that induces thymic atrophy and 
splenomegaly.  Numerous studies have established that exposure to propanil can inhibit 
the function of a variety of immune cell populations i cluding macrophages, T cells, and 
natural killer cells (Barnett and Gandy, 1989; Barnett et al., 1992; Xie et al., 1997; Zhao 
et al., 1998).  Murine studies have demonstrated that propanil inhibits the antibody 
response in the spleen to the model T cell-independent-type 2 (TI-2) antigen DNP-Ficoll 
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and the T-dependent (TD) antigen sheep red blood cells (SRBC) (Barnett and Gandy, 
1989; Barnett et al., 1992).  2,4-D is a chlorinated phenoxy compound design d as a 
synthetic form of the plant hormone auxin (Munro et al., 2002).  Reports on the 
immunotoxic effects of 2,4-D are inconclusive.  Studies using a mouse model 
demonstrated that oral exposure to 2,4-D at the timof vaccination with SRBC increased 
the number of antibody producing cells (ASC) in the spleen (Blakley, 1986).  Conversely, 
another report found that exposure to a mixture of 2,4-D and the herbicide picloram 
decreased the number of plaque-forming cells in the spl en following SRBC vaccination 
(Blakley, 1997).  Thus, additional studies are needed to determine the effects of 2,4-D on 
the humoral immune response.   
S.  pneumoniae kills approximately 1 million children aged 5 years or younger 
annually and remains one of the most common causes of pneumococcal death worldwide.  
Due to its prevalence, it is a well-characterized model for studying the humoral immune 
response.  Vaccination with HKSP elicits a TD antibody response and a TI-2 antibody 
response (Wu et al., 1999).  Pneumococcal surface protein A (PspA) is a TD antigen on 
S. pneumoniae that acts as a virulence factor by inhibiting the functions of complement 
(Tu et al., 1999).  Phosphorylcholine (PC) is a cell wall polysaccharide and the 
immunodominant antigen that elicits the TI-2 antibody response.  PC is a virulence factor 
that functions by transporting the bacterium across the epithelial and endothelial 
membranes (Cundell et al., 1995; Tuomanen et al., 1995).  Current vaccine strategies use 
a 23-valent polysaccharide vaccine or a 7-valent cojugate vaccine, both of which 
produce a robust anti-polysaccharide response (Bogaert et al., 2004).  The kinetics of the 
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serum antibody response and the predominant isotypes produced to PspA and PC are well 
characterized (Wu et al., 2000; Wu et al., 1999). 
Our laboratory focuses on studying potential synergistic effects on the immune 
system following exposure to a mixture of propanil d 2,4-D.  Previous studies show 
that exposure to either propanil or 2,4-D alone induced thymic atrophy and reduced the 
number of double positive (CD4+CD8+) thymocytes (de la Rosa et al., 2005).  In the bone 
marrow, exposure to either herbicide alone decreased the number of pre-B 
(B220+CD43+IgM lo) cells and IgM+ B (B220+CD43-IgMhi) cells (de la Rosa et al., 2003).  
However, exposure to the mixture of propanil and 2,4-D caused greater-than-additive 
decreases in the same cell populations in the thymus and bone marrow suggesting that 
interactions of the mixture increased the toxicity of the individual chemicals (de la Rosa 
et al., 2003; de la Rosa et al., 2005).   
  Based on the previous reports on the immunotoxic effects of propanil and 2,4-D, 
it was originally hypothesized that exposure to the herbicides would inhibit the humoral 
immune response after vaccination with HKSP and that exposure to the mixture would be 
more immunotoxic than the individual compounds.  However, in contrast to the 
hypothesis, the results demonstrated that propanil and 2,4-D differentially affected the 
immune response to HKSP and there were no apparent int ractions between the two 
herbicides.  Exposure to propanil significantly increased the number of PC-specific ASC 
in the spleen.  2,4-D had no effect on the PC respon e in the spleen but significantly 
decreased the number of PC-specific ASC in the bonemarrow.  The decrease in ASC in 
the bone marrow after exposure to 2,4-D correlated with a significant decrease in the PC-
specific serum antibody titers.  There was no effect on the response to PspA by any of the 
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treatments.  In addition, these results extend our knowledge of the humoral immune 
response to vaccination with HKSP by characterizing the primary antibody response to 
PC in the bone marrow and the spleen in conjunction with the serum antibody response.  
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MATERIALS AND METHODS 
Mice. 
Six to eight week old C57Bl/6 female mice were purchased from Charles River 
Farms (Wilmington, DE).  Mice were housed in microisolator cages in pathogen free 
conditions at West Virginia University’s animal facility.  Mice were kept on a 12 hr light-
dark cycle and allowed to acclimate to the facility for 1 week.  Food and water was 
provided ad libidum.  These studies were conducted in accordance with all federal and 
institutional guidelines for animal use and were approved by the West Virginia 
University Institutional Animal Care and Use Committee. 
Chemicals. 
Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem 
Service (West Chester, PA).  Commercial-grade 2,4-D amine (47.2% dimethylamine salt 
of 2,4-dichlorophenoxyacetic acid, 52.8% inert ingredients, Universal Cooperatives, Inc., 
Minneapolis, MN) was purchased from Southern States Cooperative (Morgantown, WV).  
Bacterial preparation and immunization. 
S. pneumoniae strain R36A (a gift from Meenal Elliott, West Virginia University) 
an avirulent, nonencapsulated strain, was used for all experiments.  Strain R36A was 
chosen because it is a commonly used strain of S. pneumoniae and the kinetics of the 
serum antibody response and the predominant isotypes o PC and PspA have been well 
established (Wu et al., 1999; Wu et al., 2000).  Strain R36A was grown to mid-log phase 
in Todd-Hewitt broth  (Becton Dickinson, Sparks, MD) + .05% yeast extract (Becton 
Dickinson) and stored at –70°C.  For immunization, stock was cultured in a candle jar for 
18 hrs at 37°C on blood agar plates (Becton Dickinson).  A few characteristic colonies 
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were selected and suspended in 200 ml Todd-Hewitt bro h + .05% yeast extract.  Bacteria 
were grown at 37°C to an absorbance reading at 650nm of 0.4.  Bacteri  w re heat killed 
for 4 hours at 60°C.  A final concentration of 109 CFU/ml was established in PBS based 
on colony counts.  Sterility was confirmed by culture.  Heat-killed stock was stored at -
20°C in 1 ml aliquots.  Mice were immunized intraperitoneally (i.p.) with 2x108 CFU. 
Exposure of mice to herbicides. 
Mice (5-6/ group) were treated with either single doses of herbicides (propanil or 
2,4-D) or a 1:1 mixture of both herbicides by i.p. njection within one hour of HKSP 
vaccination.  Mice were treated with a range of concentrations of herbicide based on 
milligrams of herbicide/ kilogram of body weight (mg/kg).  Propanil was dissolved in 
peanut oil and animals were treated with 25, 50, 10or 150 mg/kg.  2,4-D was diluted in 
sterile PBS and mice were treated with 150 mg/kg.  2,4-D concentration was based on the 
amount of active 2,4-D in the commercial preparation. The route of exposure and the 
doses used were based on previous studies that demonstrated a mixture interaction at 150 
mg/kg propanil and 150 mg/kg 2,4-D on thymocyte populations (de la Rosa et al., 2005).  
Control animals were treated with the vehicle peanut oil only as previous studies 
determined that there was no difference between animals treated with the peanut oil 
vehicle compared to the PBS vehicle. 
Preparation of spleen and bone marrow cell suspensions. 
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott 
Laboratories, North Chicago, IL) on days 3, 5, 7, 10, and 14 following herbicide exposure 
and vaccination.  Spleen wet weights were recorded.  Spleens were mechanically 
dissociated through Spectra nylon mesh (Spectrum Labs, Rancho Dominguez, CA) in 
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complete cell media containing RPMI-1640 (BioWhitaker, Walkersville, MD), 10% heat 
inactivated fetal bovine serum (FBS, Hyclone Laborat ries, Inc, Logan, UT), 10 mM 
HEPES (Sigma, St. Louis, MO), 1 mM L- glutamine (Gibco, Rockville, MD), 5x10-5 M 
2-mercaptoethanol (Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml streptomycin 
(Gibco).  To collect bone marrow cells, one hind leg was removed from each animal.  
Femur and tibia were flushed with complete media for single cell suspensions.  Red 
blood cells in the spleen and bone marrow populations were lysed with Tris-buffered 
ammonium chloride.  Cell suspensions were washed twice and counted by 
hemacytometer in Trypan blue. 
Flow cytometric analysis. 
Cells were stained with the appropriate combinations f rat anti-mouse B220-
APC (RA3-6B2), rat anti-mouse CD23-PE (B3B4), rat anti-mouse CD21-FITC (7G6), rat 
anti-mouse CD4-FITC (GK1.5), or rat anti-mouse CD8α-PE (53-6.7) (all from BD 
PharMingen, San Diego, CA).  All steps were performed in PBS supplemented with 1% 
FBS and 0.04% sodium azide (Sigma).  Briefly, 1 x 106 cells were stained in a total 
volume of 25 µl of antibodies at the appropriate concentrations fr 25 minutes on ice in 
the dark.  After incubation, cells were washed twice and fixed in 0.04% 
paraformaldehyde overnight at 40C (Fisher Scientific, Pittsburgh, PA).  The following 
day cells were washed twice to remove the paraformaldehyde and resuspended in 1 ml of 
staining media.  For each sample, 10,000 cells werecoll cted for analysis on a Becton-
Dickinson FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).  
Analysis was performed using WinMDI software (Joseph Trotter, Scripps Institute, San 
Diego, CA).  Population percentages, obtained from fl w cytometric analysis, were used 
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to calculate the absolute cell number by multiplying the percentage of cells in a 
population by the total number of cells harvested pr organ.  Marginal zone B cells are 
defined as B220+CD21/35hi CD23neg/low, follicular B cells are defined as B220+CD21/35int 
CD23hi (Oliver et al., 1997).  B cells are defined as all cells that are B220+ and include 
marginal zone B cells and follicular B cells.    
Measurement of antibody secreting B cells (ASC) in the bone marrow and spleen. 
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbo , MI) were coated 
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) or 50 µl PspA (10 
µg/ml) (PspA was a generous gift from Clifford Snapper, USUHS) overnight at 4°C.  In 
all subsequent steps, plates were washed with PBS + .01% Tween-20.  Plates were 
blocked with 200 µl/well complete media + 25% FBS for 2 hours at 37°C.  Plates were 
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or 
1x106 cells/ml.  All samples were plated in triplicate.  Plates were incubated for 4-6 hours 
at 37°C in a 5% CO2 incubator.  Plates were washed and goat anti-mouse alkaline 
phosphatase (AP) conjugated IgG, IgG1, IgG2a, IgG2b, IgG3, or IgM antibodies 
(Southern Biotechnology Associates, Birmingham, AL), diluted 1/250 in PBS + 1%BSA 
+ .05% Tween-20, were added to the appropriate wells (100 µl/well).  Plates were 
incubated overnight at 4°C and washed.  SIGMAFAST 5-bromo-4-chloro-3-indolyl 
phosphate/nitro blue tetrazolium tablets (Sigma-Aldrich, St. Louis, MO) were dissolved 
in distilled water and added at 100 µl/ well.  Color development was stopped by washing 
with distilled water.  The number of spots/well was counted using a dissection 
microscope (Olympus Optical Co., Melville, NY).  The number of ASC was calculated 
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by using the mean number of spots from triplicate wells.  Data are expressed as the 
number of ASC per 1 x 106 B cells or as the number of ASC per spleen or bone marrow.     
Measurement of PC- and PspA- specific titers. 
Serum samples were prepared via blood collected from the heart.  Immulon 2 
plates (for PC) or Immulon 4 plates (for PspA) (ThermoLabsystems, Franklin, MA) were 
coated overnight at 4°C with 5 µg/ml PC-BSA or 10 µg/ml PspA (50 µl/well).  Plates 
were washed, blocked with 3% BSA + PBS at 37°C for 2 hours.  Plates were washed and 
100 µl/well of twofold dilutions of sera in PBS +1% BSA were added starting at 1/400 
for the IgG and IgM ELISAs and 1/250 for the IgG subclasses.  Plates were then 
incubated for 1 hour at 37°C and washed.  AP conjugated antibodies (100 µl/well) were 
added for 1 hour at 37°C.  Plates were washed and phosphatase substrate tablets (Sigma-
Aldrich) were dissolved in PNPP (p-Nitrophenyl Phosphate, Disodium Salt) substrate 
buffer.  Plates were developed and absorbance read at 405nm on a µQuant 
spectrophotometer (Bio-Tek instruments, Winooski, VT) using KCJunior software (Bio-
Tek instruments).  To determine the titer a standard pooled sera was diluted and plated on 
each ELISA plate.  The titer for each sample was determined by comparison to the 
standard sera when the OD 405nm for the standard was 0.200 at a 1:3200 dilution for 
IgM and IgG or at 1:2000 for IgG2b and IgG3.  These dilutions were chosen because 
they are in the linear part of the curve for the respective isotypes. 
Measurement of ex vivo PC-specific antibody production.  
Spleen cells were cultured in vitro with no additional stimulation for 5 days at 
37°C and 5% CO2 at a concentration of 5x105 cells/ml in 500 µl complete media in 48 
well tissue culture plates (Costar, Corning Inc., Acton, MA).  All cultures were 
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performed in duplicate.  The protein synthesis inhibitor cycloheximide was added to 
replicate samples at a concentration of 75 µg/ml (50 µl/well) to distinguish the amount of 
antibody produced e novo in culture from preformed antibody secreted during the 
culture period (Dhanjal et al., 1992).  Supernatants were collected and antibody ELISAs 
were performed as described above.  De novo antibody synthesis was determined by 
subtracting the absorbance readings from cycloheximide treated cells from absorbance 
readings from non-cycloheximide treated cells.  
Statistics. 
One-way analysis of variance (ANOVA) was performed for all statistical analyses 
using a Dunnett’s t-test to compare herbicide treated nimals with control animals.  A 
significance level of p ≤ 0.05 was used for all tests.  Identification of possible mixture 
interactions was determined using a partial factorial design.  A mixture interaction was 
defined as the sum of the responses of the individual components of the mixture is 
significantly different from the response of the mixture treatment.  Statistical analysis 
was performed using JMP software (SAS Institute Inc., Cary, NC).  All experiments were 
performed 3 or more times with similar results.  The figures are representative data from 
one experiment.  
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RESULTS 
Propanil exposure increased the number of PC-specific antibody secreting B cells in 
the spleen. 
  To determine if propanil and 2,4-D had either individual effects or cooperative 
effects on the humoral response in the spleen, mice wer  vaccinated with HKSP and 
treated with either a single dose of propanil (150 mg/kg), 2,4-D (150 mg/kg), or a mixture 
(150/150 mg/kg).  Serum titers to the PC antigen ar detectable by day 4 and peak at day 
6-7 following HKSP vaccination (Wu et al., 2000; Wu et al., 1999).  Splenic ASC have 
been reported to peak 2-3 days prior to serum titers (Verheul et al., 1990).  Based on 
these reports, days 3, 5, 7, and 10 post-exposure wer  chosen to analyze the in vivo time 
course of the PC-specific antibody response.     
Initial experiments in vehicle control animals immunized with HKSP 
demonstrated that IgM ASC were detectable at day 3 (30 + 10 ASC/1 x 106 B cells, 
Figure 1A) and peak 5 to 7 days post-exposure (144 + 73 ASC and 252 + 42 ASC, 
respectively, Figure 1A).  There was no statistical difference between day 5 and day 7.  
By day 10, the number of splenic ASC in control animals had decreased 2-fold (83 + 35 
ASC).  The predominant isotypes produced were IgM, I G2b, and IgG3 and all had 
similar kinetics (Figure 1A, 1B, and 1C, respectively).  Comparable results were obtained 
when the number of ASC per spleen were determined (Figure 1D, 1E, and 1F).  IgG1 and 
IgG2a were below the limit of detection by ELISPOT at all time points. 
 Following exposure to propanil or the mixture of pro anil and 2,4-D, the number 
of PC-specific IgM (Figure 1A, 1D), IgG2b (Figure 1B, 1E), and IgG3 (Figure 1C, 1F) 
ASC were significantly increased 5 days after immunization (3-4 fold over vehicle 
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control).  Similar fold increases were determined for the number of ASC per whole organ 
(Figure 1D, 1E, 1F) and for the number of ASC normalized to one million B cells (Figure 
1A, 1B, 1C) in all experiments.  There was a statistically significant 4-6-fold increase in 
the number of IgM, IgG2b, and IgG3 ASC in the animals treated with propanil alone or 
the mixture at day 7 post-exposure (Figure 1A - 1F).  By day 10, the number of ASC was 
declining in all groups, but was still significantly increased 3.5 fold in propanil and 
mixture-treated animals over control animals (Figure 1A - 1F).  2,4-D exposure alone did 
not alter the splenic ASC response compared to the control at any of the days measured 
(Figure 1A - 1F).  Propanil and mixture-treated animals produced statistically similar 
ASC responses in the spleen, which suggests that the propanil component of the mixture 
is responsible for the increase in ASC in the spleen.   
Previous studies had demonstrated that propanil treatment induces splenomegaly 
(Barnett and Gandy, 1989).  The spleen weights were d t rmined after herbicide 
exposure and HKSP vaccination.  Propanil and the mixture of propanil and 2,4-D, but not 
2,4-D alone, caused an increase in spleen weight at 7 and 10 days post-exposure (Figure 
2).  However, flow cytometric analysis of the major cell populations in the spleen at all 
time points determined that there were no significant changes in any of the treatment 
groups in the number of total B220+ B cells, CD21/35hi CD23neg/low marginal zone B 
cells, CD21/35int CD23hi follicular B cells, CD4+ T cells, and CD8+ T cells (Table 1, 
representative data from day 7 post-exposure and vaccination).    The total number of 
bone marrow cells was also comparable for the vehicle (28.5 ± 1.8 x 106), propanil (27.6 
± 3.5 x 106), 2,4-D (25.4 ± 3.8 x 106), and mixture treated groups (27.4 ± 3.2 x 106). 
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Additional experiments were performed to determine the dose response to 
propanil that enhanced the ASC response in the splen.  The lowest observed adverse 
effect level (LOAEL) dose of propanil that induced an increase in PC-specific ASC over 
control animals was 50 mg/kg (Figure 3A – 3F).  A 25 mg/kg dose of propanil failed to 
increase the number of splenic ASC over control anim ls (Figure 3A – 3F).  A higher 
dose of propanil of 200 mg/kg increased the ASC respon e 4-6 fold, similar to the 150 
mg/kg dose (data not shown).    
Ex vivo splenic antibody production is increased in propanil-treated mice. 
To determine if there was a concomitant increase in antibody production from the 
spleens of animals that had an increase in ASC, spleens were harvested 7 days post-
exposure and immunization and cultured in vitro for 5 days.  The supernatants were 
harvested and IgM and total IgG determined by ELISA.  Spleen cells from propanil and 
mixture-treated animals produced antibody at concentrations 3-4 fold higher than spleen 
cells from the vehicle control or 2,4-D- treated animals (Figures 4A and 4B).  Analyses 
performed from day 5 and day 10 post-exposure and immunization had similar results 
(data not shown).      
2,4-D decreased the number of PC-specific ASC in the bone marrow.  
The number of PC-specific ASC in the bone marrow was also measured on days 
3, 5, 7, and 10 post-exposure and vaccination.  Individual isotypes were not detectable in 
the bone marrow at days 3 and 5 after immunization.  However, IgM and total IgG were 
detectable at the early time points (Figure 5A – 5D).  2,4-D and mixture herbicide 
exposure decreased the number of PC-specific IgM and IgG ASC in the bone marrow 
approximately 2-fold by day 5 compared to the vehicl  controls (Figure 5A – 5D).  There 
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was a significant decrease at days 7 and 10 (2-3 fold) in ASC in the bone marrow 
(Figures 5A – 5D).  Propanil-treated animals had responses comparable to the vehicle 
controls at all time points (Figure 5A – 5D).  These results suggest that the 2,4-D 
component of the mixture is responsible for the reduction in ASC in the bone marrow.   
Propanil exposure did not increase the PC-specific titers, however 2,4-D exposure 
decreased the PC-specific titers. 
PC-specific titers were measured to determine if the increase in ASC in the 
spleens of propanil-treated mice, or the decrease in bone marrow ASC in 2,4-D-treated 
mice, altered serum titers.  Individual isotypes were not detectable at day 3.  Propanil and 
vehicle control animals had comparable titers of IgM, IgG2b, and IgG3 at 5, 7, and 10 
days post-exposure and immunization (Figure 6A, 6B, and 6C).  These results 
demonstrate that the increased splenic ASC in propanil-treated mice do not affect the 
serum antibody titers.  However, 2,4-D and mixture treatments significantly reduced the 
PC-specific IgM, IgG2b, and IgG3 isotypes 3-4 fold from vehicle control and propanil-
treated animals by day 10 (Figure 6A, 6B, and 6C).  The serum titers of mixture and 2,4-
D-treated groups were not significantly different, i dicating that 2,4-D is the chemical 
component of the mixture responsible for the decrease in titers.  The results also indicate 
a correlation between the reduced bone marrow ASC response and the decrease in serum 
antibody levels.    
Herbicide exposure does not affect the antibody response to PspA. 
 To determine if exposure to propanil, 2,4-D, or the mixture would affect the 
response to a TD antigen, mice were treated with the herbicides and vaccinated with 
HKSP.  The peak serum antibody response to PspA has been demonstrated to be at 14 
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days post-vaccination (Wu et al., 1999).  The results demonstrate that the number of 
splenic IgM and total IgG PspA-specific ASC was comparable to the vehicle control in 
the propanil, 2,4-D and mixture-treated animals 14 days after herbicide exposure and 
vaccination with HKSP (Figure 7A – 7D).  The PspA-specific serum antibody titers were 
also not affected by herbicide exposure and were comparable for all of the treatment 
groups (data not shown).  The PspA-specific ASC in the bone marrow were below the 





 Propanil and 2,4-D are immunotoxic herbicides commnly applied together as a 
mixture (Crop Protection Handbook, 2003; Farenhorst and Prokopowich, 2003).  
Previous findings have demonstrated that the two herbicides exert greater-than-additive 
immunotoxic effects on the primary immune organs, the thymus and bone marrow (de la 
Rosa et al., 2003; de la Rosa et al., 2005).  However, the present study demonstrated that 
there was no subsequent effect on the mature lymphocyte populations in the spleen.  The 
increase in total spleen cell number in the mixture-treated group is probably due to the 
presence of immature precursor cell populations as determined by differential analysis 
(not shown).  Furthermore, increased immunotoxicity due to mixture exposure did not 
occur in the humoral response to HKSP examined in the present study.  At the 150 mg/kg 
1:1 mixture tested, the mixture combination failed to produce a greater-than-additive 
effect on ASC or the serum antibody levels.  Splenic PC-specific ASC were increased to 
the same extent in both propanil and mixture-treated mice, suggesting that propanil was 
responsible for the increase in splenic ASC.  Reduction in the number of bone marrow 
PC-specific ASC and serum antibody titers was dependent on 2,4-D treatment.  These 
experiments indicate that propanil and 2,4-D modulate the immune response to 
vaccination with HKSP independently. 
 Propanil magnified the splenic PC-specific ASC response without altering the 
kinetics of the response or shifting the isotype comp sition.  The earliest observed 
increase due to propanil exposure was 5 days post-exposure.  Maximal effects were 
observed at day 7 and ASC decreased by day 10.  Both T helper 1 (Th1) and Th2 
cytokines alter the antibody response.  IFN-γ, a Th1 cytokine, promotes IgG3 production 
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and TGF-β, a Th2 cytokine, promotes a shift to IgG2b production (Stavnezer, 1996).  The 
retention of the predominant PC-specific isotypes IgG3 and IgG2b suggests that propanil 
does not skew the cytokine profile of the immune response.  The kinetics of the splenic 
antibody response in propanil and vehicle-treated anim ls were similar, suggesting that 
proliferation and activation is not unregulated as would be indicated by a continued 
increase in ASC at day 10.   
 Despite a several fold increase in the number of PC-specific ASC in the spleen, 
and an increased ex vivo production of PC-specific antibody by splenocytes from 
propanil-treated animals in comparison to the control, he serum antibody titers were 
comparable for the two groups.  There are several possible explanations for this result.  
First, it is possible that the increased amount of antibody produced in propanil-treated 
animals remains localized to the spleen.  Second, the antibodies produced in the spleen in 
propanil-treated mice may be rapidly catabolized if serum antibodies levels are at a 
saturated concentration, therefore no increase in srum titers would be detected.  
However, the second possibility is unlikely since mixture-treated animals also had 
increased splenic ASC but reduced serum titers.  Several earlier reports established the 
bone marrow as the primary source of serum antibodies (reviewed in Benner et al., 
1981).    Exposure to propanil had no effect on the number of bone marrow PC-specific 
ASC.  In contrast to propanil, 2,4-D decreased PC-specific ASC in the bone marrow and 
the decrease correlated with a decrease in PC-specific titers.  Splenic ASC were 
comparable to control animals after 2,4-D exposure.  Taken together, the results suggest 
that 2,4-D decreased serum PC-specific titers by decreasing bone marrow ASC and 
demonstrates the importance of bone marrow ASC for PC-specific titers during the 
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primary response to HKSP.  The ability of a chemical to decrease the number of plasma 
cells in the bone marrow could have long-term implications for maintaining circulating 
levels of protective antibody after immunizations. 
In contrast to the results presented here, propanil exposure has previously been 
reported to suppress the number of plaque-forming cells after immunization with the TI-2 
antigen DNP-Ficoll, and the TD antigen, SRBC (Barnett and Gandy, 1989; Barnett et al., 
1992).  The nature of the antigen may be important for the immunomodulation of the 
immune response by propanil.  DNP-Ficoll and PC are both model TI-2 antigens.  
However, in the present study, PC is presented in the context of whole HKSP, a complex 
particulate immunogen.  It was previously demonstrated that the requirements for the 
humoral response to PC, after immunization with HKSP, is substantially different than 
after immunization with purified polysaccharide prearations (Wu et al., 1999).  
Although the PC antibody response is classically considered to be T-independent, Wu et 
al, (1999) demonstrated that the IgG isotype responses to PC after immunization with 
HKSP was decreased in T cell receptor β knock-out mice.  In addition, they demonstrated 
that CD4+ T cells and CD8+ T cells contributed to an optimal antibody response, and the 
PC response was significantly decreased in CD40L knoc out mice (Wu et al., 1999).  
Further studies demonstrated that noncognate T cell help was required for an optimal PC 
response after HKSP immunization (Wu et al., 2002).  Therefore, propanil could affect 
one of the components necessary for the response to PC after immunization with HKSP 
that is not required after immunization with soluble DNP-Ficoll. 
The time of exposure to the herbicide may also be important to the subsequent 
effects on the immune response.  In the previous studies that demonstrated propanil 
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suppressed the plaque-forming cell response to SRBC and DNP-Ficoll, the antigens were 
administered 3 days after propanil exposure (Barnett and Gandy, 1989; Barnett et al., 
1992).  In the present study, propanil was administered at the time of HKSP vaccination.  
This may suggest that propanil is acting as an adjuv nt to affect innate immune 
mechanisms and enhance the immune response to PC.  
The antibody response to vaccination with HKSP is influenced by the early innate 
immune response.  S. pneumoniae has pathogen associated molecular patterns on its 
surface that can stimulate signaling pathways through pattern recognition receptors such 
as toll-like receptor-2 (TLR2) (Yoshimura et al., 1999).  It was recently demonstrated 
that the IgG2b and IgG3 antibody response to PC after immunization with heat-killed S. 
pneumoniae type 14 is decreased in TLR-2 knockout mice (Khan et al., 2005).  The 
complement pathways are also important for the innate immune response to S. 
pneumoniae that can influence the subsequent adaptive immune response (Brown et al., 
2002).  Conjugation of the complement component, C3d, to pneumococcal capsular 
polysaccharide, has been demonstrated to enhance the antibody response to the 
polysaccharide dependent on the dose of antigen (Test et al., 2001).  Similarly, 
preliminary studies in our laboratory suggest that e dose of HKSP is important, as mice 
vaccinated with suboptimal doses of HKSP did not have an increase in ASC.  The effect 
of propanil on specific components of the innate immune response has not been 
investigated.  
Propanil may alter the immune response through interac ions with the endocrine 
system.  Propanil induces thymic atrophy primarily through the induction of 
glucocorticoids, however, inhibition of glucocortico d production does not completely 
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abrogate thymic atrophy (Cuff et al., 1996; de la Rosa et al., 2005).  In addition, 
glucocorticoids are reported to inhibit Th1 responses and enhance Th2 responses 
(Ashwell et al., 2000; Miyaura and Iwata, 2002).  Propanil did not alter the major isotype 
response to PC, which suggests that the T cell response and subsequent production of 
cytokines driving B cell switching was not affected.  This suggests that additional 
mediators may play a role in the immunotoxic effects of propanil.  Propanil also 
decreases the pre-B cell and IgM+ B cell populations in the bone marrow via an unknow  
mechanism (de la Rosa et al., 2003).  Similar to propanil, 17β-estradiol exposure has 
been shown to induce thymic atrophy and decrease immature B cell populations in the 
bone marrow (Erlandsson et al., 2003).  Chronic exposure to 17β-estradiol has been 
reported to increase ASC to bacterial and autoantige s in C57BL/6 mice (Verthelyi and 
Ahmed, 1998).  In addition, exposure to 17β-estradiol was demonstrated to increase 
activation of the marginal zone B cell population and lead to the production of 
autoantibodies by the marginal zone B cells (Grimaldi et al., 2001).  Marginal zone B 
cells are crucial in the generation of the immune response to TI-2 antigens (reviewed in 
Zandvoort and Timens, 2002).  Mice deficient in marginal zone B cells have a deficient 
antibody response to TI-2 antigens (Guainamard et al., 2000).  If propanil induced the 
production of 17-β estradiol it could enhance the antibody response to PC through the 
effects of 17-β estradiol on the marginal zone B cell population.  Preliminary studies in 
our laboratory have demonstrated that propanil does n t increase the number of PC-
specific splenic ASC in ovariectomized mice suggesting an important potential role for 
17β-estradiol.   
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The mechanism by which 2,4-D decreased the bone marrow PC-specific ASC is 
unknown.  However, there are several possibilities.  Homing of plasma cells from the 
spleen to the bone marrow is dependent on the expression of the chemokine receptor, 
CXCR4, on splenic plasma cells and its ligand, CXCL12, in the bone marrow (Erickson 
et al., 2003).  The splenic ASC in 2,4-D-treated mice could be defective in the expression 
of CXCR4.  It is also possible that production of CXCL12 in the bone marrow could be 
defective.  Finally, support of plasma cells in thebone marrow could be affected due to 
damage to the bone marrow microenvironment. 
In contrast to the effect on the TI-2 antigen, PC, exposure to propanil, 2,4-D or 
the mixture had no effect on the response to the TD antigen, PspA.  The number of PspA-
specific ASC in the spleen and the serum titers to PspA were comparable to the controls 
for all of the treatment groups.  This could suggest that the effects of both propanil and 
2,4-D occur early after vaccination when the TI-2 antigen response is being generated.  If 
propanil has effects on the innate immune system or on marginal zone B cells which are 
critical to the response to TI-2 antigens, as discus ed above, the effects may not impact 
the subsequent response to the TD antigen, PspA.  A second possibility is that the time of 
exposure to the herbicides during the immune response to each antigen is critical.  In the 
experiments presented here, herbicide exposure was on the day of HKSP vaccination.  
The peak response to PC was determined 7 days post-exposure while the peak response 
to PspA is at day 14.  If the herbicides mediate their effect during the time antigen-
specific B cells are undergoing activation or expansio , and the effect is short-term, then 
the later response to PspA may not be affected.  Similar to PspA, propanil exposure does 
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not increase the number of splenic IgM ASC to SRBC, another TD antigen, when 
administered at the time of SRBC immunization (de la Rosa, unpublished results).      
As the use of herbicides escalates, it is necessary to have an accurate 
understanding of the risks associated with their use.  This report illustrates the importance 
of studying immunotoxic effects using naturally occurring microbial pathogens and the 
diverse effects that different compounds can have.  The enhanced antibody response after 
exposure to propanil has implications for the potential of this class of compounds to be 
environmental factors in autoimmune disease.  In contrast, other compounds, such as 2,4-
D, may impair the ability of the host to mount an appropriate protective immune response 
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Figure 1.  Propanil and mixture exposure increases the number of PC-specific ASC 
in the spleen.   
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated 
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.  
Spleens were removed at days 3, 5, 7, and 10.  Numbers of PC-specific IgM (A, D), 
IgG2b (B, E), and IgG3 (C, F) ASC were determined by ELISPOT assay. All values 
represent the mean ± SD of ASC per 1x106 B cells (A, B, and C) or per spleen (D, E, F).  
Propanil and mixture treatments are significantly different from vehicle control on days 



































Figure 2.  Propanil and mixture exposure increase spleen weight.   
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated 
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.  
Spleens were removed at days 3, 5, 7, and 10 and the wet weights determined.  Results 
are expressed as the ratio of spleen weight to bodyweight. Propanil and mixture 



















Table 1. Spleen cell populations 7 days after herbicide exposure and HKSP 
vaccination. 
 






CD4+ T cells CD8+ T cells 
Vehicle   80 ± 13.6    30 ± 3.6
d  1.9 ± 0.25  20 ± 3.8  18 ± 5.1  11 ± 3.7  
Propanil 108 ± 31.8  34 ± 6.4  2.1 ± 0.31  23 ± 4.2  22 ± 5.9  15 ± 3.5  
2,4-D   76 ± 17.6  33 ± 7.7  1.8 ± 0.42  22 ± 4.9  18 ± 5.0  12 ± 3.5  
Propanil/2,4-D  143 ± 35.7e  40 ± 5.4  2.1 ± 0.43  26 ± 2.4  27 ± 3.1  17 ± 0.9  
a C57BL/6 mice (5/group) were vaccinated with HKSP and treated with vehicle, 150 
mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mg/kg mixture of propanil and 2,4-D.  
Spleens were harvested on day 7. 
b Total number of spleen cells (x 106) ± SD.   
c Individual cell populations were determined by flow cytometric analysis as described in 
the Methods.   
d Data represents the total number of cells (x 106) ± SD. 















































































































Figure 3.  Propanil increases the number of splenic ASC in a dose dependent 
manner.   
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated 
with vehicle control (0), 25 mg/kg, 50 mg/kg, and 150 mg/kg propanil.  Spleens were 
removed at day 7.  Numbers of PC-specific IgM (A, D), IgG2b (B, E), and IgG3 (C, F) 
ASC were determined by ELISPOT assay. All values represent the mean ± SD of ASC 
per 1x106 B cells (A, B, and C) or per spleen (D, E, F).  The asterisk (*) represents a 
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Figure 4.  Propanil and mixture exposure increases ex vivo antibody production by 
splenocytes following HKSP vaccination.   
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated 
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.  
Spleens were harvested on day 7 and cultured in vitro for 5 days.  Antibody supernatants 
were collected and analyzed by ELISA.  De novo PC-specific IgM (A) and IgG (B) 
production was determined by subtracting cycloheximide treated samples from the total 
antibody produced.  Values represent the mean d  novo antibody produced ± SD.  
Propanil and mixture treatments are significantly different from vehicle control at 







































































Figure 5. 2,4-D and mixture exposure decreases the number of PC-specific bone 
marrow ASC.   
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated 
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.  Bone 
marrow was harvested on days 3, 5, 7, 10.  Numbers of PC-specific IgM (A, C) and IgG 
(B, D) ASC were determined by ELISPOT assay.  Values represent the mean ± SD of 
ASC per 1x106 bone marrow cells (A, B) or per total bone marrow (D, E).  2,4-D and 
mixture treatments are significantly different from vehicle control on days 5, 7, and 10 












































Figure 6.  2,4-D and mixture exposure decreases PC-specific titers.   
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated 
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.  
Serum was collected on days 3, 5, 7, 10.  The titers of PC-specific IgM (A), IgG2b (B), 
and IgG3 (C) were determined by ELISA.  Values represent the mean ± SEM.  2,4-D and 
mixture treatments are significantly different from vehicle control at day 10 for IgM and 






















































Figure 7.  Herbicide exposure has no effect on the number of splenic PspA-specific 
ASC.   
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated 
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.  
Spleens were harvested on day 14.  Numbers of PspA-specific IgM (A, C) and IgG (B, 
D) ASC were determined by ELISPOT assay.  Values represent the mean ± SD of ASC 


























CHAPTER 4: FURTHER CHARACTERIZATION OF THE 
EFFECT OF PROPANIL EXPOSURE ON THE HUMORAL 




















 Previous studies demonstrated that propanil enhances the antibody response to the 
TI-2 antigen PC when presented on the surface of killed whole bacteria (de la Rosa, 
2005).  However, propanil did not increase the number of ASC to the TD antigen PspA 
on day 14 in mice that were vaccinated and treated with herbicides on day 0 (de la Rosa, 
2005).  In addition, the increased number of PC-specific ASC in propanil-treated animals 
did not cause an elevated response in PC-specific serum titers.  The following 
experiments were performed to answer a number of questions raised from these findings 
that are important in determining the immune-based m chanisms involved in enhancing 
the humoral response. 
 The context in which the antigen is presented to the immune system can alter the 
response in a number of ways.  For example, S. pneumoniae contains a number of 
pathogen associated molecular patterns (PAMPS) that are recognized by Toll-like 
receptors (Sen et al., 2005).  TLR have been shown to be important for enhanced 
antibody responses (Sen t al., 2006).  Processing and presentation by the APCs differs in 
mice immunized with particulate or soluble antigens (Ramachandra et al., 1999).  An 
example of a soluble antigen that induces a TI-2 PC-specific response independent of 
TLR activation is PC-Ficoll.  The following experiments utilized PC-Ficoll to evaluate 
the importance of soluble versus particulate antiges in the ability of propanil to enhance 
the immune response. 
 The inability of propanil to increase the number of PspA-specific ASC suggests 
that propanil may induce changes on a specific subset of B cells responsible for TI-2 
responses and the effect is independent of T-cell help.  Alternatively, propanil may 
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enhance the antibody response only within a limited timeframe following herbicide 
exposure.  For example, immunization of mice with DNP-Ficoll 3 days following 
propanil exposure suppresses the antibody response on day 7 (Barnett et al., 1992).  
Given that the PspA response is not measurable until day 6 and peaks around 10-14 days, 
it is possible that propanil, which is eliminated from the body within 2 days, may not 
remain in the animal long enough to enhance the PspA response (Izmerov, 1984).  
Experiments were also performed to determine the effect of exposure to herbicides at 
different time points following HKSP immunization o the PspA response.   
 The inability of propanil to increase serum titers despite a robust enhancement of 
the splenic response and increased ex vivo antibody production suggest a number of 
explanations.  Antibody catabolism has been discussed in Chapter 3.  Alternatively, the 
increased antibodies may not exit the spleen into the serum due to binding of the 
antibodies to HKSP in the spleen.  Finally, the serum antibody titers may be increased at 




 Six to eight week old C57Bl/6 female mice were purchased from Hill Top Lab 
Animals (Scottdale, PA).  Mice were housed in microisolator cages in pathogen free 
conditions at West Virginia University’s animal facility.  Mice were kept on a 12 hr light-
dark cycle and allowed to acclimate to the facility for 1 week.  These studies were 
conducted in accordance with all federal and institutional guidelines for animal use and 
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were approved by the West Virginia University Institutional Animal Care and Use 
Committee. 
Reagents 
 Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem 
Service (West Chester, PA).  PC-Ficoll containing 6 PC molecules per molecule of Ficoll 
was purchased from Biosearch Technologies (Novato, CA).  PC-KLH containing 15 PC 
molecules per molecule of Ficoll was purchased from Biosearch Technologies.   
Bacterial preparation and immunization with R36A 
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to 
mid-log phase in Todd-Hewitt broth  (Becton Dickinso , Sparks, MD) + .05% yeast 
extract (Becton Dickinson) and stored at –80°C.  For immunization, stock was cultured in 
a candle jar for 18 hrs at 37°C on blood agar plates (Becton Dickinson).  A few 
characteristic colonies were selected and suspended i  200 ml Todd-Hewitt broth + .05% 
yeast extract.  Bacteria were grown at 37°C to an absorbance reading at 650nm of 0.4 and 
heat killed for 4 hours in a 60°C water bath.  A final concentration of 109 CFU/ml was 
established in PBS based on colony counts.  Sterility was confirmed by culture.  Heat-
killed stock was stored at -20°C in 1 ml aliquots.  Mice were immunized ip with eith r 
5x106 or 2x108 CFU. 
Animal exposures 
 Propanil was dissolved in peanut oil for a final con entration of 15 mg/ml for all 
experiments.  Mice (5/group) were treated ip with eer 150 mg of propanil/kg of body 
weight (mg/kg) or vehicle on the same day as immunization.  For PC-Ficoll, mice were 
immunized i.p. with 50µg of PC-Ficoll in 200 µl PBS as in a previous study (Wu et al., 
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1999).  For PC-KLH immunizations, mice were immunized i.p. with 100µg of PC-KLH 
in 200 µl PBS.   
Preparation of splenocytes 
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott 
Laboratories, North Chicago, IL) vaccination.  Spleen wet weights were recorded.  
Spleens were mechanically dissociated through Spectra nylon mesh (Spectrum Labs, 
Rancho Dominguez, CA) in complete cell media containing RPMI-1640 (BioWhitaker, 
Walkersville, MD), 10% heat inactivated fetal bovine serum (FBS, Hyclone Laboratories, 
Inc, Logan, UT), 10 mM HEPES (Sigma), 1 mM L- glutamine (Gibco, Rockville, MD), 
5x10-5 M 2-mercaptoethanol (Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml 
streptomycin (Gibco).  Red blood cells in the spleen w re lysed with Tris-buffered 
ammonium chloride.  Cell suspensions were washed twice and counted using a 
hemacytometer.  Viability was determined using Trypan blue dye exclusion. 
Measurement of antibody secreting B cells (ASC) in the spleen 
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbo , MI) were coated 
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) or 50 µl PspA (10 
µg/ml) (PspA was a generous gift from Clifford Snapper, USUHS) overnight at 4°C.  In 
all subsequent steps, plates were washed with PBS + .01% Tween-20.  Plates were 
blocked with 200 µl/well complete medium + 25% FBS for 2 hours at 37°C.  Plates were 
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or 
1x106 cells/ml.  All samples were plated in triplicate.  Plates were incubated for 4-6 hours 
at 37°C in a 5% CO2 incubator.  After washing, goat anti-mouse alkaline phosphatase 
(AP) conjugated IgG, IgG1, IgG2a, IgG2b, IgG3, or IgM antibodies (Southern 
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Biotechnology Associates, Birmingham, AL), diluted 1/250 in PBS + 1%BSA + .05% 
Tween-20, were added to the appropriate wells (100 µl/well).  Plates were incubated 
overnight at 4°C and washed.  SIGMAFAST 5-bromo-4-chloro-3-indolyl phosphate/nitro 
blue tetrazolium tablets (Sigma-Aldrich, St. Louis, MO) were dissolved in distilled water 
and added at 100 µl/ well.  Color development was stopped by washing with distilled 
water.  The number of spots/well was counted using a dissection microscope (Olympus 
Optical Co., Melville, NY).  The number of ASC was calculated by using the mean 
number of spots from triplicate wells.  The number of ASC was normalized to 1x106 B 
cells.  Comparable fold increases were noted when normalized to whole spleen. 
Flow cytometric analysis 
Splenic cells were stained with the appropriate combinations of rat anti-mouse 
B220-APC (RA3-6B2).  All steps were performed in PBS supplemented with 1% FBS 
and 0.04% sodium azide (Sigma).  Briefly, 1 x 106 cells were stained in a total volume of 
25 µl of antibodies at the appropriate concentrations fr 25 minutes on ice in the dark.  
After incubation, cells were washed twice and fixed in 0.04% paraformaldehyde 
overnight at 4°C (Fisher Scientific, Pittsburgh, PA).  The following day cells were 
washed twice to remove the paraformaldehyde and resusp nded in 1 ml of staining 
media.  For each sample, 10,000 cells were collected for analysis on a Becton-Dickinson 
FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).  Analysis was 
performed using WinMDI software (Joseph Trotter, Scripps Institute, San Diego, CA).  
Population percentages, obtained from flow cytometric analysis, were used to calculate 
the absolute cell number by multiplying the percentage of cells in a population by the 
total number of cells harvested per organ.   
 104 
Measurement of PC- and PspA- specific titers 
Serum samples were prepared via blood collected from the heart.  Immulon 2 
plates (for PC) or Immulon 4 plates (for PspA) (ThermoLabsystems, Franklin, MA) were 
coated overnight at 4°C with 5 µg/ml PC-BSA or 5 µg/ml PspA (50 µl/well).  Plates were 
washed, blocked with 3% BSA + PBS at 37°C for 2 hours.  Plates were washed and 100 
µl/well of twofold dilutions of sera in PBS +1% BSA were added starting at 1/400 for the 
IgG and IgM ELISAs and 1/250 for the IgG subclasses.  Plates were then incubated for 1 
hour at 37°C and washed.  AP conjugated antibodies (100 µl/well) were added for 1 hour 
at 37°C.  Plates were washed and phosphatase substrate tablets (Sigma-Aldrich) were 
dissolved in PNPP (p-Nitrophenyl Phosphate, Disodium Salt) substrate buffer.  Plates 
were developed and absorbance read at 405nm on a µQu nt spectrophotometer (Bio-Tek 
instruments, Winooski, VT) using KCJunior software (Bio-Tek instruments).   
Statistics 
ANOVA was performed for all statistical analyses using a Tukey-Kramer t-test to 
perform multiple comparisons between all treatment groups.  A significance level of p ≤ 
0.05 was used for all tests.  Statistical analysis wa performed using JMP software (SAS 
Institute Inc., Cary, NC).  All experiments were performed 3 or more times with similar 
results.  The figures are representative data from one experiment. 
 
RESULTS 
Propanil increases the number of PC-specific ASC following PC-Ficoll 
immunization. 
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 Previous studies have demonstrated that propanil increases the antibody response 
to PC following immunization with the particulate antigen HKSP.  To determine if the 
propanil-induced antibody enhancement requires immunization with whole bacteria, mice 
were vaccinated with the soluble TI-2 antigen PC-Ficoll and treated on the same day with 
propanil or vehicle.  The number of splenic PC-specific ASC and the PC-specific serum 
titers were determined 7 days later by ELISPOT and ELISA, respectively.  Propanil 
increased the number of PC-specific IgG2b, IgG3 and IgM ASC 3-4 fold in PC-Ficoll 
immunized animals (Figure 1).  The fold increase in ASC in propanil-treated and PC-
Ficoll immunized mice was similar to propanil-treatd HKSP immunized mice.  
However, the baseline PC response to PC-Ficoll was 6-10 fold lower than after 
vaccination with HKSP (Figure 1).  However, PC-specific serum titers in propanil-treated 
mice were not significantly increased following eith r PC-Ficoll or HKSP immunization 
compared to the controls (Figure 2).  This data suggests that propanil induces a similar 
effect on the immune response to a soluble TI-2 antige . 
Propanil does not enhance the antibody response to a suboptimal HKSP 
immunization. 
These experiments were performed to determine if the propanil-induced 
enhancement of the antibody response has a minimum threshold for antigen stimulation.  
To determine if propanil exposure can increase the antibody response to a suboptimal 
immunization to the same level as an optimal immunization, mice were immunized with 
5x106 or 2x108 CFU of HKSP and treated on the same day with propanil or vehicle.  The 
number of PC-specific ASC was determined at day 7.  The number of PC-specific ASC 
in vehicle-treated mice immunized with 5x106 CFU HKSP is decreased 4-5-fold from 
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mice immunized with 2x108 CFU HKSP (Figure 3).  In addition, propanil does not
significantly affect the number of PC-specific ASC in mice immunized with 5x106 CFU 
HKSP.  This data suggests that propanil enhancement of the antibody response has a 
minimum threshold of antigen stimulation to induce th effect.   
Propanil increases secondary antibody responses to PC and PspA. 
 
Previous data demonstrated that propanil enhances a prim ry TI-2 antibody 
response but not a primary TD response.  These experiments were performed to 
determine if propanil enhances a TI-2 or TD secondary antibody response and if multiple 
exposures to propanil can produce either greater enhancement or prolonged enhancement 
of the antibody response.  Mice were immunized with 2x108 HKSP on day 0 and day 14.  
Mice were exposed to propanil on either day 0, day 14, or days 0 and 14.  PC and PspA- 
specific antibody responses were measured on day 21.  The number of PC-specific ASC 
from mice treated with propanil once on day 0 and mice treated with propanil twice on 
days 0 and 14 were not significantly different from vehicle controls (Figure 4A).  
However, PC-specific ASC from mice exposed to propanil once on day 14 were 
increased 2-3 fold compared to controls (Figure 4A).  None of the propanil exposure 
treatments significantly affected PC-specific serum titers (Figure 5A).  
The effect of propanil on the PspA-specific response was similar to the PC-
specific response.  The number of PspA-specific ASC from mice exposed to propanil 
once on day 14 was increased 2-fold compared to vehicle-treated mice (Figure 4B).  
Propanil exposure on day 0 or days 0 and 14 did not significantly affect the number of 
PspA-specific ASC (Figure 4B).  None of the propanil exposure treatments significantly 
affected PspA-specific serum titers (Figure 5B).  Altogether, these data suggest that 
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propanil enhances the antibody response to both protein and polysaccharides.  However, 
enhanced splenic ASC did not increase serum titers on day 21.  
Delayed propanil exposure enhances a primary antibody response to PspA. 
 The previous findings demonstrating that propanil enhances the secondary 
antibody response to PspA when mice are exposed on day 14 suggest that the 
enhancement of the antibody response is dependent on the time of propanil exposure 
relative to the developing antibody response.  To determine if propanil can increase the 
number of PspA-specific ASC during a primary response, mice were immunized with 
HKSP on day 0 and treated with propanil on day 9.  The PspA and PC antibody responses 
were measured on day 14.  The number of PspA-specific ASC was increased 
approximately 2-fold compared to vehicle-treated mice (Figure 6A).  In addition, the 
number of PC-specific ASC was also increased 4-6-fold in propanil-treated mice 
compared to vehicle controls (Figure 6B).  This data demonstrates that the enhancement 
of the antibody response is dependent on the conditi  of the antibody response when 
mice are exposed to propanil. 
Propanil does not enhance the antibody response following PC-KLH immunization. 
 To determine if propanil requires the TD antigen to be presented in a particulate 
form such as HKSP to enhance the antibody response, mic  were immunized with PC-
KLH or HKSP and treated with propanil or vehicle on day 0.  The number of PC-specific 
ASC was determined on day 7.  Both high affinity and low affinity PC-specific ASC 
were also determined by using a high and low conjugation ratio of PC-BSA.  To detect 
high affinity ASC, ELISPOT plates were coated with 2PC-BSA.  Low affinity ASC were 
detected by 15PC-BSA coated plates.  PC-KLH immunization produced a 2-fold greater 
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number of ASC in vehicle-treated animals compared to vehicle-treated animals 
immunized with HKSP (Figure 7A).  Interestingly, pro anil did not enhance the PC-
specific response following PC-KLH immunization (Figure 7A).  Analysis of the affinity 
of PC-specific antibodies demonstrates that the number of low affinity ASC is 20%, 65%, 
and 220% greater than high affinity IgM, IgG3, and IgG2b ASC, respectively (Figure 7A 
vs. Figure 7B).  This data indicates that high and low affinity ASC are detectable with 
this assay.  The number of low affinity PC-specific ASC in propanil-treated animals was 
increased approximately 4-fold for IgG2b and 5-fold f r IgG3 and IgM (Figure 7A).  The 
number of high affinity PC-specific ASC in propanil-treated animals were increased 
approximately 6-fold, 5-fold, and 4-fold for IgG2b, IgG3, and IgM, respectively (Figure 
7B).  Altogether, this data suggests that propanil does not preferentially increase either 
high or low affinity ASC. 
 
DISCUSSION 
 This set of experiments addressed a number of questions concerning the effect of 
propanil on the antibody response.  Effects of propanil on humoral responses to 
particulate and soluble antigens also provide important information on any putative 
effects on antigen processing.  As mentioned previously, the role of T cells in the 
amplification of the antibody response can be assessed through TI-2 and TD comparison 
studies.  Finally, determining when during the time of the response the immune system is 
susceptible to the effects of propanil exposure was also addressed.  The results from these 
initial experiments may help to focus experiments studying the immunological 
mechanisms regulating the enhanced antibody response.   
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 These data suggest that the increased antibody response is not due to a 
nonspecific polyclonal increase in ASC.  Propanil increased the PC-specific response 
following HKSP and PC-Ficoll immunization.  However, p opanil does not increase the 
PC-specific response following PC-KLH immunization, despite a robust antibody 
response at day 7.  In addition, propanil induction of onspecific polyclonal activation 
would predict a greater increase in low affinity PC-specific B cells.  However, the data 
indicates that both high and low affinity PC-specific ASC are increased equally.  
Previous reports demonstrated that the low affinity PC-specific serum titers are increased 
120% compared to high affinity PC-specific serum titers in samples collected on days 6 
or 9 (Wu and Ward, 1993).  However, the affinity of individual isotypes was not 
determined (Wu and Ward, 1993).  Our study supports the previous affinity analysis 
however precise comparisons are difficult due to the different time points and antigen 
employed.  Altogether, these data suggest an antigen-sp cific increase in antibody 
production. 
 Another unresolved finding in the previous chapter was the discrepancy between 
increased ASC and increased ex vivo antibody production in propanil-treated animals, 
but unchanged serum antibody titers.  The results from Chapter 3 indicate that antibody 
serum titers are more sensitive to changes in the number of BM ASC.  Since the number 
of BM ASC are not increased in propanil-treated anim ls despite an increase in splenic 
ASC, propanil treatment may not increase the antibody serum titers since the increased 
number of plasma cells do not survive in the BM.   
 Propanil failed to amplify the antibody response exposure following a suboptimal 
HKSP immunization.  This data provided an interesting f nding that propanil exposure 
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increased the antibody response to a weak PC-Ficoll response but not to a weak HKSP 
immunization.  The low conjugation ratio of the PC-Ficoll used in this experiment (6 PC-
Ficoll) was lower than that used in previous experim nts (25 PC-Ficoll) which generated 
serum titers comparable to optimal HKSP immunization (Wu et al., 1999).  A possible 
explanation for the discrepancy between responses is that the low PC-concentration on 
PC-Ficoll activates high affinity B cells.  Propanil is able to amplify the PC response to 
low PC-Ficoll immunization because the concentration of PC-Ficoll molecules is in 
excess, allowing for receptor engagement by the incr ased number of responding PC-
specific B cells.  In contrast the low dose of HKSP would limit the number of individual 
PC expressing bacterium thus fewer BCR are able to bind to HKSP.  This hypothesis 
would suggest that propanil cannot increase the number of PC-specific ASC in 
suboptimally vaccinated mice because the increased number of responding B cells 
require antigen stimulation to differentiate to plasma cells.  Altogether, these data suggest 
that propanil enhancement of the antibody response is not dependent on particulate or 
soluble antigen presentation by the APC. 
 A second question addressed by these set of experiments was whether the 
enhancement of the antibody response by propanil was specific for TI-2 responses.  
Given the major differences in the processes leading to B cell activation in TD and TI-2 
responses as noted in the General Introduction, addressing this issue is important for 
determining the mechanisms responsible for the increased numbers of ASC.  These data 
demonstrate that enhancement of the antibody response is dependent on when the animal 
is exposed to propanil during the antibody response.  Propanil increased the antibody 
response to a TD antigen when it is given 5 days prior the peak antibody response in 
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HKSP immunized mice.  Although PC-KLH elicits a robust TD PC-specific response at 
day 7, previous reports have demonstrated that the T15+ antibody response following PC-
KLH immunization is maximal on day 13 in Balb/c mice (Wiens et al., 2003).  The data 
suggests that propanil exposure to PC-KLH on day 8 would amplify the anti-PC 
response.   
 These data indicate that the amplification of the antibody response by propanil is 
not a direct effect on the B cells and may require T cell involvement.  This hypothesis is 
supported by the observation that enhancement of the PC-specific response is not 
observed in HKSP immunized animals until day 5, despit  actively differentiating and 
proliferating B cells by day 3.  Similarly, PC-KLH immunization produces a greater 
number of PC-specific ASC on day 7 than a HKSP immunization.  This also indicates 
robust B cell differentiation and proliferation.  One of the differences between TD and 
TI-2 responses is the nature of T cell help and other costimulation molecules early on 
during B cell activation.  For instance, T cell help is required for the first 3-4 days of the 
PC response and the first 5-6 days for the PspA response (Wu et al., 2002).  B7-
dependent costimulation is required for the first 1-2 days during the PC response in 
contrast to the first 5-6 days for the PspA response (Wu et al., 2000).  It is possible that 
propanil may affect T cell dependent costimulation, which could explain the delayed 
enhancement of the PC response until day 5 and the requirement of delayed propanil 
exposure to enhance TD responses.     
 Altogether these data eliminate a number of possible immunological mechanisms 
by which propanil amplifies the TI-2 and TD humoral responses.  Antibody enhancement 
does not require a particulate antigen on a whole killed bacterium.  Increased antibody 
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responses are antigen specific and not polyclonal.  However, more experimentation is 
required to resolve the discrepancy between ASC and serum titers and to determine the 















































































Figure 1.  Propanil exposure increases the number of PC-specific ASC following 
PC-Ficoll immunization.   
Female C57BL/6 mice (5/group) were treated with 150mg/kg propanil or vehicle control 
and vaccinated with 2x108 CFU HKSP or PC(6)-Ficoll.  Numbers of PC-specific IgG2b, 
IgG3, and IgM ASC were determined by ELISPOT assay on day 7.  Values represent the 
mean ± SD of ASC/1x106 B cells.  # Significantly different from Vehicle + PC-Ficoll, p 

















Figure 2.  Propanil does not affect PC-specific serum titers following PC-Ficoll 
immunization.   
Female C57BL/6 mice (5/group) were treated with 150mg/kg propanil or vehicle control 
and vaccinated with 2x108 CFU HKSP or PC(6)-Ficoll.  IgG2b, IgG3, and IgM PC-
specific serum titers were determined by ELISA on day 7.  Values represent the mean 





































































Figure 3.  Propanil exposure does not affect PC-specific ASC in suboptimally HKSP 
immunized mice.   
Female C57BL/6 mice (5/group) were treated with 150mg/kg propanil or vehicle control 
and vaccinated with 2x108 or 5x106 CFU HKSP.  Numbers of PC-specific IgG2b, IgG3, 
and IgM ASC were determined by ELISPOT assay on day 7.  Values represent the mean 
± SD of ASC/1x106 B cells.  # Significantly different from Vehicle 5x106, p ≤ .05.  * 
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Figure 4.  Day 14 propanil exposure increases the number of PC-specific and PspA-
specific ASC following a HKSP boost on day 14.   
Female C57BL/6 mice (5/group) were treated with vehicl  control or 150 mg/kg propanil 
on day 0, day 14 or day 0 and day 14 and vaccinated on day 0 and day 14 with 2x108 
CFU HKSP.  (A) Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined 
by ELISPOT assay on day 21.  (B) Numbers of PspA-specific IgG and IgM ASC were 
determined by ELISPOT assay on day 21.  Values repres nt the mean ± SD of 
ASC/1x106 B cells.  * Significantly different from vehicle control, p ≤ .05. 
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Figure 5.  Propanil exposure does not affect serum titers following secondary HKSP 
immunization.   
Female C57BL/6 mice (5/group) were treated with vehicl  control or 150 mg/kg propanil 
on day 0, day 14 or day 0 and day 14 and vaccinated on day 0 and day 14 with 2x108 
CFU HKSP.  (A) IgG2b, IgG3, and IgM PC-specific serum titers were determined by 
ELISA on day 21.  (B) IgG and IgM PspA-specific ASC were determined by ELISA on 

































































































































Figure 6.  Day 9 propanil exposure increases the number of PC and PspA-specific 
ASC.   
Female C57BL/6 mice (5/group) were treated with vehicl  control or 150 mg/kg propanil 
on day 9 and vaccinated on day 0 with 2x108 CFU HKSP.  (A) Numbers of PspA-specific 
IgG1, IgG2a, and IgM ASC were determined by ELISPOT assay on day 14.  (B) 
Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined by ELISPOT assay 
on day 14.  Values represent the mean ± SD of ASC/1x106 B cells.         * Significantly 
different from vehicle control, p ≤ .05. 
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Figure 7.  Propanil exposure does not affect the number of PC-specific ASC 
following PC-KLH.   
Female C57BL/6 mice (5/group) were treated with vehicl  control or 150 mg/kg propanil 
and vaccinated on day 0 with 2x108 CFU HKSP or PC-KLH.  Numbers of PC-specific 
IgG2b, IgG3, and IgM ASC were determined by ELISPOT assay on day 7.  (A) Low 
affinity B cells were detected using PC(15)-BSA coated plates. (B) High affinity B cells 
were detected using PC(2)-BSA coated plates.  Values represent the mean ± SD of 











CHAPTER 5: EVIDENCE FOR A NOVEL ENDOCRINE 
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ABSTRACT 
 Steroid hormones are known to affect the humoral immune response to a variety 
of antigens.  However, the mechanisms regulating these effects are poorly understood.  
The immunotoxic chemical, propanil, and estrogen have similar effects on the immune 
system including augmentation of humoral immune respon es.  Propanil enhances the 
number of phosphorylcholine (PC)-specific IgG2b, IgG3, and IgM antibody secreting 
cells (ASC) in the spleen 4-6-fold 7 days after vaccination of female C57BL/6 mice with 
heat-killed Streptococcus pneumoniae (HKSP).  Several experiments were performed to 
test the hypothesis that propanil increases the response via an estrogenic pathway.  
Ovariectomy abrogated the effect of propanil on the PC-specific ASC response.  Both in 
vitro and in vivo assays indicate that propanil does not bind either ERα or ERβ.  
Exogenous estradiol administration in ovariectomized mice failed to restore the effect of 
propanil on the PC response.  Treatment of female mic with a pure ER antagonist, ICI 
182,780, or the progesterone antagonist, RU-486, did not inhibit the increase in ASC.  
These data suggest that estrogen and progesterone do not regulate the effect of propanil.  
However, complete inhibition of steroid synthesis wth the GnRH antagonist, antide, 
abrogated the increased response in propanil-treated mice, indicating a necessary role for 
steroid synthesis.  Experiments in male mice demonstrated that propanil increased the 
number of ASC comparable to female mice.  However, orchiectomy did not inhibit this 
effect, suggesting that androgens do not regulate the amplification of the humoral 
response.  These data suggest a novel role for the ovarian hormones in the regulation of 




  Numerous studies have characterized the immunomodulating effects of the 
steroid hormone 17β-estradiol (E2) on developing lymphocyte populations in the thymus 
and bone marrow and on the peripheral humoral immune response.  Studies have 
demonstrated that E2 induces thymic atrophy through a Fas/FasL pathway dependent on 
both estrogen receptor (ER) α and β (Do et al., 2002; Erlandsson et al., 2001; Yao and 
Hou, 2004).  E2 treatment induces thymic atrophy primarily by decreasing the number of 
CD4+CD8+ double positive thymocytes (Screpanti et al., 1989).  E2 also inhibits B 
lymphopoiesis in the bone marrow (Erlandsson et al., 2003; Islander  et al., 2003).  
Specifically, E2 decreases pro-B cell, pre-B cell, and mature B cells of the bone marrow 
in an ERα and ERβ dependent manner (Erlandsson et al., 2003).  Studies on the effects 
of E2 on specific immune responses have demonstrated that chronic exposure to E2 
increases both the number of splenic antibody secreting cells (ASC) and the serum 
antibody titers to bacterial and autoantigens (Meyers and Petersen, 1985; Verthelyi and 
Ahmed, 1998).  Recent data suggest that E2 skews the genetic expression profile of B 
cells to enhance survival and to lower tolerance, which may contribute to the enhanced 
antibody response after E2 exposure (Frasor et al., 2003; Grimaldi et al., 2002).  It has 
been proposed that naturally occurring and synthetic compounds capable of acting 
through an estrogenic pathway may be able to induce the same immunomodulating 
effects as the endogenous hormone. 
Reports on endocrine disrupting chemicals (EDC) that are known estrogen 
mimics demonstrate that these compounds induce similar i mune enhancement as E2 
(Sobel et al. 2005; Yurino et al., 2004).  One study demonstrated that in vitro exposure to 
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bisphenol A (BPA) and diethylstilbesterol (DES) increased IgM secretion from B1 cells 
(Yurino et al., 2004).  In addition, chronic DES exposure accelerated the onset of 
systemic lupus erythematosus (SLE) in BWF1 mice (Yurino et al., 2004).  In another 
study illustrating the ability of EDC to enhance an autoimmune disease, the 
organochlorine pesticides chlordecone, methoxychlor, and DDT accelerated the 
progression of SLE in (NZB x NZW)F1 mice (Sobel et al., 2005).  Additionally, the anti-
DNA titers were also increased in chlordecone treated nimals (Sobel et al., 2005).  
These reports suggest that EDC have the potential to impact the immune system and 
accelerate the progression of autoimmune diseases. 
The amide class herbicide 3,4-dichloropropionanilide (propanil) is predominantly 
used for the control of grassy weeds in rice crops.  Exposure to propanil causes a diverse 
array of immunotoxic effects that are similar to thse seen in animals treated with E2.  
Specifically, in vivo exposure to propanil induces thymic atrophy, with reduced double 
positive and single positive thymocyte populations (Cuff et al., 1996; de la Rosa et al., 
2005).  The thymic atrophy is associated with an increase in glucocorticoid production 
(Cuff et al., 1996; de la Rosa et al., 2005).  However, administration of the glucocorticoid 
receptor antagonist RU486 did not completely abrogate the atrophy suggesting that 
glucocorticoids are only partially responsible for inducing thymic atrophy (de la Rosa et 
al., 2005).  Propanil also decreases the number of immature IgM+ B cells and pre-B cells 
in the bone marrow 7 days post-exposure, however the mechanism is unknown (de la 
Rosa et al., 2003).   
Recently, propanil has been demonstrated to enhance the humoral immune 
response to a bacterial vaccine (Salazar et l., 2005).  Heat-killed Streptococcus 
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pneumoniae (HKSP) was used as the model for measuring the antibody response.  HKSP 
elicits a robust IgG2b, IgG3, and IgM response to the immunodominant T-independent 
type 2 (TI-2) polysaccharide phosphorylcholine (PC) (Wu et al., 1999).  When propanil is 
administered to mice simultaneously with a HKSP vaccine, the number of splenic ASC 
specific for PC is increased 4-6 fold over control animals (Salazar et al., 2005).  The 
current studies were designed to investigate the mechanism for the increase in PC 
antibody production following exposure to propanil.   
Only limited studies have reported the endocrine disrupting effects of propanil.  
Using an in vitro luciferase reporter assay, propanil was found to be weakly anti-
androgenic and lacked estrogenic receptor α- and β-binding activity (Kojima et al., 
2004).  Another report found that the major metabolite f propanil, 3,4-dichloroaniline 
(3,4-DCA), binds the androgen receptor in vitro (Bauer et al., 1998).  Given the paucity 
of information describing the potential endocrine disrupting effects of propanil in vivo, 
one of the goals of this study was to better characte ize propanil as an EDC, using both in 
vivo and in vitro models.   
As described above, propanil induces a number of immunotoxic effects also 
caused by E2.  The hypothesis for the present studies was that propanil increased the 
antibody response to HKSP vaccination through an estrogenic mechanism.  The results 
demonstrate that propanil requires the ovaries and steroid synthesis to induce an increase 
in the antibody response in female mice.  However, the experiments demonstrate that the 
enhanced antibody response following exposure to propanil occurs independently of the 
estrogen pathway.  These studies suggest that the ovaries may regulate the systemic 
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humoral immune response through a novel, estrogen-independent mechanism and that 





MATERIALS AND METHODS 
Mice 
 Six to eight week old C57Bl/6 female and male mice were purchased from Hill 
Top Lab Animals (Scottdale, PA).  Ovariectomized (OVX), castrated (CAS), and sham-
operated mice were surgically gonadectomized at Hill Top Lab Animals.  Mice were 
housed in microisolator cages in pathogen free conditi s at West Virginia University’s 
animal facility.  Mice were kept on a 12 hr light-dark cycle and allowed to acclimate to 
the facility for 1 week.  Gonadectomized mice were housed at least 2 weeks following 
surgery to allow endogenous hormones to decline.  Food and water were provided a
libidum.  These studies were conducted in accordance with all federal and institutional 
guidelines for animal use and were approved by the West Virginia University 
Institutional Animal Care and Use Committee. 
Chemicals 
Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem 
Service (West Chester, PA).  17β-estradiol (E2) was purchased from Sigma Chemical 
Co. (St. Louis, MO) and diluted in 99% peanut oil (p.o.) and 1% EtOH.  ICI 182,780 
(ICI) was purchased from Tocris Bioscience (Ellisvile, MO).  ICI was diluted in 95% 
p.o. and 5% EtOH.  The GnRH antagonist, antide, was purchased from Bachem 
(Torrance, CA) and dissolved in 20% propylene glycol and 0.85% saline.  The 
progesterone antagonist, RU486, was purchased from Sig a Chemical Co. and dissolved 




Bacterial preparation and immunization 
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to 
mid-log phase in Todd-Hewitt broth  (Becton Dickinso , Sparks, MD) + .05% yeast 
extract (Becton Dickinson) and stored at –80°C.  For immunization, stock was cultured in 
a candle jar for 18 hrs at 37°C on blood agar plates (Becton Dickinson).  A few 
characteristic colonies were selected and suspended i  200 ml Todd-Hewitt broth + .05% 
yeast extract.  Bacteria were grown at 37°C to an absorbance reading at 650nm of 0.4 and 
heat killed for 4 hours in a 60°C water bath.  A final concentration of 109 CFU/ml was 
established in PBS based on colony counts.  Sterility was confirmed by culture.  Heat-
killed stock was stored at -20°C in 1 ml aliquots.  Mice were immunized ip with 2x108 
CFU.  This dose of vaccine has previously been demonstrated to elicit an optimal PC-
specific antibody response that peaks at day 7 post-vaccination (Wu et al., 1999; Wu et 
al., 2000).   
Animal exposures 
 Propanil was dissolved in p.o. for a final concentration of 15 mg/ml or 20 mg/ml 
for all experiments.  For the experiments measuring antibody responses, mice (5/group) 
were treated ip with either 150 mg of propanil/kg of b dy weight (mg/kg) or vehicle on 
the same day as vaccination with heat-killed S. pneumoniae (HKSP).  The dose of 
propanil was chosen based on previous studies that demonstrate an increase in the 
antibody response to PC in vaccinated mice at 150 mg/kg (Salazar et al., 2005). 
 In experiments using E2, ovariectomized mice were injected sc with a daily dose 
of E2 (10 µg/kg).  Animals received the first dose of E2 1 hr prior to herbicide or vehicle 
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treatment and vaccination.  Subsequent E2 treatments were given at the same time daily.  
Animals were sacrificed 24 hrs following the final E2 exposure. 
In experiments using the ER antagonist, ICI 182,780 (10 mg/kg/day), was injected 
sc into female mice.  Animals were treated with the first dose of ICI 1 hr prior to 
herbicide or vehicle exposure and vaccination.  Subsequent ICI exposures were given at 
the same time daily throughout the course of the experiment. 
In experiments using the GnRH antagonist, antide (60 µg/mouse), female mice 
were injected sc every 48 hours 14 days prior to propanil or vehicle exposure and 
vaccination (Couse t al., 2003).  Subsequent antide treatments were given at the same 
time every 48 hours throughout the course of the experiment. 
For the uterotrophic assays, OVX mice were treated with either a single ip 
injection of the vehicle or propanil (150 mg/kg), or 3 daily sc injections of E2 (10 
µg/kg/day).  Mice were euthanized 24 hours after the last E2 exposure, and the wet 
weights of the uteri were recorded.  
In experiments using the progesterone receptor antago ist, RU486 (12.5 mg/kg), 
female mice were injected sc 2 hours prior to propanil treatment, 12 hours following 
propanil treatment, followed by injections every 24 hours throughout the duration of the 
experiment.  For thymic atrophy experiments, mice were injected with 200 mg/kg of 
propanil or vehicle control.  The dose of propanil was based on previous studies on 
propanil-induced thymic atrophy (de la Rosa et l., 2005).  Thymic weights were 
recorded on day 3.  For HKSP experiments, mice were tr ated with 150 mg/kg of 
propanil or vehicle control and vaccinated.  Splenic antibody responses were measured 
on day 7.   
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Serum estradiol levels 
 Serum estradiol levels were determined for mice treated with antide for 14 days 
using the Estradiol EIA kit (Diagnostic Automation Inc., Calabasas, CA), according to 
the kit instructions.  Briefly, serum samples collected from the saphenous vein or E2 
standards were added to the provided 96-well microtite  plates coated with anti-E2 
antibody.  Anti-E2 antibody conjugated to peroxidase was added, and the wells were 
incubated for 90 min at room temperature.  The wells were washed and substrate was 
added to each well for 20 min.  The reaction was stopped and read at 450 nm with a 
µQuant spectrophotometer (Bio-Tek Instruments, Winooski, VT).  The level of detection 
for the assay was 1 pg/ml.   
Preparation of splenocytes 
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott 
Laboratories, North Chicago, IL) on days 5 or 7 following herbicide exposure and 
vaccination.  Spleen wet weights were recorded.  Spleens were mechanically dissociated 
through Spectra nylon mesh (Spectrum Labs, Rancho Dominguez, CA) in complete cell 
media containing RPMI-1640 (BioWhitaker, Walkersville, MD), 10% heat inactivated 
fetal bovine serum (FBS, Hyclone Laboratories, Inc,Logan, UT), 10 mM HEPES 
(Sigma), 1 mM L- glutamine (Gibco, Rockville, MD), 5x10-5 M 2-mercaptoethanol 
(Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml streptomycin (Gibco).  Red blood 
cells in the spleen were lysed with Tris-buffered ammonium chloride.  Cell suspensions 
were washed twice and counted using a hemacytometer.  Viability was determined using 
Trypan blue dye exclusion. 
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Measurement of antibody secreting B cells (ASC) in the spleen 
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbo , MI) were coated 
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) overnight at 4°C.  
In all subsequent steps, plates were washed with PBS + .01% Tween-20.  Plates were 
blocked with 200 µl/well complete medium + 25% FBS for 2 hours at 37°C.  Plates were 
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or 
1x106 cells/ml.  All samples were plated in triplicate.  Plates were incubated for 4-6 hours 
at 37°C in a 5% CO2 incubator.  After washing, goat anti-mouse alkaline phosphatase 
(AP) conjugated IgG, IgG2b, IgG3, or IgM antibodies (Southern Biotechnology 
Associates, Birmingham, AL), diluted 1/250 in PBS + 1%BSA + .05% Tween-20, were 
added to the appropriate wells (100 µl/well).  Plates were incubated overnight at 4°C and 
washed.  SIGMAFAST 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium 
tablets (Sigma-Aldrich, St. Louis, MO) were dissolved in distilled water and added at 100 
µl/ well.  Color development was stopped by washing with distilled water.  The number 
of spots/well was counted using a dissection microscope (Olympus Optical Co., Melville, 
NY).  The number of ASC was calculated by using the mean number of spots from 
triplicate wells.  The number of ASC was normalized to 1x106 B cells.  Comparable fold 
increases were noted when normalized to whole spleen (Salazar et al., 2005). 
Flow cytometric analysis 
Splenic cells were stained with the appropriate combinations of rat anti-mouse 
B220-APC (RA3-6B2), rat anti-mouse CD4-FITC (GK1.5), or rat anti-mouse CD8α-PE 
(53-6.7) (BD PharMingen, San Diego, CA).  All steps were performed in PBS 
supplemented with 1% FBS and 0.04% sodium azide (Sigma).  Briefly, 1 x 106 cells were 
 132 
stained in a total volume of 25 µl of antibodies at the appropriate concentrations fr 25 
minutes on ice in the dark.  After incubation, cells were washed twice and fixed in 0.04% 
paraformaldehyde overnight at 4°C (Fisher Scientific, Pittsburgh, PA).  The following 
day cells were washed twice to remove the paraformaldehyde and resuspended in 1 ml of 
staining media.  For each sample, 10,000 cells werecoll cted for analysis on a Becton-
Dickinson FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).  
Analysis was performed using WinMDI software (Joseph Trotter, Scripps Institute, San 
Diego, CA).  Population percentages, obtained from fl w cytometric analysis, were used 
to calculate the absolute cell number by multiplying the percentage of cells in a 
population by the total number of cells harvested pr organ.  Previous experiments have 
determined that the number of CD4+ T cells, CD8+ T cells, and B cells is not changed 
after propanil exposure (Salazar et al., 2005). 
ER binding assay 
ER competitive binding assays were performed using purified recombinant ERα 
and ERβ (Panvera, Madison, WI).  Reactions were performed in 10 mM Tris, 1.5 mM 
EDTA, 1.0 mM dithiothreitol, and 10% glycerol at pH 7.4.  Reactions containing 1 nmol 
ER, 10 nmol [3H]-E2, and the indicated concentrations of competing u labeled E2 or 
propanil were performed in reaction buffer at 4°C for 18 to 20 h.  [3H]-E2 bound to ER 
was separated from free [3H]-E2 by adding a 60% hydroxylapatite solution followed by 
repeated centrifugation and washing.  The amount of [3H]-E2 bound to E2 was 
determined by liquid scintillation. 
Ishikawa cells and alkaline phosphatase activity  
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Ishikawa cells (a generous gift from Richard B. Hochberg, Yale University 
Medical School, New Haven, Connecticut) were maintained in MEM medium (Sigma), 
10% fetal bovine serum, as described (Littlefield et al., 1990).  Ishikawa cells were 
treated as described to assess the effect of propanil n estrogen-inducible alkaline 
phosphatase (Littlefield et al., 1990). Briefly, cultures were rinsed twice with estrogen-
free basal medium and maintained in this medium for 24 hours. Cells were then 
trypsinized and plated into 96 well plates (1x104 cells/well) in the presence or absence 
(negative control) of indicated concentrations of estrogen (positive control) or propanil. 
All cell treatments were performed in quadruplicate. After 72 hr, cultures were treated as 
described in detail, and alkaline phosphatase activity was determined by measuring the 
conversion of p-nitrophenyl phosphate to p-nitrophenol.  MTT Cell Proliferation Kit 
(Roche Applied Science, Indianapolis, IN) was used as specified by the manufacturer to 
assess effects on cell numbers.  Propanil had no effect on the proliferation of Ishikawa 
cells (data not shown).  
Statistics 
One-way analysis of variance (ANOVA) was performed for all statistical analyses 
using a Tukey-Kramer t-test to perform multiple comparisons between all treatment 
groups.  A significance level of p ≤ 0.05 was used for all tests.  Statistical analysis wa  
performed using JMP software (SAS Institute Inc., Cary, NC).  All experiments were 






Ovariectomization abrogates the antibody increase induced by propanil. 
 To test the hypothesis that propanil increases the antibody response after 
vaccination with HKSP through an estrogenic mechanism, OVX or sham-operated mice 
were vaccinated with HKSP and treated with propanil or the vehicle.  All sham-operated 
mice exposed to propanil had a significantly increased number of PC-specific ASC 
compared to sham-operated vehicle-treated mice (Figure 1).  PC-specific IgM and the 
dominant PC isotypes, IgG2b and IgG3, were significantly increased in propanil-treated 
animals (Figure 1).  Spleen cells from these mice were also cultured in vitro for 5 days 
and the production of antibody measured by specific ELISA.  There was an increase in 
antibody production that corresponded with the increase in ASC (data not shown).  
Ovariectomy abrogated the ability of propanil to increase the number of PC-specific ASC 
in the spleen (Figure 1).  Comparable results were obtained when the data were 
normalized to 1 x 106 splenic B cells (Figure 1) or to the total spleen (data not shown).  
The number and percentage of B cells, CD4+ T cells and CD8+ T cells in the spleen was 
similar for all groups as determined by flow cytometry  (data not shown).  These data 
indicate that the ovaries are required for propanil to induce increases in the PC antibody 
response.   
Propanil does not bind to estrogen receptors in vivo or in vitro. 
To determine if propanil increased the PC antibody response by binding directly 
or indirectly with ERα, in vivo uterotrophic assays were performed.  OVX mice were 
treated once with 150 mg/kg of propanil.  Positive control animals were treated daily with 
E2 (He et al., 2003).  Uterine weights were recorded 3 days following the first exposure.  
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As expected, E2 treatment significantly increased ut rine weight (Figure 2).  Propanil, 
however, did not increase the uterine weights compared to vehicle treated animals 
(Figure 2).  This data suggests that propanil does n t directly or indirectly activate ERα, 
which is primarily responsible for the E2-induced uterine proliferation (Weihua et al., 
2000).   
To establish if propanil interacts directly with the ERα or ERβ, an in vitro 
competitive ER binding assay was performed.  Propanil did not bind either ERα or ERβ 
over a wide range of concentrations (Figure 3), confirming a previous report (Kojima et 
al., 2004).  In addition, propanil was administered to Ishikawa cells, which express both 
ERα and ERβ.  Propanil did not increase estrogen-inducible alkaline phosphatase activity 
compared to controls, further supporting that propanil does not bind ERα or ERβ (Figure 
4).  
Administration of exogenous E2 does not restore the enhanced antibody response in 
propanil-treated OVX mice. 
To determine if propanil requires E2 to enhance the antibody response to HKSP, 
OVX mice were exposed once to either propanil or vehicl  control.  In addition, half of 
the propanil-treated and vehicle-treated OVX mice received daily sc E2 for 7 days.  All 
groups were vaccinated with HKSP on day 0.  The PC-specific responses from the OVX 
mice were compared with sham-operated mice.  Uterine weights and PC-specific splenic 
ASC were measured on day 7.  Uterine weights of OVX mice were significantly lower 
than sham-operated vehicle mice (Figure 5A).  Exogen us E2 administration restored 
uterine weights of OVX mice comparable to uterine weights of sham-operated mice 
(Figure 5A, OVX Vehicle + E2 vs. Vehicle, OVX Propanil + E2 vs. Vehicle).  The 
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addition of exogenous E2 to propanil-treated OVX mice failed to restore the increase in 
PC-specific ASC (Figure 5B, OVX Propanil + E2 vs. Propanil).  All ovariectomized mice 
had a similar number of PC-specific ASC as vehicle control animals (Figure 5B).  These 
results suggest that the inability of propanil to enhance the antibody response in OVX 
mice was not due to the absence of E2.   
An ER antagonist does not inhibit the ability of propanil to enhance the antibody 
response. 
 The previous experiment demonstrated that the addition of exogenous E2 did not 
restore the ability of propanil to enhance the antibody response in OVX mice.  However, 
it is possible that the dose of exogenous E2 given does not accurately mimic the level of 
E2 in mice with intact ovaries.  To determine if signaling through the estrogen receptor is 
required for the increased immune response, mice wer tr ated with the ERα and ERβ 
antagonist ICI 182,780.  Normal female mice were vaccinated and treated with propanil 
or vehicle on day 0, and given daily treatments with ICI 182,780.  Uterine weights were 
measured to confirm the efficacy of the ICI treatment and the PC-specific antibody 
response was determined.  The uterine weights of all animals receiving the ER antagonist 
were significantly reduced compared to control animls (Figure 6A).  Treatment with the 
ER antagonist did not affect the basal PC-specific ASC response in vehicle-treated mice 
(Vehicle vs. Vehicle + ICI, Figure 6B).  Propanil-exposed mice treated with ICI had an 
increased ASC response comparable to propanil alone (Propanil vs. Propanil + ICI, 
Figure 6B).  These results demonstrate that the ER antagonist did not inhibit the increase 
in PC-specific ASC in propanil-treated animals, which suggests that signaling through the 
estrogen receptor pathway is not required for propanil to enhance the antibody response.   
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Inhibition of steroid synthesis in propanil-treated mice abrogates the increase in 
ASC.  
 Chemical inhibition of steroid synthesis was conducted to determine if a gonadal 
steroid other than estradiol regulates the propanil amplification of the humoral immune 
response.  Animals were treated with the GnRH antagonist antide for 14 days prior to 
propanil exposure and HKSP vaccination to ensure complete suppression of ovarian 
steroid synthesis (Couse et al., 2003).  Serum estradiol levels were determined prior to 
propanil treatment on day 14.  All mice had non-detectable levels of estradiol, which is 
indicative of the efficacy of the antide treatments (data not shown).  Uterine weights and 
the immune response to PC were determined 7 days post-vaccination.  Antide-treated 
animals had significantly decreased uterine weights (Figure 7A).  Treatment with antide 
did not affect the basal PC-specific ASC response (Vehicle vs. Vehicle Antide, Figure 
7B).  The number of PC-specific ASC in mice treated with antide and exposed to 
propanil were not significantly different from the v hicle controls (Vehicle vs. Propanil 
Antide, Figure 7B), but were significantly different from the propanil-treated control 
animals that had an increased ASC response (Propanil vs. Propanil Antide, Figure 7B).  
These results demonstrate that steroid synthesis is necessary for the enhanced immune 
response in the spleens of mice exposed to propanil.   
A progesterone receptor antagonist does not inhibit antibody enhancement by 
propanil. 
 Progesterone is another steroid hormone that has been shown to affect antibody 
production.  The progesterone antagonist, RU486, was utilized to determine if 
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progesterone signaling is required for the increased antibody response.  As previously 
stated, propanil induces thymic atrophy which is partially inhibited by RU486 (de la Rosa 
et al., 2005).  To determine the efficacy of the RU486 trea ments, mice were treated with 
RU486 2 hours prior to propanil or vehicle treatment, a d at 12 and 24 hours post-
exposure.  RU486 partially abrogated thymic atrophy as determined by measurement of 
the thymic weights and by quantification of the CD4+CD8+ thymocyte population (Figure 
8A and 8B), demonstrating that RU486 is efficacious via the sc route. 
 To determine if blockade of the progesterone receptor inhibits the increased 
antibody response, mice were injected with RU486 2 hours prior to propanil exposure 
and vaccination.  Mice were subsequently injected with RU486 12 hours post-exposure 
and every 24 hours following propanil treatment.  Treatment with the progesterone 
antagonist did not affect the basal PC-specific ASC response in vehicle-treated mice 
(Vehicle vs. Vehicle + RU486, Figure 8C).  Propanil-exposed mice treated with RU486 
had an increased ASC response comparable to propanil alone (Propanil vs. Propanil + 
RU486, Figure 8C).  These results demonstrate that the progesterone antagonist did not 
inhibit the increase in PC-specific ASC in propanil-treated animals, which suggests that 
progesterone is not required for propanil to enhance the antibody response. 
Propanil enhances the antibody response in both normal and orchiectomized males. 
 To determine if propanil increased the antibody respon e in a gender specific 
manner, male mice were vaccinated and treated with propanil or vehicle (Figure 9).  The 
PC-specific splenic ASC were measured after 7 days.  Propanil increased the IgG2b, 
IgG3 and IgM PC-specific splenic ASC approximately 3-fold (Vehicle vs. Propanil, 
Figure 9).  Castration did not significantly affect the propanil-induced increase in PC-
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specific ASC.  Castrated males treated with propanil roduced approximately the same 
fold increase in PC-specific ASC as normal propanil-treated male mice (Propanil vs. 
Propanil Castrated, Figure 9).  These results suggest that androgens are not involved in 
the amplification of the immune response after propanil exposure.   
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DISCUSSION 
 Gonadal steroid regulation of the immune system is poorly understood.  The 
majority of the research into the effects of sex stroids on the humoral immune response 
involves the hormones estradiol, progesterone, and testosterone.  Estradiol has been 
demonstrated to increase the number of antigen-specific splenic ASC several fold 
(Verthelyi and Ahmed, 1998).  The other major gonadal hormones progesterone and 
testosterone are generally considered to be immunosuppressive.  The data presented here 
suggest a novel role for the amplification of the TI-2 humoral immune response by the 
ovary that is independent of estrogen or progesterone.  This report also demonstrates the 
novel use of propanil exposure to study the mechanism for gonadal steroid regulation of 
antibody responses.   
Previous reports demonstrated that propanil induces a number of immunotoxic 
effects that suggest a manipulation of the estrogenic pathway (de la Rosa et al., 2003; de 
la Rosa et al., 2005; Salazar et al., 2005).  Propanil has been classified by two studies as 
non-estrogenic and weakly anti-androgenic, as determin d by receptor binding assays 
(Bauer et al, 1998; Kojima et al., 2004).  However, given the heavy usage of propanil and 
the importance of studying endocrine disruption, extensive characterization of propanil as 
a potential EDC is warranted.  Synthetic chemicals n manipulate the estrogenic 
pathway in a number of ways including 1) direct binding of ERs, 2) indirect ER 
activation by stimulating ER phosphorylation, 3) altered expression of the ER, 4) 
changing the levels of hormone expression, or 5) modifying the intracellular estrogenic 
signaling pathway (Borgest e al., 2002).   
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The uterotrophic assay is the classic method to determine the in vivo estrogenic 
activity of a chemical.  Measuring uterine weights after 3 days of chemical exposure is a 
sensitive assay for detecting weak ER agonists (O'Connor et al., 1996).  In vivo exposure 
to propanil did not induce an increase in uterine weight.  Disadvantages of the 
uterotrophic assay include the inability to decipher antagonistic or agonistic activity in 
different organs, a lack of specificity, and the inability to measure ERβ binding activity 
(O'Connor et al., 1996; Weihua et al., 2000).  For instance, chemicals such as tamoxifen 
act either as ER antagonists or agonists within different organs or at different 
concentrations (Watanabe et al., 1997).  Therefore, the ERα and ERβ binding activity of 
propanil were determined using in vitro assays.  Propanil did not compete for E2 binding 
to either ERα or ERβ nor did it increase estrogen-inducible alkaline phosphatase activity 
in ER-responsive cells.  The results of the uterotrophic assay, ER binding studies, and the 
ER-inducible alkaline phosphatase assay establish that propanil is not a classic EDC. 
Increasing ER expression levels might also affect antibody activity since the ER is 
found on many immune cells including B cells (Grimaldi et al., 2002).  Removal of E2 
from circulation would eliminate the ability of ER expressing cells to respond.  However, 
subcutaneous administration of E2 to OVX mice failed to restore the stimulatory effect of 
propanil on the antibody response to HKSP, which indicates that propanil does not 
require the presence of E2 to exert its effect on the splenic antibody response.  This also 
suggests that propanil exposure does not induce antibody stimulation by increasing the 
ability of cells to bind E2.  In addition, the data shows that high concentrations of E2 for 
a short period of time (7 days) do not affect the TI-2 antibody response.   
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Chronic low E2 exposure increases splenic ASC (Myers and Petersen, 1985; 
Verthelyi and Ahmed, 1998).  However, high levels of E2, such as during the third 
trimester of pregnancy, is immunosuppressive (Confavreux et al., 1998).  Measuring E2 
serum levels is compounded by a number of factors including estrous cycling and the 
selection of several time points for hormone analysis.  An alternative approach to directly 
measuring estradiol serum levels is to inhibit the eff cts of E2 by blocking the ER.  The 
ER antagonist ICI 182,780 has been demonstrated to completely attenuate the ability of 
ERα and ERβ to regulate transcription by 1) impairing receptor dimerization, 2) 
increasing receptor degradation, thereby lowering ER expression, and 3) disrupting 
nuclear localization of the ER/ligand complex (Wakeling, 2000).  Several reports have 
shown that administration of ICI 182,780 1 hr prior t  EDC exposure is sufficient to 
inhibit the effect of an EDC (Ciana et al., 2001; Jung et al., 2005; Papaconstantinou et al, 
2001).   Propanil does not appear to trigger antibody stimulation by acting on the 
estrogenic signaling pathway, as indicated by the failure of ICI 182,780 to inhibit the 
increased ASC response following propanil treatment.  These data strongly suggest that 
propanil does not affect the TI-2 antibody response via an estrogenic mechanism.   
The GnRH antagonist antide was utilized to determine if gonadal steroids regulate 
the ovarian-dependent stimulation of the antibody response.  Antide treatment abrogated 
the effect of propanil similar to ovariectomy, suggesting that propanil stimulates the 
antibody response via a gonadal dependent mechanism in fe ales.  Antide treatment not 
only blocks the effects of GnRH, but also decreases th  production of LH and FSH from 
the pituitary and eliminates the secretion of gonadal hormones (Couse et al, 2003; Fallest 
et al., 1995).  The hypothalamic hormone, GnRH, and the pituitary hormones, LH and 
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FSH, have all been demonstrated to regulate the antibody response (Athreya et al., 1993; 
Jacobson and Ansari, 2004).  Since ovariectomized animals have elevated levels of LH 
and FSH compared to antide-treated animals, but have similar antibody responses 
following propanil exposure, it can be inferred that LH and FSH do not participate in the 
increase in the number of PC-specific ASC (Wakeling et al., 1991; Couse t al., 2003).  
Other non-estrogenic hormones in the steroid synthesis pathway can regulate the 
antibody response.  Androgens can induce immunosuppression (Brick et al., 1985).  As 
mentioned previously, propanil has some anti-androgenic activity.  However, antibody 
studies evaluating the effects of anti-androgens indicate that they are not 
immunostimulatory (O'Connor et al., 2002).  In addition, removal of the primary source 
of testosterone in males via castration did not affect the ability of propanil to enhance the 
antibody response.  Altogether, this data does not support an androgenic mechanism. 
Progesterone has been demonstrated to be primarily immunosuppressive in 
pregnant women (Beagley and Gockel, 2003).  Observations in pregnant women with 
autoimmune diseases such as multiple sclerosis have demonstrated that progesterone and 
estradiol levels are at the highest during the third tr mester when the severity of disease 
decreases (Confavreux et al., 1998).  However, some studies have demonstrated that the 
number of antigen-specific ASC in the vaginal tissue is increased following mucosal 
immunization and progesterone treatment Johansson et al., 1998).  Blockade of the 
progesterone receptor with RU486 did not have any effect on the stimulation of the 
antibody response in propanil-treated mice.  This suggests that antibody enhancement 
does not require a progesterone-dependent mechanism.  
 144 
Loss of the increased PC response following ovariectomy or inhibition of steroid 
synthesis may be the result of an indirect effect caused by the loss in homeostatic steroid 
hormone levels.  Immunomodulatory hormones, such as GnRH and E2, are produced 
locally in lymphoid organs.  Studies have shown that e gonads regulate these locally 
produced lymphoid hormones, suggesting another potential mechanism for ovarian 
regulation of the humoral immune response.  For instance, GnRH has been demonstrated 
to have immunomodulating effects independent of other hormones.  Reports have shown 
that GnRH receptor mRNA and GnRH mRNA are expressed in murine spleen cells and 
human B lymphocytes (Jacobson et al., 1998;  Khan et al., 2003; Silveira et al, 2002).  In 
addition, the spleen has been demonstrated to have a higher affinity for GnRH peptide 
compared to other endocrine and nonendocrine organs including the testes and liver 
(Khan et al., 2003).  Three weeks of exogenous GnRH treatment increases both the total 
IgG serum levels in female ovariectomized mice and the proliferation of B and T 
lymphocytes in response to LPS and ConA stimulation, respectively (Jacobson and 
Ansari, 2004).   
The classically studied source of GnRH is the hypothalamus, although it is 
unlikely that hypothalamic produced GnRH can directly affect spleen function since the 
concentration of GnRH in the portal blood is low and rapidly metabolized (Eskay et al., 
1975).  Evidence suggests that the ligand for GnRH receptors on splenic lymphocytes is 
likely to be derived from another endogenous source and may act in an autocrine or 
paracrine fashion in non-pituitary organs (Chen et al., 1999).  Both GnRH mRNA and 
GnRH receptor mRNA are altered in splenocytes through t the estrous cycle, however, 
the exact mechanism of this regulation is unknown (Jacobson et al., 1998).   
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 It is possible that the ovaries are involved in regulating the local GnRH 
production in the spleen, which contributes to the increased antibody response in 
propanil-treated animals.  This hypothesis might also explain the contrasting results 
between castrated and ovariectomized animals.  There is data which indicates that male 
and female discrepancies in immune function exist in response to GnRH treatment 
following gonadectomy (Jacobson  et al., 1999).  These data suggest that the sexual 
disparities exist due to a residual effect caused by hormonal differences experienced early 
in development.    
Additional evidence exists suggesting gonad-mediate hormone regulation in 
lymphocytes and the spleen.  A recent report demonstrated that removal of the ovaries 
alters the activity of the steroid hormones aromatase and 17β-hydroxysteroid 
dehydrogenase locally in the spleens and T cells of mice (Samy et al., 2001).  In addition, 
castration had the opposite effect on the activity of these enzymes (Samy et al., 2001).  
The role of these steroidogenic pathways in the splen and T cells on the humoral 
immune response has not been evaluated.  Propanil my act by disrupting the ovarian 
control of the steroidogenic enzymes in the spleen ading to altered B cell activation.  
Analyzing the local spleen-specific and ovary-specific hormone receptor mRNA, 
hormone mRNA, and the activity of steroid enzymes would yield valuable clues to the 
mechanism regulating this effect. 
In contrast to the results presented here, previous studies have demonstrated that 
exposure to propanil can decrease the response to a T dependent and a T-independent 
antigen (Barnett et. al., 1992; Barnett and Gandy, 1989).  In the previous st dies, 
C57Bl/6 female mice were exposed i.p. to propanil on day 0, immunized i.v. on day 3 
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with the TI-2 antigen DNP-Ficoll, or the T dependent a tigen, SRBC, and the plaque-
forming cell response in the spleen determined on day 7.  In the present studies, propanil 
was administered i.p. on day 0 and the mice immunized .p. with HKSP on day 0.  The 
PC-specific ASC response was determined on day 7.  It is possible that the different 
results between the studies in the PC antibody response is due to the nature of the 
antigen, purified antigen versus whole heat-killed bacteria.  However, preliminary studies 
in the laboratory have demonstrated a similar enhancement of the ASC response to the 
TI-2 antigen PC-Ficoll when propanil is administered at the time of PC-Ficoll 
immunization.  Therefore, the timing of propanil exposure and immunization may be the 
critical factor in the ultimate effect that propanil has on the humoral immune response. 
Preliminary studies demonstrate that propanil can be given 3 days after HKSP 
immunization and still enhance the PC immune respone.  In addition, preliminary 
experiments demonstrate that propanil can also enhance the ASC response in the spleen 
to a T dependent antigen on HKSP, PspA.  The PspA-specific serum antibody titers peak 
approximately 14 days post-immunization.  Propanil must be given on day 9 after 
immunization to enhance the PspA response.   If the animals are exposed to propanil at 
the time of immunization on day 0 there is no effect on the immune response to PspA on 
day 14.  Taken together, these studies suggest that propanil exposure must occur near the 
time of the peak antibody response to increase the response.  It is not yet known if the 
ovaries are required for the enhancement of the immune response to PC-Ficoll or PspA.    
 Altogether, these data support two novel findings.  First, propanil enhances the 
antigen-specific antibody response in females in an ovary-dependent, estrogen-
independent manner unlike other EDC reported to date.  Second, the data suggests a 
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novel role for antibody stimulation by the ovaries following chemical exposure.  Future 
studies will utilize propanil as a unique tool to examine interactions between the immune 
and endocrine systems with an emphasis on how the ovaries contribute to regulation of 
humoral immune responses.  
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Figure 1.  Ovariectomy abrogates the propanil-induced increase in PC-specific 
splenic ASC.   
OVX and sham-operated female C57BL/6 mice (5/group) were treated with 150 mg/kg 
propanil or vehicle control and vaccinated with 2x108 CFU HKSP.  Numbers of PC-
specific IgG2b, IgG3, and IgM ASC were determined by ELISPOT assay on day 7.  
Values represent the mean ± SD of ASC/1x106 B cells.  * Significantly different from all 








































Figure 2.  Propanil does not increase uterine weights in OVX mice.   
C57BL/6 mice (5/group) were ovariectomized and treated with vehicle control (open 
bar), 150 mg/kg propanil (hatched bar), or 10µg/kg/day of E2 (black bar).  Uterine 
weights were recorded after 3 days.  Values represent th  mean ± SD.  * Significantly 









































































Figure 3.  Propanil does not bind to ERα or ERβ.   
Competitive binding assays determined the binding of pr panil to ERα or ERβ in the 
presence of [3H]-E2.  Values represent the percent of [3H]-E2 bound to ER in the 




























































Figure 4.  Propanil does not increase estrogen-inducible alkaline phosphatase 
activity in Ishikawa cells.   
Ishikawa cells were treated with propanil (1 µm, 3µM, 10 µM, or 100 µM) or E2 (10 pM 
or 100 pM).  Alkaline phosphatase activity was measured after 72 hours.  Values 
represent the mean absorbance recorded in the propanil r E2 treated cells.  * 
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Figure 5.  Addition of exogenous E2 does not restore the increase in PC-specific 
ASC of propanil-treated animals.   
OVX and sham-operated female C57BL/6 mice (5/group) were treated with 150 mg/kg 
propanil or vehicle control and vaccinated with 2x108 CFU HKSP.  OVX mice were 
treated with 10µg/kg/day of E2 or the vehicle.  Spleens and uteri we removed after 7 
days.  (A) Uterine weight.  * Significantly different from vehicle control, p ≤ .05.  (B) 
Numbers of PC-specific IgG2b, IgG3, and IgM ASC.  Values represent the mean ± SD of 
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Figure 6.  Addition of the ER antagonist ICI 182,780 does not block the increase in 
ASC in propanil-treated animals.   
C57BL/6 mice (5/group) were vaccinated with 2x108 CFU HKSP, and treated with 150 
mg/kg propanil or vehicle control, with or without ICI 182,780 (10 mg/kg/day) or 
vehicle.  Spleens and uteri were removed after 5 days.  (A) Uterine weight.  * 
Significantly different from vehicle control, p ≤ .05.  (B) Numbers of PC-specific IgG2b, 
IgG3, and IgM ASC.  Values represent the mean ± SD of ASC/1x106 B cells.  * 
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Figure 7.  Antide treatment abrogates the propanil-induced increase in PC-specific 
ASC.   
C57BL/6 female mice were treated with antide (60µg/mouse) or vehicle for 14 days as 
described in Methods.  Mice were vaccinated on day 14 with 2x108 CFU HKSP and 
treated with 150 mg/kg propanil or vehicle.  Spleens a d uteri were removed 7 days post-
vaccination.  (A) Uterine weight.  * Significantly different from vehicle control, p ≤ .05.  
(B) Numbers of PC-specific IgG2b, IgG3, and IgM ASC.  Values represent the mean ± 
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Figure 8.  Treatment with the progesterone antagonist RU486 does not inhibit the 
increase in ASC in propanil-treated animals.   
C57BL/6 female mice were treated with RU486 as described in the Methods.  Thymic 
wet weights and thymocyte populations were determined on day 3.  (A) Thymus to body 
weight ratio.  * Significantly different from the vehicle control and vehicle + RU486, p ≤ 
.05.  (B) CD4+CD8+ cells.  * Significantly different from the vehicle control and vehicle 
+ RU486, p ≤ .05.  # Significantly different from vehicle, propanil, and vehicle + RU486, 
p ≤ .05.  (C) Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined by 
ELISPOT assay on day 7 post-vaccination.  Values represent the mean ± SD of 
ASC/1x106 B cells or per spleen.  * Significantly different from the respective vehicle 



















































Figure 9.  Propanil enhances the antibody response in both normal and 
orchiectomized males.   
Sham-operated and castrated C57BL/6 male mice were vaccinated with 2x108 CFU 
HKSP and treated with 150 mg/kg propanil or vehicle control.  Spleens were removed 
after 7 days.  Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined by 
ELISPOT assay.  Values represent the mean ± SD of ASC/1x106 B cells or per spleen.  * 





























CHAPTER 6: PROPANIL EXPOSURE DOES NOT 
ENHANCE SURVIVAL TO A VIRULENT S. PNEUMONIAE 




















 The previous experiments demonstrated that propanil enhances the number of PC-
specific ASC in the spleen, but does not affect serum antibody titers.  Previous reports 
have shown that PC-specific antibody is protective against a lethal challenge with S. 
pneumoniae (Briles et al., 1992; Wallick et al., 1983).  However, protection is correlated 
with circulating antibodies in the serum (Fischer et al., 1995).  These experiments were 
conducted to determine if propanil enhances the survival of HKSP immunized animals 
lethally challenged with S. pneumoniae. 
 Previous studies evaluating the survival of mice following HKSP immunizations 
have been performed using an immunization schedule of one ip injection on day 0 and a 
second immunization on day 14 followed by lethal challenge on day 21 (Wallick et al., 
1983; Briles et al., 1992; Fischer et al., 1995).  However, PC-specific titers peak by day 7 
and subsequent immunizations do not significantly icrease the PC antibody titers (Wu et 
al., 2002; Wu et al., 1999).  Analysis of the idiotypes produced in response to HKSP 
immunization demonstrates that the high affinity T15+ is increased as much as 20-fold (2 
µg/ml to 40 µg/ml) following the second immunization in C57BL/6 mice (Ruppert et al., 
1980).  These studies suggest that the second immunizatio  enhances survival by 
increasing the percent of high affinity PC-specific antibody produced in C57BL/6 mice 
rather than increasing the total amount of PC-specific antibodies in the serum. 
 Previous experiments primarily concentrated on the effect of a single exposure of 
propanil on a primary antibody response.  Therefore, th  following experiments utilized a 
lethal challenge exposure model following a primary immunization.  A single primary 
immunization with HKSP was found to induce a suboptimal level of protection against a 
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 Six to eight week old C57Bl/6 female mice were purchased from Hill Top Lab 
Animals.  Mice were housed in microisolator cages in pathogen free conditions at West 
Virginia University’s animal facility.  Mice were kept on a 12 hr light-dark cycle and 
allowed to acclimate to the facility for 1 week.  These studies were conducted in 
accordance with all federal and institutional guidelines for animal use and were approved 
by the West Virginia University Institutional Animal Care and Use Committee. 
Reagents 
 Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem 
Service.   
Bacterial preparation 
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to 
mid-log phase in Todd-Hewitt broth + .05% yeast extract and stored at –80°C.  For 
immunization, stock was cultured in a candle jar for 18 hrs at 37°C on blood agar plates.  
A few characteristic colonies were selected and suspended in 200 ml Todd-Hewitt broth 
+ .05% yeast extract.  Bacteria were grown at 37°C to an absorbance reading at 650nm of 
0.4 and heat killed for 4 hours in a 60°C water bath.  A final concentration of 109 CFU/ml 
was established in PBS based on colony counts.  Sterility was confirmed by culture.  
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Heat-killed stock was stored at -20°C in 1 ml aliquots.  Mice were immunized ip with 
2x108 CFU. 
 S. pneumoniae strain D39, an encapsulated virulent strain from which R36a was 
derived, was grown on blood agar plates for 18 hr at 37°C.  A few colonies were added to 
Todd-Hewitt broth + 10% FBS and grown to mid-log phase (approximately 1x108 
CFU/ml).  Bacterial concentration was confirmed by plating.  Bacteria was stored in 10% 
glycerol at -80°C.  For lethal challenge, bacteria was thawed, washed in PBS, and 
resuspended at the appropriate concentration (approximately 2x107 CFU/ml).   
Animal exposures 
Propanil was dissolved in peanut oil for a final con entration of 15 mg/ml for all 
experiments.  Mice (4-8/group) were treated ip with e er 150 mg of propanil/kg of body 
weight (mg/kg) or vehicle on the same day as immunization.  On day 7, mice were 
challenged either ip or iv with D39.  Survival was monitored for 7 days, at which time the 
experiment was terminated.  An LD50 dose of S. pneumoniae was experimentally 
determined prior to these studies.   
 
RESULTS 
IP injected oil enhances survival to a lethal challenge to D39. 
 To determine if ip injection of the vehicle affects survival against a lethal 
challenge of S. pneumoniae, 3 groups of mice were vaccinated ip with HKSP andtreated 
with saline, vehicle or propanil.  Immunized mice tr ated with either vehicle or propanil 
had an increased survival rate (60%) compared to immunized alone animals only 
immunized with HKSP (0%) (Figure 1).  It is possible that oil may increase survival by 
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inducing a general inflammatory reaction.  Previous research demonstrated that ip oil 
exposure increases the number of inflammatory cellsin the spleen (data not shown).  
These data suggest that interpretations from studies using an ip challenge model is 
complicated by the effects of the vehicle.   
IP injected oil does not affect survival to an iv D39 challenge. 
 The previous experiment demonstrated that evaluation of the effects of propanil 
on survival to a lethal challenge requires altering the route of exposure to the virulent 
bacteria.  Previous studies have shown that ip and iv routes of challenge have 
approximately the same degree of virulence (Briles et al., 1992).  Mice were treated with 
or without the vehicle, immunized ip with HKSP and challenged iv with virulent S. 
pneumoniae.  Survival of immunized animals was not affected by ip vehicle treatment 
(Figure 2). Therefore, the iv route of challenge was chosen for future experimentation. 
Propanil treatment does not increase survival in suboptimally immunized mice. 
 To determine if the increased number of PC-specific ASC induced by propanil 
affects survival, vaccinated mice were treated with propanil or vehicle and challenged 
with 2x106 CFU of D39 on day 7.  Results were compared to naïve nimals treated with 
propanil or vehicle.  The CFU of D39 used was determined to be a LD50 in HKSP 
vaccinated mice.  Immunization with HKSP did not consistently increase survival 
compared to naïve animals (Figures 3A and 3B).  In addition, propanil exposure in naïve 
animals did not affect survival compared to vehicle treated naïve animals (Figure 3A).  
Finally, propanil-treatment did not increase survival n immunized mice compared to 




 These experiments begin to address the significance of the increased number of 
PC-specific ASC in the spleen.  The experiments also ddress the question of whether 
antibody serum titers or ASC in the spleen are more important for virulent bacterial 
challenges.  These results demonstrate that one vaccination of HKSP is not sufficient to 
increase survival to a lethal challenge.  Furthermore, propanil was not able to enhance 
survival following a suboptimal immunization.   
As previously mentioned, a second immunization with HKSP increases the 
percent of T15+ antibodies in the serum.  The inability to protect mice following one 
HKSP injection is likely due to the relatively low concentration of T15+ antibodies.  
Previous reports have shown that T15+ idiotype antibodies are more effective at 
protecting against a lethal challenge than other idiotypes produced to PC (Nicoletti e  al., 
1993; Briles et al., 1982a; Briles et al., 1984).  Experiments have shown that passive 
immunization with T15+ antibodies increases protection from a lethal ip S. neumoniae 
challenge in a dose dependent fashion (Briles et al., 1982a).  Given the importance of 
T15+ antibodies for protection, future experiments should evaluate the effect of propanil 
on PC-specific idiotypes in both the spleen and serum. 
 Alternative strategies to examine the effect of prpanil on mortality include 
studying the effect of propanil on a secondary immunization.  Our previous results 
demonstrate that propanil treatment at the time of the second immunization results in an 
increased PC-specific ASC response in the spleen.  Challenging propanil and vehicle- 
treated mice that have been immunized twice would determine if propanil increases 
survival following an optimal immunization.   
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 Altogether, this data begins to address relevance of an increased local antibody 
response in resolving a virulent challenge.  Immunization with an alternative antigen that 
may increase serum titers such as PC-Ficoll or PC-KLH would be valuable in exploring 
the necessity of a corresponding increase in serum titers.  In addition, passive 
immunization with pooled antibody collected from ex vivo splenic cultures from 
propanil-treated animals would determine the efficacy of the antibodies produced from 
the amplified response.  Altogether, these studies support previous reports demonstrating 
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Figure 1.  IP oil injection increases survival to a lethal ip S. pneumoniae challenge.   
Female C57BL/6 mice (5-7/group) were immunized ip wth 2x108 CFU HKSP and 
treated ip with saline, 150 mg/kg propanil or vehicle.  Mice were challenged ip with a 





































Figure 2.  IP oil injection does not affect survival to a lethal iv S. pneumoniae 
challenge.   
Female C57BL/6 mice (5/group) were immunized ip with 2x108 CFU HKSP and treated 
ip with saline or vehicle.  Mice were challenged iv with a 2x106 CFU D39 S. pneumoniae 



























































Figure 3.  Propanil exposure does not increase survival to a lethal challenge 
following a suboptimal immunization.   
(A) Female C57BL/6 mice (4-8/group) were immunized ip with 2x108 CFU HKSP or 
saline and treated ip with 150 mg/kg propanil or vehicl .  Mice were challenged iv with a 
2x106 CFU D39 S. pneumoniae on day 7.  (A) Values represent the percent of surviving 
mice.  (B) Values represent the number of surviving mice. 
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CHAPTER 7: GENERAL DISCUSSION 
Objective 
These studies were designed to 1) examine the effect of an exposure to a mixture 
of herbicides on the humoral response utilizing the HKSP immunization model, 2) 
determine the mechanism regulating the propanil-induce  enhancement of the PC-
specific response induced by propanil, and 3) determin  if propanil acts as an adjuvant 
that enhances the efficacy of an immunization.   
Endocrine regulation of the humoral response 
 Propanil was found to require ovarian steroid synthesis to enhance the PC-specific 
response following HKSP immunization.  However, the data demonstrates that propanil 
enhances the humoral response independent of an estrog nic mechanism.  In addition, 
evidence was presented suggesting that progesterone is not involved in the increased 
response.  Castration of male mice did not affect the propanil-induced response in male 
mice, suggesting an androgenic independent mechanism.  This data eliminates the vast 
majority of published mechanisms by which the gonads directly regulate the antibody 
response.   
 A valid hypothesis must account for the two primary observations: 1) the ovaries 
are required for enhancement, and 2) the testes are not r quired.  These observations 
suggest that the unknown factor produced by the ovaries required for antibody 
enhancement is also produced outside of the male gonads, assuming a similar mechanism 
for antibody enhancement in male and females.  There are two hypotheses that may 
explain the data.  1) Propanil exposure induces the ovaries to produce or suppress 
protein(s) with a novel function that stimulates the antibody response.  The site of protein 
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synthesis in males is outside of the gonads.  2) Alternatively, when mice are 
ovariectomized or steroid synthesis is inhibited, this disrupts local splenic hormone 
regulation.  Propanil may act directly on the splenic hormones.  However, disruption of 
ovarian regulation interferes with the ability of the spleen to respond to propanil.  Both 
hypotheses represent novel roles for the ovarian regulation of the humoral immune 
response. 
 The first hypothesis suggests that propanil exposure alters ovarian function either 
directly or indirectly.  There are several difficulties with this hypothesis.  Presently, the 
existing literature has not characterized a protein or hormone associated with ovarian 
regulation of the antibody response that induces a similar response as observed in the 
propanil exposure model.  Identification of the responsible protein(s) will be difficult 
since there is not a small group of likely candidates and detection would require a large 
screen of proteins and mRNA via such techniques such as proteomics and RNA 
microarrays.  Additionally, the data indicates that the protein(s) would be synthesized 
independent of the testes in males.  Locating the responsible protein in males would be 
more difficult since a target site has not been idetifi d. 
 The second hypothesis proposes that propanil affects the local endocrine-
regulated genes in the spleen.  As mentioned in Chapter 5, the spleen contains a number 
of sex hormone mRNAs as well as sex hormone receptor mRNAs and steroidogenic 
enzymes.  The ovaries and testes contribute to regulation of these hormones, receptors, 
and enzymes (Samy et al., 2001; Jacobson et al., 1998; Jacobson et al., 1999).  Notably, 
the ovaries and testes differentially regulate these local endocrine systems.  The 
significance of global hormones on the immune respon e is well established.  However, 
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the impact of local production of endocrine mediators in the spleen and lymphocytes is 
poorly understood.  It is possible that propanil does not affect ovarian function, but 
instead exerts its effects on the spleen.  Removal of the ovaries may disrupt local splenic 
hormone production, thereby preventing “normal” enhancement of the antibody response 
by propanil.  Addition of the ovarian hormones such as E2 and progesterone to OVX 
mice prior to propanil exposure would address whether e ovarian hormones act in a 
supplementary fashion.  Although E2 treatments in OVX mice did not restore the 
enhanced response following propanil exposure, studies suggest that both progesterone 
and E2 are required for accurate mimicry of ovarian hormone production.  For example, 
complete GNRH and LH feedback regulation in OVX mice requires both progesterone 
and E2 (Dalkin et al., 1990).  Failure of E2 and progesterone supplements in OVX mice 
to restore the propanil enhancement of the antibody response would suggest that propanil 
is exerting its effect on the ovaries and not the spl en.   
 The results gathered by testing either one of these ypotheses would yield novel 
findings.  Since the discovery of endocrine-related hormones and receptors in lymphoid 
organs, their function is largely unknown.  Propanil could be used as a model reagent to 
study these locally produced hormones and their contribution to immune regulation.  
Alternatively, discovery of a novel protein or a novel function of an ovarian protein could 
lead to a number of studies elaborating the role of this protein in normal immune function 
and disease. 
Immune mediators of the enhanced humoral response 
 Although it is known that the ovaries are required for the enhanced humoral 
response, the role of lymphocytes and costimulating molecules is unknown.  As 
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mentioned in the General Introduction, there are a number of ways the PC-specific 
antibody response is enhanced.  Both the innate and the adaptive immune system regulate 
the antibody response.  Complement receptors enhance the antibody response by 
lowering the activation requirements of the B cell.  APC such as FDC also enhance the 
antibody response via a CR2 dependent mechanism.  As discussed in Chapter 4, propanil 
is not able to enhance the antibody response to a suboptimal immunization.  In addition, 
affinity analysis suggests that lower affinity PC-specific B cells are not increased.  This 
data suggests that a complement-mediated mechanism does not contribute to the 
enhanced response.   
 Other innate immune mechanisms such as MZ macrophages, cytokines and TLR 
regulate the TI-2 response via different mechanisms.  MZ macrophages negatively 
regulate the PC-specific response.  The data indicates that propanil did not affect the 
number of splenic macrophages.  However, measurements of the MZ subpopulation was 
not performed, therefore this mechanism cannot be eliminated.  Cytokines are important 
for early isotype switching.  Since both the IgG isotypes and IgM are increased equally 
following propanil exposure, enhanced isotype switching is not likely to be responsible 
for the enhanced response.  The available literature has shown that TLR stimulation 
increases the PC-specific response in a dissimilar anner compared to propanil exposure.  
However, TLR9 stimulation enhances polysaccharide specific antibody titers (Sen et al., 
2006).  As previously shown, propanil does not enhance antibody titers.  Furthermore, 
propanil enhancement of the number of splenic ASC is not further increased at later time 
points.  Altogether, the data does not strongly indicate a specific innate immune 
mechanism for enhanced TI-2 responses following propanil exposure.   
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 T cells possess a number of costimulating molecules that enhance the TI-2 
antibody response.  The inability of propanil to enha ce the PC-KLH response on day 7 
and the inability of a day 0 propanil-treatment to enhance the PC-specific response on 
day 3 suggests a role for T cells in the enhanced response.  A direct method for 
evaluating the role of T cells is T cell deletion studies.  As mentioned previously in the 
Discussion of Chapter 4, T cells are not required for normal PC-specific responses after 4 
days.  It has also been shown that delayed propanil exposure enhances the PC-specific 
response similarly to simultaneous vaccination and propanil treatment.  Conflicting 
reports present evidence for a necessity of either CD4+or CD8+ T cells in PC antibody 
responses (Wu et al., 2002; Kobrynski et al., 2005).  An initial study could employ an 
anti-CD8, anti-CD4, or an anti-CD3 antibody on day 4 following HKSP immunization.  
Mice could then be exposed to propanil to determine the necessity of the different 
subpopulations of T cells in the amplified PC-response.   
 A possible mechanism for T cell mediated enhancement of the antibody response 
in propanil-treated mice is via a CD40 dependent pathw y.  As mentioned in the General 
Introduction, anti-CD40 treatment enhances the TI-2antibody response with similar 
kinetics (Garcia et al., 1999a).  In addition, CD40 ligation is also important for TD 
responses.  The number of TI-2 antigen-specific ASC is not increased until day 6 
following anti-CD40 treatment (Garcia et al., 1999a).  Immunohistochemistry analysis 
suggests that the increase is the result of extended rounds of proliferation rather than an 
increase in recruitment of low affinity B cells to the response (Garcia et al., 1999a).  In 
addition, splenomegaly is observed in anti-CD40 treated animals with similar kinetics 
seen in propanil treated mice (Garcia et al., 1999a).  The splenomegaly observed in the 
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anti-CD40 treated animals are the result of an increase in white pulp and IgD+ cells 
(Garcia et al., 1999a).  Propanil treatment is hypothesized to increase splenomegaly via 
an influx in undifferentiated cells (de la Rosa, dissertation).  Another discrepancy 
between the two treatments is the predominant IgG1 and IgG3 increase in anti-CD40 
treated mice (Garcia et al., 1999a).  However, IgM was not measured in this repo t, 
making conclusions about the effects on isotype switching difficult.  Altogether, these 
similarities in responses suggest a plausible T cell dependent mechanism to enhance the 
TI-2 response.  However, a CD40 mechanism could stil  be plausible if T cells are not 
involved in the enhanced response.  Some studies have shown a T cell independent 
source for CD40L ligation (Grammer t al., 1999).   
 Studies exploring the immunological regulation of the antibody response may also 
aid in determining the mechanism for ovarian regulation by narrowing the search for 
enzyme or hormone mRNA.  Identification of the affected immune cells important for the 
antibody enhancement will aid in a more precise analysis of the kinetics of activation of 
individual cells.  Understanding the exact time of activation will further narrow the range 
of time for the mechanism of endocrine mechanism.  Using both endocrine directed and 
immunological approaches will be necessary for effici nt identification of the 
mechanisms involved. 
Proliferation vs. polyclonal activation of B cells 
 Three primary methods for amplifying the number of ASC is by increasing the 
proliferation of activated B cells, by increasing the number of B cells recruited activated 
in the response, or increased differentiation.  The evidence presented in Chapters 3 and 4 
suggest that polyclonal activation is not the mechanism by which propanil enhances the 
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number of ASC.  Polyclonal activation is characteriz d by increased lower affinity B 
cells, increased number of nonspecific antibodies, and increased recruitment of B cells 
into the follicles and red pulp of the spleen.  An increase in proliferation is characterized 
by extended rounds of division, which leads to more B cells derived from the same 
progenitor cell.  This results in an increased number of ASC with identical affinity and 
isotype.  The third method for increasing the number of ASC is increased differentiation.  
This mechanism would suggest an increase in switching.  Since all the predominant IgG 
isotypes are enhanced equally and IgM is also enhanced similarly to the IgG isotypes, 
this indicates that increased switching is not respon ible for the increase in ASC.  
 Although our data suggests an increase in proliferat on rather than polyclonal 
activation or increased differentiation, more specific experiments are necessary for a 
more definitive conclusion.  More precise affinity analysis could be conducted using 
idiotype analysis since the affinities of the various idiotypes are known.  Identifying the 
number of T15 and M167 idiotypes in propanil and vehicl -treated animals is another 
way of conducting affinity analysis.  Determining if propanil increases the number of 
T15+ B cells similarly as other idiotypes will provide information on the polyclonal 
activation.  In addition, T15 and M167 analysis provides information on the contribution 
of B1 B cells and MZ B cells since T15 plasma cells are predominantly derived from B1 
cells and M167 are predominantly MZ B cells (Martin et al., 2001).  Finally, 
incorporating immunohistochemistry data and BrdU assay  would provide information 
on the proliferation and recruitment of B cells into the antibody response.  These studies 
would provide a more definitive assessment of polycl nal and proliferative activity 
following propanil exposure.  In addition, determining the method of enhancement would 
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aid future experiments studying the immunological and endocrine mechanisms regulating 
the response. 
Correlating serum antibody titers with ASC responses 
 An important question remaining from Chapters 3 and 4 is the lack of increased 
titers despite a several fold increase in the number of splenic ASC.  Addressing this issue 
is important for future studies examining the effect of propanil exposure on a virulent 
challenge.  The x vivo antibody production from spleens of propanil-treated animals 
suggests that the increased number of splenic ASC produce antibodies normally.  In 
addition, BM ASC were also demonstrated to contribue to the serum titers.  However, 
splenic ASC in propanil-treated animals do not migrate to the BM in greater numbers. 
One explanation for the lack of increased titers could be that plasma cells from the spleen 
must migrate and survive in the BM in greater numbers to produce an increase in serum 
titers.   
 There are several possibilities for a lack of increased BM ASC in propanil-treated 
animals.  The plasma cells may fail to migrate from the spleen to the BM.  Alternatively, 
the BM may be unable to support the increased number of ASC.  In order to address the 
issue of migration in propanil-treated animals, analysis of apoptosis could be performed.  
Previous studies indicate that splenic ASC that do not migrate to the BM will undergo 
apoptosis (Smith et al., 1996).  To determine if the increased number of splenic ASC are 
migrating to the BM or undergoing apoptosis, annexi V staining could be performed in 
splenic plasma cells and measured by flow cytometry.  Increased levels of annexin 
expression from propanil-treated ASC compared to vehicle-treated animals would 
provide evidence suggesting that the increased ASC do not migrate in greater numbers 
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because the plasma cells undergo apoptosis.  To address the impact of splenic plasma cell 
migration to the BM on antibody titers, ex vivo production of antibodies could be 
measured from the BM, spleen and peripheral blood.  Comparing the quantity of antibody 
produced from ASC from each site would address the importance of successful migration 
of plasma cells from the spleen to the BM to could be measured. Splenic, BM and 
peripheral blood ASC could be cultured x vivo and the amount of antibody produced 
into the supernatant could be quantitated.  Directly comparing the amount of antibody 
produced by these three sources would provide evidence for or against the hypothesis that 
increased splenic ASC must migrate to the BM to increase serum titers.  Altogether, these 
experiments would provide experimental evidence to address the correlation between 
serum titers and BM and splenic ASC. 
The effect of propanil on a survival to a virulent S. pneumoniae challenge 
 Determining the effect of propanil exposure on the host’s mortality following 
virulent challenge is important for assessing the rel vance of the antibody enhancement 
model.  Several additional experiments would provide more conclusive results 
concerning propanil’s efficacy as an adjuvant.  As mentioned in Chapter 6 Introduction, 
the T15 response is strongly linked to effective clearance of virulent S. pneumoniae.  Two 
immunizations with HKSP are necessary for an optimal i munization.  In addition, the 
T15 response following one injection of HKSP in Balb/c mice is approximately the same 
as double immunization in C57BL/6 mice (Ruppert et al., 1980).   
 From this data, two experiments can be derived to evaluate the effect of propanil 
on an optimal immunization.  As demonstrated in Chapter 4, propanil enhances a 
secondary PC response to HKSP.  However, the effect o  propanil on the T15 idiotype 
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has not been determined in C57BL/6 mice.  C57BL/6 mice could be immunized twice 
with HKSP to elicit an optimum response.  Challenging mice treated with propanil during 
a secondary response would determine if propanil enhances the optimal response.  
Alternatively, Balb/c mice could be substituted forC57BL/6 mice in the protection 
experiments since propanil enhances the response in Balb/c mice similarly to C57BL/6 
mice (Schafer, personal communication).  From these exp riments, the protective effect 
of a propanil exposure on the optimal antibody respon e can be determined.  Combined 
with the suboptimal data and serum antibody analysis, these studies would provide the 
requisite information to draw conclusions about the rel vance of the enhanced splenic 
ASC response.   
2,4-D as a model to study plasma cell homing and survival 
 The experiments in Chapter 3 demonstrated that 2,4-D reduces both the number 
of ASC in the BM and serum antibody titers.  Although the mechanism is unknown as 
well as the antigen specificity of the effect, this di covery yielded a novel finding 
concerning the early importance of BM ASC to the prima y TI-2 serum titers.  Future 
studies could use 2,4-D as a model reagent to study BM plasma cells.  
 The mechanism regulating the 2,4-D induced decrease in BM ASC should be 
determined prior to employing 2,4-D as a model.  Possible mechanisms include 1) 
defective migration out of the spleen, 2) failure to home properly to the BM, or 3) 
inability to support plasma cells upon homing to the BM due to disruption of the BM 
microenvironment.  Upon establishing the mechanism of action, 2,4-D could then be used 
as a specific disruptor of long-lived BM plasma cells. 
Summary 
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 This dissertation presented findings that have implications for both the emerging 
studies of endocrine-mediated immune interactions and the field of endocrine disruption.  
As we begin to understand the purpose of the expression of endocrine-related genes in 
lymphocytes and lymphoid organs as well as the impact of these genes on basic immune 
function, new tools and models will be needed to address these basic questions.  The 
novel effect of enhancing the number of splenic ASC in conjunction with ovarian steroid 
synthesis may yield valuable insight into this emerging field.  Determining the 
mechanism by which propanil interacts with both the endocrine and immune system may 
not only yield new information into how these systems interact, but also, these 
experiments may reveal that propanil will serve as a u eful tool for studying other 
endocrine-immune interactions. 
 Secondly, endocrine disruption is of recent concer in the field of toxicology.  A 
large number of ubiquitously occurring compounds have the potential for endocrine 
disruption.  The impact of these newly discovered en ocrine disruptors on human health 
is currently being addressed.  However, given the promiscuous binding nature of the ER 
and the need for rapid, large-scale screening, moststudies have focused exclusively on 
evaluating the affinity of a chemical or compound to the ER.  Rapid, comprehensive 
examinations of other potential nonestrogenic effects of compounds on the endocrine 
system are absent in the field of toxicology.  Although propanil interacts with the 
endocrine system at high doses in our model, these exp riments may be useful in 
discovering alternative nonestrogenic mechanisms for chemicals to interact with the 
endocrine system.  Once the molecular targets are identified in this propanil exposure 
model, other chemicals could be rapidly screened for similar effects.  As demonstrated in 
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our model as well as others, endocrine disruption can affect a number of other biological 
systems in the host organism.  Given the impact of the endocrine system on the overall 
health of the organism as well as the dependence of the modern economy on the chemical 
industry, thorough evaluation of these compounds is necessary for sustained human and 
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